data_2lzy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lzy _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 CA-C-O 120.301 -0.166 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.04 164.95 21.27 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.495 0.318 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.97 129.91 34.76 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.65 41.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.385 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.88 157.13 17.08 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.446 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.5 16.38 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.173 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.29 -64.73 1.02 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.697 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.71 3.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.28 70.15 21.84 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.2 Cg_endo -93.28 170.99 2.1 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 123.225 2.617 . . . . 0.0 111.912 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.2 m -85.54 106.16 16.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.342 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.2 -40.57 1.52 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.341 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.18 -178.5 2.15 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.263 1.975 . . . . 0.0 111.45 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.55 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.67 55.16 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.649 2.233 . . . . 0.0 114.548 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.55 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.26 48.32 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.202 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.28 159.96 18.12 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.853 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.65 105.02 17.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.1 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.961 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.43 -51.28 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.268 -1.138 . . . . 0.0 113.71 -0.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 34.02 19.17 Favored Glycine 0 C--N 1.344 0.995 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.271 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.56 81.5 17.19 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.61 -33.63 2.85 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 125.293 -0.711 . . . . 0.0 112.792 -0.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.92 154.17 20.45 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.165 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.28 -166.79 14.15 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.806 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.522 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.44 154.38 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.14 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.858 0.361 . . . . 0.0 110.528 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -105.54 155.96 18.69 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.41 133.14 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.734 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.406 HD11 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.186 -0.912 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 CA-C-O 120.292 -0.171 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.14 165.03 21.19 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.506 0.322 . . . . 0.0 110.391 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.94 129.86 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.61 41.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.465 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.86 157.07 17.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.432 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.53 16.27 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.146 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.14 -64.61 1.03 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.76 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.76 3.38 0.47 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.22 70.15 21.24 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.28 170.9 2.11 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.16 2.573 . . . . 0.0 111.859 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.4 m -85.4 106.13 16.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.365 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.22 -40.48 1.51 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.381 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.23 -178.46 2.15 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.247 1.965 . . . . 0.0 111.466 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.55 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -65.6 55.08 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.723 2.282 . . . . 0.0 114.559 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.3 48.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.202 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 159.9 18.25 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.823 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.6 104.98 17.07 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.949 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -129.45 128.14 23.12 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.46 -51.27 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.57 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.664 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 34.03 19.04 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.28 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.53 81.52 17.28 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.74 2.81 Favored 'Cis proline' 0 C--N 1.373 1.847 0 C-N-CA 125.282 -0.716 . . . . 0.0 112.749 -0.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -88.75 154.09 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.216 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.523 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.29 -166.81 14.16 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.793 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.523 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.4 mm -133.36 154.36 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.13 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.825 0.345 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.58 155.93 18.73 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.218 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.45 133.12 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.332 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 CA-C-O 119.972 -0.349 . . . . 0.0 113.324 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -97.72 167.01 11.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.306 0.243 . . . . 0.0 110.574 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -82.78 137.16 34.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.393 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.92 124.19 38.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.69 156.93 17.3 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.357 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.45 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.164 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.82 -64.61 1.02 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.739 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.09 3.4 0.44 Allowed 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.3 70.3 22.25 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.79 170.14 2.4 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.202 2.601 . . . . 0.0 111.807 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 m -83.85 106.32 15.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.737 0.303 . . . . 0.0 110.479 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -79.71 -40.6 1.41 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.313 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.59 -178.23 2.18 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.206 1.937 . . . . 0.0 111.422 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.73 55.27 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.598 2.198 . . . . 0.0 114.515 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.89 156.18 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.247 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.3 160.02 18.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.813 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.51 105.2 17.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.007 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.9 22.73 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.061 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.69 -51.53 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.598 0 C-N-CA 124.28 -1.133 . . . . 0.0 113.695 -0.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.52 34.1 17.51 Favored Glycine 0 C--N 1.344 1.027 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.267 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.46 81.41 17.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.56 -33.88 2.76 Favored 'Cis proline' 0 C--N 1.37 1.709 0 C-N-CA 125.227 -0.739 . . . . 0.0 112.743 -0.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.53 154.06 20.65 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.22 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.22 -167.22 14.55 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.769 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 HD11 ' O ' ' A' ' 30' ' ' GLY . 13.3 mm -133.1 154.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' THR . 81.2 m -86.96 98.26 11.15 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.595 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.22 155.2 19.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.237 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.79 132.93 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.742 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.405 HD13 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.182 -0.914 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.531 0 CA-C-O 120.083 -0.287 . . . . 0.0 113.365 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -96.68 167.07 11.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.399 0.28 . . . . 0.0 110.597 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.59 137.49 34.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.477 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 p -126.93 124.56 39.79 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.448 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -102.61 156.49 17.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.413 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.62 15.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.04 -64.44 1.04 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.72 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.433 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.1 2.93 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.46 70.28 23.92 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.2 Cg_endo -92.65 169.89 2.5 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.128 2.552 . . . . 0.0 111.784 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.2 m -82.11 105.94 13.62 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.5 m -79.39 -40.59 1.48 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.293 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.12 -178.12 2.32 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.257 1.971 . . . . 0.0 111.41 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.545 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -66.0 55.43 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.634 2.223 . . . . 0.0 114.436 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.545 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.01 156.09 48.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.23 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.02 159.84 18.06 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.795 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.44 105.25 17.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.92 22.74 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.022 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.66 -51.67 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 124.252 -1.145 . . . . 0.0 113.667 -0.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.56 34.41 16.45 Favored Glycine 0 C--N 1.344 1.014 0 C-N-CA 121.435 -0.412 . . . . 0.0 113.196 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.27 81.25 18.33 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.96 2.73 Favored 'Cis proline' 0 C--N 1.373 1.852 0 C-N-CA 125.174 -0.761 . . . . 0.0 112.794 -0.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.2 154.0 20.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -151.11 -167.05 14.32 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.819 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 30' ' ' GLY . 12.8 mm -132.98 153.91 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 22' ' ' THR . 90.5 m -86.83 98.33 11.13 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.59 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.31 155.14 19.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.27 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.75 132.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.772 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.406 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.358 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 CA-C-O 120.293 -0.171 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.16 165.11 21.05 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.52 0.328 . . . . 0.0 110.397 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.98 129.98 34.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.01 123.8 41.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.329 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.75 156.89 17.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 15.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.135 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.09 -64.69 1.01 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.743 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.22 0.46 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.2 70.27 21.21 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.9 Cg_endo -93.27 170.89 2.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.164 2.576 . . . . 0.0 111.816 178.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 m -84.89 105.98 16.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.707 0.289 . . . . 0.0 110.341 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.1 -40.52 1.54 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.378 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.21 -178.48 2.16 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.254 1.969 . . . . 0.0 111.495 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.55 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.74 55.13 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.672 2.248 . . . . 0.0 114.51 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.55 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.84 156.2 48.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.245 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.553 ' HG1' ' N ' ' A' ' 23' ' ' CYS . 6.2 t -112.18 159.84 18.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' N ' ' HG1' ' A' ' 22' ' ' THR . 5.2 t -98.61 104.95 17.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.48 128.1 23.1 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.45 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.561 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.669 -0.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 33.89 19.44 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 121.39 -0.433 . . . . 0.0 113.285 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.34 81.5 17.82 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.65 -33.64 2.84 Favored 'Cis proline' 0 C--N 1.372 1.792 0 C-N-CA 125.311 -0.704 . . . . 0.0 112.775 -0.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -88.83 154.11 20.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.203 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.3 -166.67 14.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.841 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.7 mm -133.39 154.34 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.12 98.58 11.37 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 120.836 0.35 . . . . 0.0 110.568 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.63 155.84 18.84 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 133.25 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.68 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.331 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 CA-C-O 120.227 -0.207 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -130.47 166.81 19.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.419 0.288 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.33 130.99 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.789 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.76 123.36 40.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.207 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.41 17.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.49 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.31 15.78 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.146 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.08 -65.09 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.08 1.64 0.41 Allowed 'General case' 0 C--N 1.349 0.568 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -118.64 73.71 11.6 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.51 170.34 2.07 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.241 2.628 . . . . 0.0 111.945 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.7 m -81.71 119.57 24.01 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.639 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -84.94 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.91 -179.82 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.537 ' O ' HD12 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.02 62.44 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.622 2.215 . . . . 0.0 114.05 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.73 158.35 44.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.336 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.51 159.71 19.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.699 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.48 104.66 16.72 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.89 127.92 23.42 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.904 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.43 -51.13 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.564 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.632 -0.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.58 34.03 20.55 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.279 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.25 81.16 18.52 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.66 -33.76 2.79 Favored 'Cis proline' 0 C--N 1.372 1.803 0 C-N-CA 125.29 -0.712 . . . . 0.0 112.854 -0.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.92 153.48 21.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.193 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.35 -167.04 14.41 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.85 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.13 154.06 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.6 m -87.29 99.07 11.7 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.64 155.52 19.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.3 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 132.94 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.351 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 CA-C-O 120.217 -0.213 . . . . 0.0 113.216 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -130.39 166.77 19.76 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 122.398 0.279 . . . . 0.0 110.404 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.33 130.98 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.752 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -123.76 123.21 40.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.268 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.45 156.47 17.58 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.38 15.8 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.191 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.03 -65.07 0.98 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.804 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.42 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.15 1.77 0.41 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.8 73.54 11.96 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.4 Cg_endo -93.43 170.29 2.1 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 123.226 2.618 . . . . 0.0 111.889 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -81.7 119.58 24.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.639 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.2 p -85.09 -36.29 0.57 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.86 5.66 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.214 1.943 . . . . 0.0 111.463 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.537 ' O ' HD12 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.99 62.47 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.584 2.19 . . . . 0.0 113.972 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.83 158.33 44.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.256 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.46 159.73 19.2 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.717 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.44 104.59 16.64 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.87 127.89 23.43 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.42 -51.03 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.208 -1.164 . . . . 0.0 113.67 -0.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.05 21.05 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 121.449 -0.405 . . . . 0.0 113.298 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.28 81.11 18.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.75 2.78 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 125.259 -0.725 . . . . 0.0 112.858 -0.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.91 153.46 21.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.208 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.35 -166.94 14.31 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.828 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.517 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.1 mm -133.16 154.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.2 98.99 11.62 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.854 0.359 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.64 155.45 19.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.408 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.15 132.92 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.308 -179.863 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.489 0 CA-C-O 120.086 -0.285 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -97.82 167.04 11.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.435 0.294 . . . . 0.0 110.548 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.6 137.29 34.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.448 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 p -126.97 124.29 39.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.58 156.78 17.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.349 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.59 15.33 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.191 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.53 -64.53 1.03 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.745 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.434 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.03 3.22 0.44 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.38 70.29 23.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.76 170.16 2.41 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.137 2.558 . . . . 0.0 111.818 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -83.22 106.1 14.73 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.745 0.307 . . . . 0.0 110.517 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -79.48 -40.65 1.46 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.251 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.85 -178.18 2.26 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.243 1.962 . . . . 0.0 111.376 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.0 Cg_exo -65.82 55.24 0.35 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.68 2.254 . . . . 0.0 114.47 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.86 156.0 48.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.28 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.03 160.0 17.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.49 105.14 17.25 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -130.06 127.94 22.74 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.57 -51.58 0.16 OUTLIER 'Cis proline' 0 C--N 1.369 1.618 0 C-N-CA 124.245 -1.148 . . . . 0.0 113.695 -0.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.45 34.33 17.03 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 121.44 -0.41 . . . . 0.0 113.231 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.48 81.34 17.62 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.544 0.172 . . . . 0.0 111.444 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.54 -33.89 2.76 Favored 'Cis proline' 0 C--N 1.373 1.835 0 C-N-CA 125.258 -0.726 . . . . 0.0 112.807 -0.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.46 154.02 20.7 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.187 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -151.14 -167.25 14.54 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.756 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 30' ' ' GLY . 13.1 mm -133.03 154.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 22' ' ' THR . 85.0 m -86.93 98.23 11.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.933 0.397 . . . . 0.0 110.581 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -105.23 155.14 19.34 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.277 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.65 132.84 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.776 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.402 HD13 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.333 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.45 0 CA-C-O 120.241 -0.199 . . . . 0.0 113.101 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.4 166.81 19.67 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.481 0.312 . . . . 0.0 110.393 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.32 131.07 35.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.699 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.87 123.47 40.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.206 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.49 156.46 17.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.519 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.34 15.61 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.143 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 -65.12 0.98 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.735 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.14 1.74 0.41 Allowed 'General case' 0 C--N 1.349 0.581 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.55 73.74 11.34 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.4 Cg_endo -93.58 170.34 2.04 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 123.227 2.618 . . . . 0.0 111.88 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 m -81.6 119.53 23.9 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.642 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.86 -36.42 0.58 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.83 5.63 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.135 1.89 . . . . 0.0 111.534 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.537 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.07 62.62 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.591 2.194 . . . . 0.0 114.058 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.89 158.36 44.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.241 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.53 159.63 19.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.805 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.38 104.55 16.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.0 mt -128.93 127.95 23.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.946 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.48 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.22 -1.158 . . . . 0.0 113.647 -0.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.54 34.06 20.59 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.486 -0.388 . . . . 0.0 113.193 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.12 81.0 19.14 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.79 -33.77 2.76 Favored 'Cis proline' 0 C--N 1.372 1.794 0 C-N-CA 125.225 -0.739 . . . . 0.0 112.833 -0.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.88 153.55 21.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.38 -166.91 14.3 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.877 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.14 154.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.1 m -87.29 99.04 11.68 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.828 0.346 . . . . 0.0 110.61 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 155.46 19.65 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.93 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.788 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.307 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.547 0 CA-C-O 120.143 -0.254 . . . . 0.0 113.128 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -129.67 166.49 19.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.432 0.293 . . . . 0.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -79.99 132.96 36.12 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.807 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.25 123.64 39.96 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.258 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.48 156.37 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.508 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.28 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.88 -65.16 0.98 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.09 1.57 0.41 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.48 73.8 11.16 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.2 Cg_endo -93.51 170.29 2.07 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.272 2.648 . . . . 0.0 111.883 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -81.31 119.56 23.82 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.3 p -84.88 -36.56 0.58 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.96 5.74 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.142 1.894 . . . . 0.0 111.552 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.537 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.95 62.76 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.587 2.191 . . . . 0.0 113.996 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.93 158.58 43.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.65 159.66 19.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.785 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.47 104.59 16.64 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.81 128.02 23.46 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.996 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.45 -50.99 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.573 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.694 -0.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.45 34.05 20.91 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.21 81.15 18.66 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.71 -33.86 2.74 Favored 'Cis proline' 0 C--N 1.371 1.741 0 C-N-CA 125.243 -0.732 . . . . 0.0 112.768 -0.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.96 153.51 21.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.518 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.23 -166.94 14.27 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.864 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.518 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.21 154.2 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.31 99.15 11.76 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.859 0.361 . . . . 0.0 110.585 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.01 155.47 19.77 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.373 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.17 132.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.777 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.404 HD11 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.292 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 CA-C-O 120.266 -0.185 . . . . 0.0 113.184 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 166.82 19.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.433 0.293 . . . . 0.0 110.434 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.34 131.18 35.59 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.726 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.86 123.54 40.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.243 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.41 17.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.483 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.42 15.53 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.239 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.64 -64.91 1.0 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.773 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.37 1.66 0.39 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.5 73.81 11.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.4 Cg_endo -93.48 170.5 2.07 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.21 2.607 . . . . 0.0 111.877 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 m -81.51 119.47 23.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.644 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.4 p -84.79 -36.48 0.59 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.644 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 Cg_endo -79.99 -179.9 5.67 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.172 1.915 . . . . 0.0 111.499 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.538 ' O ' HD12 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.05 62.79 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.565 2.177 . . . . 0.0 114.051 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.92 158.45 44.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.302 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.56 159.62 19.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.782 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.47 104.58 16.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.77 128.0 23.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.36 -51.09 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.523 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.716 -0.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.57 34.02 20.61 Favored Glycine 0 C--N 1.345 1.041 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.27 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.21 81.0 18.87 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.82 -33.8 2.74 Favored 'Cis proline' 0 C--N 1.373 1.823 0 C-N-CA 125.272 -0.72 . . . . 0.0 112.823 -0.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -87.88 153.62 21.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.203 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.39 -166.96 14.34 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.829 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 154.02 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.6 m -87.2 99.16 11.75 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.859 0.361 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.86 155.6 19.57 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.24 133.0 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.4 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.325 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 CA-C-O 120.211 -0.216 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -129.73 166.59 19.55 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.456 0.302 . . . . 0.0 110.381 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -80.04 132.99 36.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.758 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.42 123.67 39.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.242 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.33 17.66 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.525 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.32 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.214 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.69 -65.15 0.98 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.763 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t80 -151.22 1.69 0.41 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.5 73.82 11.25 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.47 170.48 2.07 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.254 2.636 . . . . 0.0 111.952 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.9 m -81.39 119.49 23.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.647 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.0 p -84.66 -36.68 0.6 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.647 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.96 -179.95 5.72 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.117 1.878 . . . . 0.0 111.456 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.539 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.7 Cg_exo -64.91 62.72 0.29 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.62 2.213 . . . . 0.0 114.018 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.9 158.64 43.74 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.331 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.71 159.66 19.47 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.708 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.49 104.47 16.51 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.75 128.02 23.49 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.988 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.38 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.583 0 C-N-CA 124.195 -1.169 . . . . 0.0 113.717 -0.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 33.96 20.8 Favored Glycine 0 C--N 1.345 1.032 0 C-N-CA 121.469 -0.396 . . . . 0.0 113.251 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -140.22 81.07 18.74 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.66 -33.9 2.73 Favored 'Cis proline' 0 C--N 1.372 1.811 0 C-N-CA 125.267 -0.722 . . . . 0.0 112.833 -0.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -87.93 153.63 21.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.24 -167.06 14.39 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.9 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.22 154.24 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.8 m -87.34 99.27 11.86 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.607 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.05 155.45 19.82 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.353 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.11 132.89 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.708 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.401 HD13 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.449 0 CA-C-O 120.3 -0.166 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.38 164.89 20.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.446 0.298 . . . . 0.0 110.302 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.7 131.92 35.51 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.588 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.27 123.82 41.07 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.365 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.67 156.77 17.29 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.475 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.68 16.61 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.226 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.2 -64.54 1.03 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.712 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.434 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.83 3.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.18 70.64 21.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.3 171.32 2.06 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.201 2.6 . . . . 0.0 111.892 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.37 105.98 15.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.768 0.318 . . . . 0.0 110.301 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 63.6 m -78.91 -39.89 1.54 Allowed Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.562 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.5 Cg_exo -71.5 -179.65 3.86 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.193 1.929 . . . . 0.0 111.176 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.554 ' O ' HD12 ' A' ' 21' ' ' LEU . 35.8 Cg_endo -64.64 56.41 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.354 2.036 . . . . 0.0 114.83 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.03 156.47 48.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.106 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.28 159.75 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.767 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.1 t -98.65 104.8 16.87 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.3 128.01 23.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.944 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.5 -51.35 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.556 0 C-N-CA 124.221 -1.158 . . . . 0.0 113.743 -0.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.27 33.9 18.83 Favored Glycine 0 C--N 1.345 1.047 0 C-N-CA 121.358 -0.448 . . . . 0.0 113.197 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.5 81.64 17.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.48 -33.7 2.84 Favored 'Cis proline' 0 C--N 1.372 1.779 0 C-N-CA 125.271 -0.721 . . . . 0.0 112.837 -0.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.91 154.24 20.4 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.523 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.21 -166.7 14.04 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.523 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.43 154.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 22' ' ' THR . 76.4 m -87.24 98.77 11.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.881 0.372 . . . . 0.0 110.57 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 153.46 22.02 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.211 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.5 tt -94.65 134.45 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.709 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.278 -179.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 CA-C-O 120.329 -0.151 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -129.25 162.44 27.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.527 0.331 . . . . 0.0 110.245 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -79.85 130.44 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.446 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 124.33 42.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.464 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.97 157.12 17.09 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.44 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.71 18.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.22 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.53 -64.51 1.06 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.782 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.437 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.39 0.46 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.14 70.34 20.63 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.53 171.25 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 123.209 2.606 . . . . 0.0 111.991 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.41 106.17 17.25 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.317 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.4 m -79.29 -40.38 1.48 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.392 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.94 -178.58 2.09 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.248 1.965 . . . . 0.0 111.488 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.551 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.3 Cg_exo -65.63 55.26 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.648 2.232 . . . . 0.0 114.567 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.551 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.83 156.34 48.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.218 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.38 160.04 18.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.4 t -98.74 105.09 17.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -129.56 128.23 23.07 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.016 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.32 -51.15 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.53 0 C-N-CA 124.295 -1.127 . . . . 0.0 113.722 -0.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 33.86 19.61 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.77 81.75 16.34 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -33.63 2.88 Favored 'Cis proline' 0 C--N 1.373 1.826 0 C-N-CA 125.326 -0.698 . . . . 0.0 112.864 -0.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -89.19 154.29 20.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.241 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.524 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.27 -166.66 14.02 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.848 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.524 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.71 154.74 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 22' ' ' THR . 70.9 m -87.12 98.54 11.35 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.812 0.339 . . . . 0.0 110.57 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -105.65 156.14 18.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.273 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.56 133.29 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.721 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.365 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.47 0 CA-C-O 120.18 -0.234 . . . . 0.0 113.157 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -129.26 166.6 19.11 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.422 0.289 . . . . 0.0 110.331 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.13 132.93 36.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.835 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.08 123.48 39.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.238 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.44 15.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.176 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.68 -64.96 0.99 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.4 1.59 0.39 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.46 73.82 11.12 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.3 Cg_endo -93.54 170.19 2.07 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.191 2.594 . . . . 0.0 111.85 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 m -81.29 119.31 23.48 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.642 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.5 p -84.88 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -80.0 -179.84 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.076 1.851 . . . . 0.0 111.519 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.54 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.66 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.57 2.18 . . . . 0.0 113.98 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.54 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.94 158.56 43.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.62 159.75 19.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.701 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.6 104.58 16.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.986 0.422 . . . . 0.0 110.862 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.84 127.85 23.44 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.059 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.52 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.549 0 C-N-CA 124.205 -1.165 . . . . 0.0 113.626 -0.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.5 33.98 20.94 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.229 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.38 81.15 18.15 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.69 -33.87 2.73 Favored 'Cis proline' 0 C--N 1.372 1.813 0 C-N-CA 125.275 -0.719 . . . . 0.0 112.803 -0.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -88.09 153.61 21.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -151.34 -167.07 14.44 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.851 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.17 154.1 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.5 m -87.18 99.21 11.77 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.759 0.314 . . . . 0.0 110.593 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -106.94 155.42 19.8 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.361 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.11 132.83 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.77 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.402 HD13 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.156 -0.925 . . . . 0.0 111.307 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.464 0 CA-C-O 120.2 -0.222 . . . . 0.0 113.183 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -129.46 166.46 19.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 122.381 0.272 . . . . 0.0 110.345 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -80.15 132.93 36.01 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.723 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.97 123.26 39.5 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.203 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.35 156.1 17.81 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.486 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.82 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.138 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -97.97 -65.02 0.99 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.71 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.66 1.51 0.37 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.23 73.95 10.5 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.7 Cg_endo -93.57 170.24 2.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.278 2.652 . . . . 0.0 111.946 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -81.44 119.42 23.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.64 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.02 -36.43 0.57 Allowed Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.64 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.92 -179.8 5.6 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.181 1.921 . . . . 0.0 111.431 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.538 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.0 62.37 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.618 2.212 . . . . 0.0 113.943 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.538 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.74 158.47 44.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.385 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.54 159.8 19.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.42 16.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.67 127.9 23.52 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.44 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.553 0 C-N-CA 124.202 -1.166 . . . . 0.0 113.625 -0.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.38 34.07 21.06 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.545 -0.359 . . . . 0.0 113.254 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.2 80.94 18.98 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.82 -33.83 2.73 Favored 'Cis proline' 0 C--N 1.372 1.806 0 C-N-CA 125.2 -0.75 . . . . 0.0 112.812 -0.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.67 153.45 21.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.248 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.42 -167.08 14.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.862 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.17 154.17 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.26 99.15 11.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.775 0.321 . . . . 0.0 110.552 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -106.96 155.29 19.95 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.88 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.4 HD11 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.297 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.406 0 CA-C-O 120.29 -0.172 . . . . 0.0 112.9 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -128.06 164.92 21.35 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.482 0.313 . . . . 0.0 110.395 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -81.01 129.84 34.73 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.571 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.04 123.59 41.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.91 157.17 17.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.55 16.85 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.163 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.9 -64.67 1.03 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.723 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.72 3.56 0.47 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.28 70.11 21.72 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.3 Cg_endo -93.24 171.02 2.11 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.242 2.628 . . . . 0.0 111.963 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 m -85.79 106.23 16.88 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.694 0.283 . . . . 0.0 110.316 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -79.25 -40.55 1.51 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.835 -0.602 . . . . 0.0 112.38 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.09 -178.53 2.13 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.309 2.006 . . . . 0.0 111.44 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.55 ' O ' HD12 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.68 55.17 0.33 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.638 2.225 . . . . 0.0 114.544 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.74 156.33 48.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.248 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 160.02 18.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.799 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.3 t -98.67 105.07 17.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.04 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.946 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.53 -51.24 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.222 -1.157 . . . . 0.0 113.62 -0.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.02 19.1 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.446 -0.407 . . . . 0.0 113.242 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.59 81.59 17.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -33.72 2.84 Favored 'Cis proline' 0 C--N 1.372 1.786 0 C-N-CA 125.295 -0.71 . . . . 0.0 112.836 -0.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.91 154.12 20.5 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.18 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.524 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.27 -166.88 14.23 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.814 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.5 mm -133.36 154.41 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.22 98.58 11.4 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.847 0.356 . . . . 0.0 110.468 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.56 155.99 18.67 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.43 133.19 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.766 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.406 HD11 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.325 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 CA-C-O 120.062 -0.299 . . . . 0.0 113.312 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -97.41 167.01 11.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.398 0.279 . . . . 0.0 110.622 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -82.61 137.39 34.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.477 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 p -127.27 123.64 36.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.467 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.96 17.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.42 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 16.11 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.209 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.74 -64.43 1.04 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -151.0 3.43 0.45 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.3 70.2 22.12 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.3 Cg_endo -92.67 170.56 2.42 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.228 2.618 . . . . 0.0 111.85 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 m -83.86 106.89 15.9 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.748 0.309 . . . . 0.0 110.474 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 64.4 m -80.02 -40.08 1.29 Allowed Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.458 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.3 Cg_exo -71.65 -179.48 3.78 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.31 2.007 . . . . 0.0 111.179 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.552 ' O ' HD13 ' A' ' 21' ' ' LEU . 35.3 Cg_endo -64.76 56.59 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.445 2.096 . . . . 0.0 114.644 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.552 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.07 156.2 48.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.2 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.3 t -112.28 159.74 18.33 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.39 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.979 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -129.98 127.96 22.8 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.014 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.516 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 44.2 Cg_endo -69.62 -51.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.578 0 C-N-CA 124.171 -1.179 . . . . 0.0 113.665 -0.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 34.68 16.27 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.444 -0.407 . . . . 0.0 113.177 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.516 ' OD1' ' HB2' ' A' ' 25' ' ' PRO . 2.8 p-10 -140.36 80.73 18.88 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.43 -34.01 2.73 Favored 'Cis proline' 0 C--N 1.372 1.778 0 CA-C-N 119.147 0.731 . . . . 0.0 112.88 -0.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.02 153.78 21.01 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.272 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.22 -167.32 14.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.77 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.52 HD11 ' O ' ' A' ' 30' ' ' GLY . 13.0 mm -133.19 153.92 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 88.1 m -86.83 98.37 11.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 120.893 0.378 . . . . 0.0 110.559 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.27 155.03 19.46 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.261 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.61 132.86 34.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.399 0 CA-C-O 120.19 -0.228 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.77 166.64 20.36 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.473 0.309 . . . . 0.0 110.355 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.35 130.89 35.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.727 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.67 123.43 40.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.283 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.525 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.29 15.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.181 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -98.93 -65.02 0.99 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.715 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.422 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.28 1.62 0.4 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.57 73.75 11.39 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.49 170.41 2.07 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.169 2.579 . . . . 0.0 111.851 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.64 119.6 24.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.641 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.95 -36.46 0.58 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.641 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.84 -179.84 5.65 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.585 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.536 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.57 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.549 2.166 . . . . 0.0 114.006 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.38 44.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.267 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.58 159.81 19.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.71 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.46 104.52 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.85 127.95 23.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.042 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.41 -51.14 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.516 0 C-N-CA 124.232 -1.153 . . . . 0.0 113.69 -0.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.62 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.436 -0.412 . . . . 0.0 113.226 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.16 81.1 18.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.78 2.77 Favored 'Cis proline' 0 C--N 1.373 1.83 0 C-N-CA 125.237 -0.735 . . . . 0.0 112.824 -0.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.91 153.61 21.17 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.43 -166.95 14.35 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.868 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 153.95 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.4 m -87.09 99.0 11.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.834 0.349 . . . . 0.0 110.634 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 152.91 23.17 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.314 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.32 134.14 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.271 -179.884 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.041 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.19 164.82 22.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.524 0.329 . . . . 0.0 110.145 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -79.95 132.88 36.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.909 0.385 . . . . 0.0 111.672 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.69 124.56 42.45 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.71 156.41 17.66 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.55 16.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.13 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.93 -65.03 0.99 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.757 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.423 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.14 1.59 0.41 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.49 73.85 11.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.6 Cg_endo -93.6 170.76 2.0 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.278 2.652 . . . . 0.0 111.924 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.92 119.76 24.35 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.64 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.07 -36.35 0.57 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.64 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.81 5.61 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.436 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.536 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.03 62.55 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.52 2.146 . . . . 0.0 114.028 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.43 44.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.6 159.78 19.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.775 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.62 16.67 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.8 128.15 23.47 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.32 -51.08 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.593 0 C-N-CA 124.257 -1.143 . . . . 0.0 113.648 -0.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.6 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.478 -0.392 . . . . 0.0 113.307 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.38 81.18 18.12 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -33.84 2.75 Favored 'Cis proline' 0 C--N 1.373 1.828 0 C-N-CA 125.251 -0.729 . . . . 0.0 112.77 -0.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.16 153.74 21.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -151.3 -166.9 14.26 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.886 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 HD12 ' O ' ' A' ' 30' ' ' GLY . 12.0 mm -133.35 154.33 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.3 99.07 11.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.73 155.56 19.56 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.337 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.27 132.94 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.403 HD13 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.354 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -109.52 96.25 6.15 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.392 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.7 m -81.62 148.86 63.08 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.834 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.33 163.96 35.96 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 123.282 2.655 . . . . 0.0 113.37 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.76 -162.04 24.04 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.99 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' OE1' HD13 ' A' ' 21' ' ' LEU . 29.1 tt0 -78.89 122.17 25.77 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.433 0.293 . . . . 0.0 110.926 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.93 32.65 7.81 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.883 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.04 164.95 21.27 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.495 0.318 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.97 129.91 34.76 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.65 41.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.385 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.88 157.13 17.08 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.446 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.5 16.38 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.173 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.29 -64.73 1.02 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.697 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.71 3.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.28 70.15 21.84 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.2 Cg_endo -93.28 170.99 2.1 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 123.225 2.617 . . . . 0.0 111.912 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.2 m -85.54 106.16 16.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.342 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.2 -40.57 1.52 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.341 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.18 -178.5 2.15 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.263 1.975 . . . . 0.0 111.45 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.55 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.67 55.16 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.649 2.233 . . . . 0.0 114.548 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.55 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.26 48.32 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.202 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.28 159.96 18.12 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.853 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.65 105.02 17.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.1 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.961 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.43 -51.28 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.268 -1.138 . . . . 0.0 113.71 -0.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 34.02 19.17 Favored Glycine 0 C--N 1.344 0.995 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.271 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.56 81.5 17.19 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.61 -33.63 2.85 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 125.293 -0.711 . . . . 0.0 112.792 -0.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.92 154.17 20.45 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.165 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.28 -166.79 14.15 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.806 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.522 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.44 154.38 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.14 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.858 0.361 . . . . 0.0 110.528 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -105.54 155.96 18.69 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.41 133.14 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.734 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.406 HD11 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.186 -0.912 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.52 96.31 6.19 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.296 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.2 m -81.68 148.83 62.78 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.89 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.36 163.99 35.84 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.26 2.64 . . . . 0.0 113.341 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.76 -162.08 24.04 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.981 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' OE1' HD12 ' A' ' 21' ' ' LEU . 29.2 tt0 -78.94 122.1 25.71 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.735 0.302 . . . . 0.0 110.912 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.0 32.75 7.71 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.842 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.14 165.03 21.19 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.506 0.322 . . . . 0.0 110.391 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.94 129.86 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.61 41.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.465 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.86 157.07 17.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.432 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.53 16.27 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.146 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.14 -64.61 1.03 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.76 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.76 3.38 0.47 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.22 70.15 21.24 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.28 170.9 2.11 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.16 2.573 . . . . 0.0 111.859 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.4 m -85.4 106.13 16.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.365 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.22 -40.48 1.51 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.381 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.23 -178.46 2.15 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.247 1.965 . . . . 0.0 111.466 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.55 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -65.6 55.08 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.723 2.282 . . . . 0.0 114.559 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.3 48.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.202 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 159.9 18.25 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.823 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.6 104.98 17.07 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.949 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -129.45 128.14 23.12 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.46 -51.27 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.57 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.664 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 34.03 19.04 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.28 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.53 81.52 17.28 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.74 2.81 Favored 'Cis proline' 0 C--N 1.373 1.847 0 C-N-CA 125.282 -0.716 . . . . 0.0 112.749 -0.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -88.75 154.09 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.216 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.523 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.29 -166.81 14.16 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.793 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.523 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.4 mm -133.36 154.36 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.13 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.825 0.345 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.58 155.93 18.73 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.218 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.45 133.12 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.332 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.254 . . . . . . . 0 C--O 1.235 0.313 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.17 96.23 6.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.346 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.0 m -81.26 148.76 64.18 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.909 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.8 164.05 34.93 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 123.328 2.685 . . . . 0.0 113.408 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.41 -164.44 23.63 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.17 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' OE1' HD13 ' A' ' 21' ' ' LEU . 28.4 tt0 -77.05 122.78 25.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.742 0.306 . . . . 0.0 111.161 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.39 0.76 58.09 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.324 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -97.72 167.01 11.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.306 0.243 . . . . 0.0 110.574 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -82.78 137.16 34.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.393 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.92 124.19 38.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.69 156.93 17.3 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.357 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.45 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.164 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.82 -64.61 1.02 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.739 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.09 3.4 0.44 Allowed 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.3 70.3 22.25 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.79 170.14 2.4 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.202 2.601 . . . . 0.0 111.807 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 m -83.85 106.32 15.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.737 0.303 . . . . 0.0 110.479 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -79.71 -40.6 1.41 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.313 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.59 -178.23 2.18 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.206 1.937 . . . . 0.0 111.422 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.73 55.27 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.598 2.198 . . . . 0.0 114.515 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.89 156.18 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.247 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.3 160.02 18.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.813 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.51 105.2 17.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.007 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.9 22.73 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.061 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.69 -51.53 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.598 0 C-N-CA 124.28 -1.133 . . . . 0.0 113.695 -0.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.52 34.1 17.51 Favored Glycine 0 C--N 1.344 1.027 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.267 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.46 81.41 17.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.56 -33.88 2.76 Favored 'Cis proline' 0 C--N 1.37 1.709 0 C-N-CA 125.227 -0.739 . . . . 0.0 112.743 -0.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.53 154.06 20.65 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.22 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.22 -167.22 14.55 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.769 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 HD11 ' O ' ' A' ' 30' ' ' GLY . 13.3 mm -133.1 154.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' THR . 81.2 m -86.96 98.26 11.15 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.595 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.22 155.2 19.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.237 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.79 132.93 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.742 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.405 HD13 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.182 -0.914 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.236 0.36 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -111.31 96.64 6.24 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.313 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.6 m -80.73 148.34 65.06 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.909 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.07 163.34 38.08 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 123.361 2.708 . . . . 0.0 113.415 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.41 -166.4 23.72 Favored Glycine 0 C--N 1.337 0.637 0 O-C-N 123.654 0.596 . . . . 0.0 112.088 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.478 ' OE1' HD13 ' A' ' 21' ' ' LEU . 28.0 tt0 -75.29 121.23 21.88 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.466 0.306 . . . . 0.0 111.165 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.18 -0.64 57.32 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.365 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -96.68 167.07 11.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.399 0.28 . . . . 0.0 110.597 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.59 137.49 34.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.477 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 p -126.93 124.56 39.79 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.448 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -102.61 156.49 17.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.413 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.62 15.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.04 -64.44 1.04 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.72 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.433 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.1 2.93 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.46 70.28 23.92 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.2 Cg_endo -92.65 169.89 2.5 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.128 2.552 . . . . 0.0 111.784 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.2 m -82.11 105.94 13.62 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.5 m -79.39 -40.59 1.48 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.293 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.12 -178.12 2.32 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.257 1.971 . . . . 0.0 111.41 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.545 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -66.0 55.43 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.634 2.223 . . . . 0.0 114.436 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.545 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.01 156.09 48.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.23 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.02 159.84 18.06 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.795 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.44 105.25 17.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.92 22.74 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.022 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.66 -51.67 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 124.252 -1.145 . . . . 0.0 113.667 -0.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.56 34.41 16.45 Favored Glycine 0 C--N 1.344 1.014 0 C-N-CA 121.435 -0.412 . . . . 0.0 113.196 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.27 81.25 18.33 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.96 2.73 Favored 'Cis proline' 0 C--N 1.373 1.852 0 C-N-CA 125.174 -0.761 . . . . 0.0 112.794 -0.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.2 154.0 20.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -151.11 -167.05 14.32 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.819 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 30' ' ' GLY . 12.8 mm -132.98 153.91 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 22' ' ' THR . 90.5 m -86.83 98.33 11.13 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.59 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.31 155.14 19.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.27 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.75 132.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.772 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.406 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.358 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -110.29 96.55 6.28 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.998 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.2 m -81.68 148.6 62.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.925 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.55 163.87 36.46 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 123.25 2.633 . . . . 0.0 113.357 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.61 -162.42 24.22 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.956 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.459 ' OE1' HD13 ' A' ' 21' ' ' LEU . 29.3 tt0 -78.67 121.93 25.32 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.768 0.318 . . . . 0.0 110.963 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.02 32.51 7.86 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.939 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.16 165.11 21.05 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.52 0.328 . . . . 0.0 110.397 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.98 129.98 34.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.01 123.8 41.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.329 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.75 156.89 17.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 15.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.135 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.09 -64.69 1.01 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.743 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.22 0.46 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.2 70.27 21.21 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.9 Cg_endo -93.27 170.89 2.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.164 2.576 . . . . 0.0 111.816 178.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 m -84.89 105.98 16.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.707 0.289 . . . . 0.0 110.341 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.1 -40.52 1.54 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.378 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.21 -178.48 2.16 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.254 1.969 . . . . 0.0 111.495 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.55 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.74 55.13 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.672 2.248 . . . . 0.0 114.51 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.55 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.84 156.2 48.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.245 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.553 ' HG1' ' N ' ' A' ' 23' ' ' CYS . 6.2 t -112.18 159.84 18.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' N ' ' HG1' ' A' ' 22' ' ' THR . 5.2 t -98.61 104.95 17.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.48 128.1 23.1 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.45 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.561 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.669 -0.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 33.89 19.44 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 121.39 -0.433 . . . . 0.0 113.285 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.34 81.5 17.82 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.65 -33.64 2.84 Favored 'Cis proline' 0 C--N 1.372 1.792 0 C-N-CA 125.311 -0.704 . . . . 0.0 112.775 -0.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -88.83 154.11 20.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.203 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.3 -166.67 14.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.841 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.522 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.7 mm -133.39 154.34 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.12 98.58 11.37 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 120.836 0.35 . . . . 0.0 110.568 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.63 155.84 18.84 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 133.25 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.68 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.331 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.65 96.21 5.85 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.348 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.8 p -87.51 147.15 41.13 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.667 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.5 Cg_endo -69.65 168.19 22.14 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.445 2.763 . . . . 0.0 113.882 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.56 -157.57 13.31 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.713 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.527 ' OE1' HD11 ' A' ' 21' ' ' LEU . 32.9 tt0 -78.87 122.2 25.79 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.766 0.283 . . . . 0.0 111.008 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.61 32.94 8.25 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.081 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -130.47 166.81 19.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.419 0.288 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.33 130.99 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.789 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.76 123.36 40.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.207 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.41 17.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.49 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.31 15.78 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.146 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.08 -65.09 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.08 1.64 0.41 Allowed 'General case' 0 C--N 1.349 0.568 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -118.64 73.71 11.6 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.428 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -93.51 170.34 2.07 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.241 2.628 . . . . 0.0 111.945 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.7 m -81.71 119.57 24.01 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.639 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -84.94 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.91 -179.82 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' O ' HD12 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.02 62.44 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.622 2.215 . . . . 0.0 114.05 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.73 158.35 44.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.336 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.529 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.51 159.71 19.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.699 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.48 104.66 16.72 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.89 127.92 23.42 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.904 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.43 -51.13 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.564 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.632 -0.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.58 34.03 20.55 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.279 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.25 81.16 18.52 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.66 -33.76 2.79 Favored 'Cis proline' 0 C--N 1.372 1.803 0 C-N-CA 125.29 -0.712 . . . . 0.0 112.854 -0.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.92 153.48 21.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.193 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.35 -167.04 14.41 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.85 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.13 154.06 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.6 m -87.29 99.07 11.7 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.64 155.52 19.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.3 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 132.94 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.4 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.351 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.46 96.21 5.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.428 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.6 p -87.56 147.17 41.08 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.581 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.4 Cg_endo -69.7 168.21 22.12 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 123.377 2.718 . . . . 0.0 113.874 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.58 -157.59 13.31 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.68 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.528 ' OE1' HD11 ' A' ' 21' ' ' LEU . 32.9 tt0 -78.85 122.32 25.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.755 0.278 . . . . 0.0 110.998 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.58 32.76 8.4 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.216 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -130.39 166.77 19.76 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 122.398 0.279 . . . . 0.0 110.404 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.33 130.98 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.752 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -123.76 123.21 40.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.268 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.45 156.47 17.58 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.38 15.8 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.191 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.03 -65.07 0.98 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.804 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.42 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.15 1.77 0.41 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.8 73.54 11.96 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.4 Cg_endo -93.43 170.29 2.1 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 123.226 2.618 . . . . 0.0 111.889 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -81.7 119.58 24.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.639 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.2 p -85.09 -36.29 0.57 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.639 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.86 5.66 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.214 1.943 . . . . 0.0 111.463 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' O ' HD12 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.99 62.47 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.584 2.19 . . . . 0.0 113.972 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.83 158.33 44.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.256 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.46 159.73 19.2 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.717 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.44 104.59 16.64 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.87 127.89 23.43 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.42 -51.03 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.208 -1.164 . . . . 0.0 113.67 -0.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.05 21.05 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 121.449 -0.405 . . . . 0.0 113.298 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.28 81.11 18.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.75 2.78 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 125.259 -0.725 . . . . 0.0 112.858 -0.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.91 153.46 21.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.208 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.517 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.35 -166.94 14.31 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.828 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.517 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.1 mm -133.16 154.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.2 98.99 11.62 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.854 0.359 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.64 155.45 19.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.408 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.15 132.92 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.308 -179.863 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.235 0.312 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.46 96.5 6.23 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.257 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.7 m -80.9 148.59 65.1 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.88 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.96 163.78 36.26 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 123.294 2.663 . . . . 0.0 113.394 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.41 -165.26 23.66 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.083 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.474 ' OE1' HD12 ' A' ' 21' ' ' LEU . 28.2 tt0 -76.36 122.12 24.01 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.462 0.305 . . . . 0.0 111.176 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.62 0.66 57.79 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.366 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -97.82 167.04 11.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.435 0.294 . . . . 0.0 110.548 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.6 137.29 34.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.448 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 p -126.97 124.29 39.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.58 156.78 17.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.349 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.59 15.33 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.191 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.53 -64.53 1.03 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.745 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.434 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.03 3.22 0.44 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.38 70.29 23.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.76 170.16 2.41 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.137 2.558 . . . . 0.0 111.818 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -83.22 106.1 14.73 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.745 0.307 . . . . 0.0 110.517 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -79.48 -40.65 1.46 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.251 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.85 -178.18 2.26 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.243 1.962 . . . . 0.0 111.376 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.0 Cg_exo -65.82 55.24 0.35 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.68 2.254 . . . . 0.0 114.47 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.86 156.0 48.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.28 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.538 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.03 160.0 17.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.49 105.14 17.25 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -130.06 127.94 22.74 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.57 -51.58 0.16 OUTLIER 'Cis proline' 0 C--N 1.369 1.618 0 C-N-CA 124.245 -1.148 . . . . 0.0 113.695 -0.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.45 34.33 17.03 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 121.44 -0.41 . . . . 0.0 113.231 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.48 81.34 17.62 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.544 0.172 . . . . 0.0 111.444 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.54 -33.89 2.76 Favored 'Cis proline' 0 C--N 1.373 1.835 0 C-N-CA 125.258 -0.726 . . . . 0.0 112.807 -0.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.46 154.02 20.7 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.187 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -151.14 -167.25 14.54 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.756 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 30' ' ' GLY . 13.1 mm -133.03 154.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 22' ' ' THR . 85.0 m -86.93 98.23 11.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.933 0.397 . . . . 0.0 110.581 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -105.23 155.14 19.34 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.277 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.65 132.84 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.776 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.402 HD13 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.333 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.254 . . . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -115.68 97.5 6.17 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.351 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.2 p -85.28 147.03 46.25 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.746 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.6 Cg_endo -69.82 168.08 22.68 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.361 2.707 . . . . 0.0 113.86 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.47 -157.52 13.38 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.672 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.527 ' OE1' HD13 ' A' ' 21' ' ' LEU . 33.0 tt0 -78.94 122.11 25.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.754 0.311 . . . . 0.0 110.998 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.72 32.79 8.31 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.101 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.4 166.81 19.67 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.481 0.312 . . . . 0.0 110.393 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.32 131.07 35.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.699 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.87 123.47 40.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.206 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.49 156.46 17.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.519 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.34 15.61 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.143 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 -65.12 0.98 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.735 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.14 1.74 0.41 Allowed 'General case' 0 C--N 1.349 0.581 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.55 73.74 11.34 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.43 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.4 Cg_endo -93.58 170.34 2.04 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 123.227 2.618 . . . . 0.0 111.88 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 m -81.6 119.53 23.9 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.642 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.86 -36.42 0.58 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.83 5.63 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.135 1.89 . . . . 0.0 111.534 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.07 62.62 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.591 2.194 . . . . 0.0 114.058 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.89 158.36 44.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.241 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.53 159.63 19.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.805 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.38 104.55 16.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.0 mt -128.93 127.95 23.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.946 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.48 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.22 -1.158 . . . . 0.0 113.647 -0.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.54 34.06 20.59 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.486 -0.388 . . . . 0.0 113.193 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.12 81.0 19.14 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.79 -33.77 2.76 Favored 'Cis proline' 0 C--N 1.372 1.794 0 C-N-CA 125.225 -0.739 . . . . 0.0 112.833 -0.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.88 153.55 21.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.38 -166.91 14.3 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.877 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.14 154.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.1 m -87.29 99.04 11.68 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.828 0.346 . . . . 0.0 110.61 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 155.46 19.65 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.93 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.788 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.402 HD13 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.307 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.254 . . . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -118.07 98.67 6.43 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.4 p -83.78 146.84 50.35 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.747 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.6 Cg_endo -69.7 168.03 22.64 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 123.404 2.736 . . . . 0.0 113.87 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.53 -157.74 13.43 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.69 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.533 ' OE1' HD12 ' A' ' 21' ' ' LEU . 33.2 tt0 -78.74 122.03 25.5 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.714 0.293 . . . . 0.0 111.029 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.02 31.35 9.26 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.128 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -129.67 166.49 19.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.432 0.293 . . . . 0.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -79.99 132.96 36.12 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.807 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.25 123.64 39.96 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.258 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.48 156.37 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.508 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.28 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.88 -65.16 0.98 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.09 1.57 0.41 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.48 73.8 11.16 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.2 Cg_endo -93.51 170.29 2.07 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.272 2.648 . . . . 0.0 111.883 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -81.31 119.56 23.82 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.645 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.3 p -84.88 -36.56 0.58 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.96 5.74 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.142 1.894 . . . . 0.0 111.552 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.95 62.76 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.587 2.191 . . . . 0.0 113.996 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.537 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.93 158.58 43.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.65 159.66 19.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.785 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.47 104.59 16.64 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.81 128.02 23.46 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.996 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.45 -50.99 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.573 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.694 -0.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.45 34.05 20.91 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.21 81.15 18.66 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.71 -33.86 2.74 Favored 'Cis proline' 0 C--N 1.371 1.741 0 C-N-CA 125.243 -0.732 . . . . 0.0 112.768 -0.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.96 153.51 21.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.518 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.23 -166.94 14.27 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.864 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.518 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.21 154.2 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.31 99.15 11.76 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.859 0.361 . . . . 0.0 110.585 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.01 155.47 19.77 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.373 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.17 132.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.777 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.404 HD11 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.292 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -120.92 100.03 6.85 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.207 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.6 p -81.92 146.77 56.54 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.843 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.9 Cg_endo -69.74 168.21 22.17 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 123.359 2.706 . . . . 0.0 113.942 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.55 -157.68 13.38 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.676 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.529 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.1 tt0 -78.75 122.07 25.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.748 0.274 . . . . 0.0 111.013 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.72 32.7 8.39 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.184 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 166.82 19.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.433 0.293 . . . . 0.0 110.434 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.34 131.18 35.59 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.726 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.86 123.54 40.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.243 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.41 17.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.483 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.42 15.53 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.239 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.64 -64.91 1.0 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.773 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.37 1.66 0.39 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.5 73.81 11.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.43 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.4 Cg_endo -93.48 170.5 2.07 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.21 2.607 . . . . 0.0 111.877 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 m -81.51 119.47 23.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.644 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.4 p -84.79 -36.48 0.59 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.644 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 Cg_endo -79.99 -179.9 5.67 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.172 1.915 . . . . 0.0 111.499 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.538 ' O ' HD12 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.05 62.79 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.565 2.177 . . . . 0.0 114.051 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.92 158.45 44.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.302 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.56 159.62 19.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.782 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.47 104.58 16.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.77 128.0 23.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.36 -51.09 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.523 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.716 -0.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.57 34.02 20.61 Favored Glycine 0 C--N 1.345 1.041 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.27 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.21 81.0 18.87 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.82 -33.8 2.74 Favored 'Cis proline' 0 C--N 1.373 1.823 0 C-N-CA 125.272 -0.72 . . . . 0.0 112.823 -0.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -87.88 153.62 21.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.203 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.39 -166.96 14.34 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.829 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 154.02 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.6 m -87.2 99.16 11.75 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.859 0.361 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.86 155.6 19.57 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.24 133.0 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.4 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.325 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.235 0.29 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -122.71 100.98 7.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.259 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.9 p -80.64 146.76 61.4 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.921 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.8 Cg_endo -69.81 168.1 22.6 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.365 2.71 . . . . 0.0 113.891 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.46 -157.61 13.44 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.678 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.531 ' OE1' HD12 ' A' ' 21' ' ' LEU . 33.2 tt0 -78.89 122.01 25.58 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.803 0.301 . . . . 0.0 111.054 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.09 31.41 9.17 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.134 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -129.73 166.59 19.55 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.456 0.302 . . . . 0.0 110.381 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -80.04 132.99 36.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.758 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.42 123.67 39.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.242 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.33 17.66 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.525 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.32 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.214 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.69 -65.15 0.98 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.763 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t80 -151.22 1.69 0.41 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.5 73.82 11.25 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.432 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -93.47 170.48 2.07 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.254 2.636 . . . . 0.0 111.952 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.9 m -81.39 119.49 23.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.647 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.0 p -84.66 -36.68 0.6 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.647 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.96 -179.95 5.72 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.117 1.878 . . . . 0.0 111.456 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.539 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.7 Cg_exo -64.91 62.72 0.29 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.62 2.213 . . . . 0.0 114.018 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.9 158.64 43.74 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.331 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.71 159.66 19.47 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.708 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.49 104.47 16.51 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.75 128.02 23.49 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.988 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.38 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.583 0 C-N-CA 124.195 -1.169 . . . . 0.0 113.717 -0.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 33.96 20.8 Favored Glycine 0 C--N 1.345 1.032 0 C-N-CA 121.469 -0.396 . . . . 0.0 113.251 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -140.22 81.07 18.74 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.66 -33.9 2.73 Favored 'Cis proline' 0 C--N 1.372 1.811 0 C-N-CA 125.267 -0.722 . . . . 0.0 112.833 -0.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -87.93 153.63 21.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.24 -167.06 14.39 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.9 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.22 154.24 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.8 m -87.34 99.27 11.86 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.607 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.05 155.45 19.82 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.353 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.11 132.89 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.708 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.401 HD13 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.236 0.348 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.87 96.91 6.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.337 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.3 m -80.63 148.67 66.28 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.97 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.16 163.92 36.84 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.357 2.705 . . . . 0.0 113.288 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.45 -162.93 23.51 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.024 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.454 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.4 tt0 -78.04 121.71 24.6 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.667 0.27 . . . . 0.0 111.007 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.52 30.97 8.62 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.885 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.38 164.89 20.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.446 0.298 . . . . 0.0 110.302 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.7 131.92 35.51 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.588 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.27 123.82 41.07 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.365 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.67 156.77 17.29 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.475 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.68 16.61 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.226 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.2 -64.54 1.03 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.712 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.434 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.83 3.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.18 70.64 21.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.3 171.32 2.06 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.201 2.6 . . . . 0.0 111.892 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.37 105.98 15.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.768 0.318 . . . . 0.0 110.301 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 63.6 m -78.91 -39.89 1.54 Allowed Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.562 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.5 Cg_exo -71.5 -179.65 3.86 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.193 1.929 . . . . 0.0 111.176 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.554 ' O ' HD12 ' A' ' 21' ' ' LEU . 35.8 Cg_endo -64.64 56.41 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.354 2.036 . . . . 0.0 114.83 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.03 156.47 48.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.106 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.28 159.75 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.767 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.1 t -98.65 104.8 16.87 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.3 128.01 23.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.944 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.5 -51.35 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.556 0 C-N-CA 124.221 -1.158 . . . . 0.0 113.743 -0.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.27 33.9 18.83 Favored Glycine 0 C--N 1.345 1.047 0 C-N-CA 121.358 -0.448 . . . . 0.0 113.197 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.5 81.64 17.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.48 -33.7 2.84 Favored 'Cis proline' 0 C--N 1.372 1.779 0 C-N-CA 125.271 -0.721 . . . . 0.0 112.837 -0.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.91 154.24 20.4 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.523 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.21 -166.7 14.04 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.523 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.43 154.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 22' ' ' THR . 76.4 m -87.24 98.77 11.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.881 0.372 . . . . 0.0 110.57 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 153.46 22.02 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.211 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.5 tt -94.65 134.45 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.709 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.278 -179.95 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.338 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -109.38 96.27 6.18 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.7 m -81.64 148.89 63.11 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.918 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.71 163.76 37.02 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 123.317 2.678 . . . . 0.0 113.399 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.18 -160.01 24.34 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 123.682 0.614 . . . . 0.0 111.892 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.444 ' OE1' HD13 ' A' ' 21' ' ' LEU . 28.9 tt0 -80.4 123.24 27.86 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.677 0.275 . . . . 0.0 110.963 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.52 33.86 7.31 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.817 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -129.25 162.44 27.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.527 0.331 . . . . 0.0 110.245 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -79.85 130.44 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.446 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 124.33 42.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.464 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.97 157.12 17.09 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.44 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.71 18.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.22 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.53 -64.51 1.06 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.782 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.437 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.39 0.46 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.14 70.34 20.63 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.53 171.25 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 123.209 2.606 . . . . 0.0 111.991 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.41 106.17 17.25 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.317 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.4 m -79.29 -40.38 1.48 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.392 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.94 -178.58 2.09 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.248 1.965 . . . . 0.0 111.488 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.3 Cg_exo -65.63 55.26 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.648 2.232 . . . . 0.0 114.567 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.551 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.83 156.34 48.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.218 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.38 160.04 18.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.4 t -98.74 105.09 17.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -129.56 128.23 23.07 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.016 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.32 -51.15 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.53 0 C-N-CA 124.295 -1.127 . . . . 0.0 113.722 -0.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 33.86 19.61 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.77 81.75 16.34 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -33.63 2.88 Favored 'Cis proline' 0 C--N 1.373 1.826 0 C-N-CA 125.326 -0.698 . . . . 0.0 112.864 -0.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -89.19 154.29 20.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.241 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.524 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.27 -166.66 14.02 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.848 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.524 HD11 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.71 154.74 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 22' ' ' THR . 70.9 m -87.12 98.54 11.35 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.812 0.339 . . . . 0.0 110.57 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -105.65 156.14 18.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.273 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.56 133.29 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.721 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.404 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.365 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.258 . . . . . . . 0 C--O 1.235 0.301 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.18 97.86 6.29 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.072 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.3 p -85.17 146.95 46.36 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.813 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.5 Cg_endo -69.65 168.06 22.5 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 123.384 2.723 . . . . 0.0 113.926 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.38 -157.56 13.49 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.76 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' OE1' HD13 ' A' ' 21' ' ' LEU . 33.2 tt0 -79.04 122.32 26.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.792 0.296 . . . . 0.0 111.009 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.85 31.09 9.57 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.157 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -129.26 166.6 19.11 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.422 0.289 . . . . 0.0 110.331 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.13 132.93 36.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.835 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.08 123.48 39.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.238 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.44 15.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.176 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.68 -64.96 0.99 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.4 1.59 0.39 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.46 73.82 11.12 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.432 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.3 Cg_endo -93.54 170.19 2.07 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.191 2.594 . . . . 0.0 111.85 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 m -81.29 119.31 23.48 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.642 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.5 p -84.88 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.642 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -80.0 -179.84 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.076 1.851 . . . . 0.0 111.519 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.54 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.66 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.57 2.18 . . . . 0.0 113.98 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.54 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.94 158.56 43.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.62 159.75 19.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.701 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.6 104.58 16.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.986 0.422 . . . . 0.0 110.862 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.84 127.85 23.44 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.059 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.52 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.549 0 C-N-CA 124.205 -1.165 . . . . 0.0 113.626 -0.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.5 33.98 20.94 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.229 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.38 81.15 18.15 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.69 -33.87 2.73 Favored 'Cis proline' 0 C--N 1.372 1.813 0 C-N-CA 125.275 -0.719 . . . . 0.0 112.803 -0.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -88.09 153.61 21.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -151.34 -167.07 14.44 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.851 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.17 154.1 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.5 m -87.18 99.21 11.77 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.759 0.314 . . . . 0.0 110.593 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -106.94 155.42 19.8 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.361 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.11 132.83 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.77 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.402 HD13 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.156 -0.925 . . . . 0.0 111.307 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.57 96.16 5.83 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.398 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.8 p -87.81 147.12 40.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.595 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.6 Cg_endo -69.71 168.32 21.82 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 123.358 2.705 . . . . 0.0 113.889 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.56 -157.67 13.36 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.727 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.532 ' OE1' HD13 ' A' ' 21' ' ' LEU . 33.1 tt0 -78.94 122.36 26.05 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.686 0.279 . . . . 0.0 111.064 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.9 31.14 9.5 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.183 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -129.46 166.46 19.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 122.381 0.272 . . . . 0.0 110.345 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -80.15 132.93 36.01 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.723 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.97 123.26 39.5 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.203 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.35 156.1 17.81 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.486 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.82 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.138 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -97.97 -65.02 0.99 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.71 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.66 1.51 0.37 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.23 73.95 10.5 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.7 Cg_endo -93.57 170.24 2.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.278 2.652 . . . . 0.0 111.946 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -81.44 119.42 23.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.64 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.02 -36.43 0.57 Allowed Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.64 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.92 -179.8 5.6 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.181 1.921 . . . . 0.0 111.431 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.538 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.0 62.37 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.618 2.212 . . . . 0.0 113.943 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.538 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.74 158.47 44.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.385 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.54 159.8 19.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.42 16.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.67 127.9 23.52 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.44 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.553 0 C-N-CA 124.202 -1.166 . . . . 0.0 113.625 -0.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.38 34.07 21.06 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.545 -0.359 . . . . 0.0 113.254 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.2 80.94 18.98 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.82 -33.83 2.73 Favored 'Cis proline' 0 C--N 1.372 1.806 0 C-N-CA 125.2 -0.75 . . . . 0.0 112.812 -0.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.67 153.45 21.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.248 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.42 -167.08 14.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.862 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.17 154.17 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.26 99.15 11.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.775 0.321 . . . . 0.0 110.552 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -106.96 155.29 19.95 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.88 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.4 HD11 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.297 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -108.69 95.62 5.78 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.2 m -81.58 149.0 63.62 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.906 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.3 164.11 35.32 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.299 2.666 . . . . 0.0 113.323 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.85 -161.77 23.92 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.989 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' OE1' HD11 ' A' ' 21' ' ' LEU . 29.1 tt0 -79.07 122.3 26.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.754 0.312 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.95 32.69 7.78 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.9 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -128.06 164.92 21.35 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.482 0.313 . . . . 0.0 110.395 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -81.01 129.84 34.73 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.571 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.04 123.59 41.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.91 157.17 17.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.55 16.85 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.163 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.9 -64.67 1.03 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.723 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.72 3.56 0.47 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.28 70.11 21.72 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.3 Cg_endo -93.24 171.02 2.11 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.242 2.628 . . . . 0.0 111.963 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 m -85.79 106.23 16.88 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.694 0.283 . . . . 0.0 110.316 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -79.25 -40.55 1.51 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.835 -0.602 . . . . 0.0 112.38 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.09 -178.53 2.13 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.309 2.006 . . . . 0.0 111.44 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.55 ' O ' HD12 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.68 55.17 0.33 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.638 2.225 . . . . 0.0 114.544 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.74 156.33 48.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.248 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 160.02 18.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.799 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.3 t -98.67 105.07 17.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.04 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.946 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.53 -51.24 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.222 -1.157 . . . . 0.0 113.62 -0.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.02 19.1 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.446 -0.407 . . . . 0.0 113.242 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.59 81.59 17.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -33.72 2.84 Favored 'Cis proline' 0 C--N 1.372 1.786 0 C-N-CA 125.295 -0.71 . . . . 0.0 112.836 -0.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.91 154.12 20.5 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.18 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.524 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.27 -166.88 14.23 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.814 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.5 mm -133.36 154.41 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.22 98.58 11.4 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.847 0.356 . . . . 0.0 110.468 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.56 155.99 18.67 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.43 133.19 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.766 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.406 HD11 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.325 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.46 96.41 6.26 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.362 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.5 m -80.96 149.03 66.06 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.912 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.13 164.17 34.97 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 123.316 2.677 . . . . 0.0 113.333 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.47 -165.04 22.71 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.108 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' OE1' HD12 ' A' ' 21' ' ' LEU . 27.7 tt0 -76.23 122.02 23.76 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.526 0.331 . . . . 0.0 111.185 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.36 57.29 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.312 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -97.41 167.01 11.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.398 0.279 . . . . 0.0 110.622 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -82.61 137.39 34.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.477 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 p -127.27 123.64 36.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.467 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.96 17.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.42 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 16.11 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.209 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.74 -64.43 1.04 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -151.0 3.43 0.45 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.3 70.2 22.12 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.3 Cg_endo -92.67 170.56 2.42 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.228 2.618 . . . . 0.0 111.85 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 m -83.86 106.89 15.9 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.748 0.309 . . . . 0.0 110.474 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 64.4 m -80.02 -40.08 1.29 Allowed Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.458 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.3 Cg_exo -71.65 -179.48 3.78 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.31 2.007 . . . . 0.0 111.179 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.552 ' O ' HD13 ' A' ' 21' ' ' LEU . 35.3 Cg_endo -64.76 56.59 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.445 2.096 . . . . 0.0 114.644 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.552 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.07 156.2 48.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.2 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.3 t -112.28 159.74 18.33 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.446 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.39 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.979 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -129.98 127.96 22.8 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.014 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.516 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 44.2 Cg_endo -69.62 -51.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.578 0 C-N-CA 124.171 -1.179 . . . . 0.0 113.665 -0.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 34.68 16.27 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.444 -0.407 . . . . 0.0 113.177 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.516 ' OD1' ' HB2' ' A' ' 25' ' ' PRO . 2.8 p-10 -140.36 80.73 18.88 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.43 -34.01 2.73 Favored 'Cis proline' 0 C--N 1.372 1.778 0 CA-C-N 119.147 0.731 . . . . 0.0 112.88 -0.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.02 153.78 21.01 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.272 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' HD11 ' A' ' 31' ' ' ILE . . . -151.22 -167.32 14.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.77 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.52 HD11 ' O ' ' A' ' 30' ' ' GLY . 13.0 mm -133.19 153.92 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 88.1 m -86.83 98.37 11.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 120.893 0.378 . . . . 0.0 110.559 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.27 155.03 19.46 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.261 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.61 132.86 34.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.253 . . . . . . . 0 C--O 1.234 0.289 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.74 98.72 6.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.067 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.1 p -84.14 147.03 49.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.723 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.8 Cg_endo -69.71 168.37 21.67 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 123.428 2.752 . . . . 0.0 113.851 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.75 -157.53 13.1 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.691 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.529 ' OE1' HD13 ' A' ' 21' ' ' LEU . 32.9 tt0 -78.88 122.32 25.96 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.745 0.307 . . . . 0.0 111.031 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.44 33.17 8.18 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.104 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.77 166.64 20.36 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.473 0.309 . . . . 0.0 110.355 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.35 130.89 35.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.727 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.67 123.43 40.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.283 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.525 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.29 15.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.181 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -98.93 -65.02 0.99 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.715 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.422 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.28 1.62 0.4 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.57 73.75 11.39 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.43 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -93.49 170.41 2.07 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.169 2.579 . . . . 0.0 111.851 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.64 119.6 24.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.641 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.95 -36.46 0.58 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.641 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.84 -179.84 5.65 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.585 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.536 ' O ' HD11 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.57 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.549 2.166 . . . . 0.0 114.006 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.38 44.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.267 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.58 159.81 19.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.71 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.46 104.52 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.85 127.95 23.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.042 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.41 -51.14 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.516 0 C-N-CA 124.232 -1.153 . . . . 0.0 113.69 -0.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.62 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.436 -0.412 . . . . 0.0 113.226 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.16 81.1 18.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.78 2.77 Favored 'Cis proline' 0 C--N 1.373 1.83 0 C-N-CA 125.237 -0.735 . . . . 0.0 112.824 -0.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.91 153.61 21.17 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.43 -166.95 14.35 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.868 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 153.95 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.4 m -87.09 99.0 11.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.834 0.349 . . . . 0.0 110.634 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 152.91 23.17 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.314 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.32 134.14 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.271 -179.884 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -116.74 98.14 6.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.2 p -84.53 147.0 48.37 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.764 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.456 ' HB3' ' OE1' ' A' ' 8' ' ' GLU . 57.5 Cg_endo -69.71 168.66 20.86 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.355 2.704 . . . . 0.0 113.959 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.99 -157.57 12.87 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.702 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.523 ' OE1' HD12 ' A' ' 21' ' ' LEU . 32.8 tt0 -78.94 122.36 26.05 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.747 0.308 . . . . 0.0 110.98 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.82 31.47 9.3 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.041 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.456 ' OE1' ' HB3' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -129.19 164.82 22.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.524 0.329 . . . . 0.0 110.145 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -79.95 132.88 36.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.909 0.385 . . . . 0.0 111.672 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.69 124.56 42.45 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.71 156.41 17.66 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.55 16.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.13 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.93 -65.03 0.99 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.757 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.423 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.14 1.59 0.41 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.49 73.85 11.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.6 Cg_endo -93.6 170.76 2.0 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.278 2.652 . . . . 0.0 111.924 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.92 119.76 24.35 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.64 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.07 -36.35 0.57 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.64 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.81 5.61 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.436 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.536 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.03 62.55 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.52 2.146 . . . . 0.0 114.028 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.43 44.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.528 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.6 159.78 19.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.775 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.62 16.67 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.8 128.15 23.47 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.32 -51.08 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.593 0 C-N-CA 124.257 -1.143 . . . . 0.0 113.648 -0.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.6 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.478 -0.392 . . . . 0.0 113.307 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.38 81.18 18.12 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -33.84 2.75 Favored 'Cis proline' 0 C--N 1.373 1.828 0 C-N-CA 125.251 -0.729 . . . . 0.0 112.77 -0.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.16 153.74 21.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 31' ' ' ILE . . . -151.3 -166.9 14.26 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.886 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 HD12 ' O ' ' A' ' 30' ' ' GLY . 12.0 mm -133.35 154.33 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.3 99.07 11.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.73 155.56 19.56 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.337 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.27 132.94 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.403 HD13 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.354 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 CA-C-O 120.301 -0.166 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.04 164.95 21.27 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.495 0.318 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.97 129.91 34.76 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.65 41.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.385 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.88 157.13 17.08 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.446 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.5 16.38 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.173 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.29 -64.73 1.02 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.697 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.71 3.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.28 70.15 21.84 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.2 Cg_endo -93.28 170.99 2.1 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 123.225 2.617 . . . . 0.0 111.912 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.2 m -85.54 106.16 16.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.342 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.2 -40.57 1.52 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.341 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.18 -178.5 2.15 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.263 1.975 . . . . 0.0 111.45 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.67 55.16 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.649 2.233 . . . . 0.0 114.548 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.26 48.32 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.202 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.28 159.96 18.12 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.853 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.65 105.02 17.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.1 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.961 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.43 -51.28 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.268 -1.138 . . . . 0.0 113.71 -0.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 34.02 19.17 Favored Glycine 0 C--N 1.344 0.995 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.271 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.56 81.5 17.19 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.61 -33.63 2.85 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 125.293 -0.711 . . . . 0.0 112.792 -0.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.92 154.17 20.45 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.165 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.28 -166.79 14.15 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.806 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.44 154.38 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.14 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.858 0.361 . . . . 0.0 110.528 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -105.54 155.96 18.69 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.41 133.14 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.734 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.186 -0.912 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 CA-C-O 120.292 -0.171 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.14 165.03 21.19 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.506 0.322 . . . . 0.0 110.391 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.94 129.86 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.61 41.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.465 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.86 157.07 17.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.432 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.53 16.27 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.146 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.14 -64.61 1.03 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.76 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.76 3.38 0.47 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.22 70.15 21.24 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.28 170.9 2.11 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.16 2.573 . . . . 0.0 111.859 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.4 m -85.4 106.13 16.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.365 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.22 -40.48 1.51 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.381 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.23 -178.46 2.15 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.247 1.965 . . . . 0.0 111.466 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -65.6 55.08 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.723 2.282 . . . . 0.0 114.559 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.3 48.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.202 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 159.9 18.25 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.823 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.6 104.98 17.07 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.949 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -129.45 128.14 23.12 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.46 -51.27 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.57 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.664 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 34.03 19.04 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.28 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.53 81.52 17.28 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.74 2.81 Favored 'Cis proline' 0 C--N 1.373 1.847 0 C-N-CA 125.282 -0.716 . . . . 0.0 112.749 -0.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -88.75 154.09 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.216 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.29 -166.81 14.16 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.793 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.4 mm -133.36 154.36 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.13 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.825 0.345 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.58 155.93 18.73 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.218 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.45 133.12 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.332 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 CA-C-O 119.972 -0.349 . . . . 0.0 113.324 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -97.72 167.01 11.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.306 0.243 . . . . 0.0 110.574 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -82.78 137.16 34.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.393 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.92 124.19 38.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.69 156.93 17.3 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.357 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.45 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.164 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.82 -64.61 1.02 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.739 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.09 3.4 0.44 Allowed 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.3 70.3 22.25 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.79 170.14 2.4 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.202 2.601 . . . . 0.0 111.807 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 m -83.85 106.32 15.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.737 0.303 . . . . 0.0 110.479 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -79.71 -40.6 1.41 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.313 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.59 -178.23 2.18 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.206 1.937 . . . . 0.0 111.422 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.564 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.73 55.27 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.598 2.198 . . . . 0.0 114.515 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.89 156.18 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.247 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.3 160.02 18.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.813 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.51 105.2 17.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.007 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.9 22.73 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.061 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.69 -51.53 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.598 0 C-N-CA 124.28 -1.133 . . . . 0.0 113.695 -0.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.52 34.1 17.51 Favored Glycine 0 C--N 1.344 1.027 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.267 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.46 81.41 17.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.56 -33.88 2.76 Favored 'Cis proline' 0 C--N 1.37 1.709 0 C-N-CA 125.227 -0.739 . . . . 0.0 112.743 -0.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.53 154.06 20.65 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.22 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.22 -167.22 14.55 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.769 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.3 mm -133.1 154.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 22' ' ' THR . 81.2 m -86.96 98.26 11.15 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.595 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.22 155.2 19.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.237 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.79 132.93 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.742 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.182 -0.914 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.531 0 CA-C-O 120.083 -0.287 . . . . 0.0 113.365 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -96.68 167.07 11.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.399 0.28 . . . . 0.0 110.597 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.59 137.49 34.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.477 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 p -126.93 124.56 39.79 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.448 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -102.61 156.49 17.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.413 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.62 15.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.04 -64.44 1.04 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.72 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.1 2.93 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.46 70.28 23.92 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.2 Cg_endo -92.65 169.89 2.5 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.128 2.552 . . . . 0.0 111.784 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.2 m -82.11 105.94 13.62 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.5 m -79.39 -40.59 1.48 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.293 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.12 -178.12 2.32 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.257 1.971 . . . . 0.0 111.41 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.561 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -66.0 55.43 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.634 2.223 . . . . 0.0 114.436 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.01 156.09 48.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.23 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.02 159.84 18.06 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.795 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.44 105.25 17.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.92 22.74 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.022 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.66 -51.67 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 124.252 -1.145 . . . . 0.0 113.667 -0.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.56 34.41 16.45 Favored Glycine 0 C--N 1.344 1.014 0 C-N-CA 121.435 -0.412 . . . . 0.0 113.196 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.27 81.25 18.33 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.96 2.73 Favored 'Cis proline' 0 C--N 1.373 1.852 0 C-N-CA 125.174 -0.761 . . . . 0.0 112.794 -0.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.2 154.0 20.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.11 -167.05 14.32 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.819 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.525 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.8 mm -132.98 153.91 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 22' ' ' THR . 90.5 m -86.83 98.33 11.13 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.59 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.31 155.14 19.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.27 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.75 132.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.772 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.358 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 CA-C-O 120.293 -0.171 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.16 165.11 21.05 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.52 0.328 . . . . 0.0 110.397 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.98 129.98 34.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.01 123.8 41.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.329 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.75 156.89 17.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 15.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.135 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.09 -64.69 1.01 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.743 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.22 0.46 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.2 70.27 21.21 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.9 Cg_endo -93.27 170.89 2.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.164 2.576 . . . . 0.0 111.816 178.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 m -84.89 105.98 16.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.707 0.289 . . . . 0.0 110.341 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.1 -40.52 1.54 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.378 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.21 -178.48 2.16 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.254 1.969 . . . . 0.0 111.495 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.74 55.13 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.672 2.248 . . . . 0.0 114.51 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.84 156.2 48.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.245 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.18 159.84 18.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.61 104.95 17.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.48 128.1 23.1 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.45 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.561 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.669 -0.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 33.89 19.44 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 121.39 -0.433 . . . . 0.0 113.285 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.34 81.5 17.82 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.65 -33.64 2.84 Favored 'Cis proline' 0 C--N 1.372 1.792 0 C-N-CA 125.311 -0.704 . . . . 0.0 112.775 -0.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -88.83 154.11 20.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.203 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.3 -166.67 14.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.841 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.7 mm -133.39 154.34 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.12 98.58 11.37 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 120.836 0.35 . . . . 0.0 110.568 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.63 155.84 18.84 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 133.25 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.68 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.412 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.331 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 CA-C-O 120.227 -0.207 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -130.47 166.81 19.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.419 0.288 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.33 130.99 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.789 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.76 123.36 40.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.207 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.41 17.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.49 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.31 15.78 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.146 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.08 -65.09 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.08 1.64 0.41 Allowed 'General case' 0 C--N 1.349 0.568 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -118.64 73.71 11.6 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.51 170.34 2.07 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.241 2.628 . . . . 0.0 111.945 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.7 m -81.71 119.57 24.01 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.625 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -84.94 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.91 -179.82 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.02 62.44 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.622 2.215 . . . . 0.0 114.05 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.73 158.35 44.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.336 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.51 159.71 19.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.699 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.48 104.66 16.72 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.89 127.92 23.42 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.904 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.43 -51.13 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.564 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.632 -0.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.58 34.03 20.55 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.279 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.25 81.16 18.52 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.66 -33.76 2.79 Favored 'Cis proline' 0 C--N 1.372 1.803 0 C-N-CA 125.29 -0.712 . . . . 0.0 112.854 -0.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.92 153.48 21.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.193 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.35 -167.04 14.41 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.85 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.13 154.06 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.6 m -87.29 99.07 11.7 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.64 155.52 19.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.3 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 132.94 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.351 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 CA-C-O 120.217 -0.213 . . . . 0.0 113.216 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -130.39 166.77 19.76 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 122.398 0.279 . . . . 0.0 110.404 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.33 130.98 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.752 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -123.76 123.21 40.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.268 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.45 156.47 17.58 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.38 15.8 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.191 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.03 -65.07 0.98 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.804 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.15 1.77 0.41 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.8 73.54 11.96 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.4 Cg_endo -93.43 170.29 2.1 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 123.226 2.618 . . . . 0.0 111.889 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -81.7 119.58 24.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.625 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.2 p -85.09 -36.29 0.57 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.86 5.66 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.214 1.943 . . . . 0.0 111.463 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.546 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.99 62.47 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.584 2.19 . . . . 0.0 113.972 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.83 158.33 44.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.256 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.46 159.73 19.2 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.717 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.44 104.59 16.64 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.87 127.89 23.43 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.42 -51.03 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.208 -1.164 . . . . 0.0 113.67 -0.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.05 21.05 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 121.449 -0.405 . . . . 0.0 113.298 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.28 81.11 18.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.75 2.78 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 125.259 -0.725 . . . . 0.0 112.858 -0.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.91 153.46 21.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.208 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.35 -166.94 14.31 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.828 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.1 mm -133.16 154.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.2 98.99 11.62 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.854 0.359 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.64 155.45 19.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.408 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.15 132.92 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.308 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.489 0 CA-C-O 120.086 -0.285 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -97.82 167.04 11.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.435 0.294 . . . . 0.0 110.548 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.6 137.29 34.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.448 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 p -126.97 124.29 39.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.58 156.78 17.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.349 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.59 15.33 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.191 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.53 -64.53 1.03 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.745 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.03 3.22 0.44 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.38 70.29 23.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.76 170.16 2.41 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.137 2.558 . . . . 0.0 111.818 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -83.22 106.1 14.73 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.745 0.307 . . . . 0.0 110.517 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -79.48 -40.65 1.46 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.251 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.85 -178.18 2.26 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.243 1.962 . . . . 0.0 111.376 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.565 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.0 Cg_exo -65.82 55.24 0.35 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.68 2.254 . . . . 0.0 114.47 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.86 156.0 48.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.28 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.03 160.0 17.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.49 105.14 17.25 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -130.06 127.94 22.74 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.57 -51.58 0.16 OUTLIER 'Cis proline' 0 C--N 1.369 1.618 0 C-N-CA 124.245 -1.148 . . . . 0.0 113.695 -0.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.45 34.33 17.03 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 121.44 -0.41 . . . . 0.0 113.231 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.48 81.34 17.62 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.544 0.172 . . . . 0.0 111.444 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.54 -33.89 2.76 Favored 'Cis proline' 0 C--N 1.373 1.835 0 C-N-CA 125.258 -0.726 . . . . 0.0 112.807 -0.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.46 154.02 20.7 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.187 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.14 -167.25 14.54 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.756 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.1 mm -133.03 154.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 22' ' ' THR . 85.0 m -86.93 98.23 11.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.933 0.397 . . . . 0.0 110.581 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -105.23 155.14 19.34 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.277 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.65 132.84 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.776 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.333 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.45 0 CA-C-O 120.241 -0.199 . . . . 0.0 113.101 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.4 166.81 19.67 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.481 0.312 . . . . 0.0 110.393 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.32 131.07 35.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.699 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.87 123.47 40.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.206 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.49 156.46 17.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.519 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.34 15.61 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.143 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 -65.12 0.98 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.735 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.14 1.74 0.41 Allowed 'General case' 0 C--N 1.349 0.581 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.55 73.74 11.34 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.4 Cg_endo -93.58 170.34 2.04 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 123.227 2.618 . . . . 0.0 111.88 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 m -81.6 119.53 23.9 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.86 -36.42 0.58 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.83 5.63 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.135 1.89 . . . . 0.0 111.534 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.07 62.62 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.591 2.194 . . . . 0.0 114.058 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.89 158.36 44.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.241 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.53 159.63 19.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.805 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.38 104.55 16.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.0 mt -128.93 127.95 23.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.946 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.48 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.22 -1.158 . . . . 0.0 113.647 -0.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.54 34.06 20.59 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.486 -0.388 . . . . 0.0 113.193 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.12 81.0 19.14 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.79 -33.77 2.76 Favored 'Cis proline' 0 C--N 1.372 1.794 0 C-N-CA 125.225 -0.739 . . . . 0.0 112.833 -0.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.88 153.55 21.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.38 -166.91 14.3 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.877 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.14 154.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.1 m -87.29 99.04 11.68 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.828 0.346 . . . . 0.0 110.61 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 155.46 19.65 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.93 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.788 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.307 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.547 0 CA-C-O 120.143 -0.254 . . . . 0.0 113.128 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -129.67 166.49 19.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.432 0.293 . . . . 0.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -79.99 132.96 36.12 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.807 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.25 123.64 39.96 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.258 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.48 156.37 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.508 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.28 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.88 -65.16 0.98 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.09 1.57 0.41 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.48 73.8 11.16 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.2 Cg_endo -93.51 170.29 2.07 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.272 2.648 . . . . 0.0 111.883 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -81.31 119.56 23.82 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.631 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.3 p -84.88 -36.56 0.58 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.631 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.96 5.74 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.142 1.894 . . . . 0.0 111.552 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.95 62.76 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.587 2.191 . . . . 0.0 113.996 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.93 158.58 43.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.65 159.66 19.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.785 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.47 104.59 16.64 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.81 128.02 23.46 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.996 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.45 -50.99 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.573 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.694 -0.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.45 34.05 20.91 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.21 81.15 18.66 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.71 -33.86 2.74 Favored 'Cis proline' 0 C--N 1.371 1.741 0 C-N-CA 125.243 -0.732 . . . . 0.0 112.768 -0.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.96 153.51 21.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.23 -166.94 14.27 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.864 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.21 154.2 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.31 99.15 11.76 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.859 0.361 . . . . 0.0 110.585 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.01 155.47 19.77 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.373 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.17 132.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.777 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.292 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 CA-C-O 120.266 -0.185 . . . . 0.0 113.184 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 166.82 19.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.433 0.293 . . . . 0.0 110.434 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.34 131.18 35.59 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.726 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.86 123.54 40.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.243 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.41 17.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.483 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.42 15.53 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.239 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.64 -64.91 1.0 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.773 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.37 1.66 0.39 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.5 73.81 11.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.4 Cg_endo -93.48 170.5 2.07 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.21 2.607 . . . . 0.0 111.877 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 m -81.51 119.47 23.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.631 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.4 p -84.79 -36.48 0.59 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.631 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 Cg_endo -79.99 -179.9 5.67 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.172 1.915 . . . . 0.0 111.499 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.05 62.79 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.565 2.177 . . . . 0.0 114.051 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.92 158.45 44.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.302 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.56 159.62 19.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.782 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.47 104.58 16.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.77 128.0 23.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.36 -51.09 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.523 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.716 -0.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.57 34.02 20.61 Favored Glycine 0 C--N 1.345 1.041 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.27 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.21 81.0 18.87 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.82 -33.8 2.74 Favored 'Cis proline' 0 C--N 1.373 1.823 0 C-N-CA 125.272 -0.72 . . . . 0.0 112.823 -0.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -87.88 153.62 21.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.203 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.39 -166.96 14.34 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.829 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 154.02 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.6 m -87.2 99.16 11.75 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.859 0.361 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.86 155.6 19.57 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.24 133.0 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.408 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.325 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 CA-C-O 120.211 -0.216 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -129.73 166.59 19.55 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.456 0.302 . . . . 0.0 110.381 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -80.04 132.99 36.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.758 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.42 123.67 39.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.242 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.33 17.66 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.525 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.32 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.214 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.69 -65.15 0.98 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.763 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t80 -151.22 1.69 0.41 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.5 73.82 11.25 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.47 170.48 2.07 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.254 2.636 . . . . 0.0 111.952 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.9 m -81.39 119.49 23.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.63 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.0 p -84.66 -36.68 0.6 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.63 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.96 -179.95 5.72 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.117 1.878 . . . . 0.0 111.456 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.7 Cg_exo -64.91 62.72 0.29 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.62 2.213 . . . . 0.0 114.018 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.9 158.64 43.74 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.331 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.71 159.66 19.47 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.708 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.49 104.47 16.51 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.75 128.02 23.49 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.988 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.38 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.583 0 C-N-CA 124.195 -1.169 . . . . 0.0 113.717 -0.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 33.96 20.8 Favored Glycine 0 C--N 1.345 1.032 0 C-N-CA 121.469 -0.396 . . . . 0.0 113.251 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -140.22 81.07 18.74 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.66 -33.9 2.73 Favored 'Cis proline' 0 C--N 1.372 1.811 0 C-N-CA 125.267 -0.722 . . . . 0.0 112.833 -0.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -87.93 153.63 21.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.24 -167.06 14.39 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.9 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.22 154.24 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.8 m -87.34 99.27 11.86 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.607 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.05 155.45 19.82 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.353 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.11 132.89 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.708 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.449 0 CA-C-O 120.3 -0.166 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.38 164.89 20.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.446 0.298 . . . . 0.0 110.302 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.7 131.92 35.51 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.588 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.27 123.82 41.07 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.365 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.67 156.77 17.29 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.475 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.68 16.61 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.226 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.2 -64.54 1.03 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.712 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.83 3.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.18 70.64 21.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.3 171.32 2.06 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.201 2.6 . . . . 0.0 111.892 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.37 105.98 15.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.768 0.318 . . . . 0.0 110.301 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 63.6 m -78.91 -39.89 1.54 Allowed Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.562 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.5 Cg_exo -71.5 -179.65 3.86 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.193 1.929 . . . . 0.0 111.176 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' O ' HD13 ' A' ' 21' ' ' LEU . 35.8 Cg_endo -64.64 56.41 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.354 2.036 . . . . 0.0 114.83 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.03 156.47 48.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.106 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.28 159.75 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.767 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.1 t -98.65 104.8 16.87 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.3 128.01 23.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.944 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.5 -51.35 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.556 0 C-N-CA 124.221 -1.158 . . . . 0.0 113.743 -0.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.27 33.9 18.83 Favored Glycine 0 C--N 1.345 1.047 0 C-N-CA 121.358 -0.448 . . . . 0.0 113.197 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.5 81.64 17.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.48 -33.7 2.84 Favored 'Cis proline' 0 C--N 1.372 1.779 0 C-N-CA 125.271 -0.721 . . . . 0.0 112.837 -0.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.91 154.24 20.4 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.21 -166.7 14.04 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.43 154.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 22' ' ' THR . 76.4 m -87.24 98.77 11.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.881 0.372 . . . . 0.0 110.57 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 153.46 22.02 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.211 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.5 tt -94.65 134.45 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.709 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.278 -179.95 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 CA-C-O 120.329 -0.151 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -129.25 162.44 27.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.527 0.331 . . . . 0.0 110.245 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -79.85 130.44 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.446 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 124.33 42.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.464 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.97 157.12 17.09 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.44 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.71 18.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.22 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.53 -64.51 1.06 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.782 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.39 0.46 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.14 70.34 20.63 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.53 171.25 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 123.209 2.606 . . . . 0.0 111.991 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.41 106.17 17.25 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.317 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.4 m -79.29 -40.38 1.48 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.392 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.94 -178.58 2.09 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.248 1.965 . . . . 0.0 111.488 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.57 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.3 Cg_exo -65.63 55.26 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.648 2.232 . . . . 0.0 114.567 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.83 156.34 48.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.218 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.38 160.04 18.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.4 t -98.74 105.09 17.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -129.56 128.23 23.07 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.016 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.32 -51.15 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.53 0 C-N-CA 124.295 -1.127 . . . . 0.0 113.722 -0.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 33.86 19.61 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.77 81.75 16.34 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -33.63 2.88 Favored 'Cis proline' 0 C--N 1.373 1.826 0 C-N-CA 125.326 -0.698 . . . . 0.0 112.864 -0.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -89.19 154.29 20.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.241 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.531 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.27 -166.66 14.02 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.848 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.531 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.71 154.74 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 22' ' ' THR . 70.9 m -87.12 98.54 11.35 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.812 0.339 . . . . 0.0 110.57 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -105.65 156.14 18.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.273 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.56 133.29 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.721 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.365 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.47 0 CA-C-O 120.18 -0.234 . . . . 0.0 113.157 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -129.26 166.6 19.11 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.422 0.289 . . . . 0.0 110.331 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.13 132.93 36.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.835 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.08 123.48 39.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.238 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.44 15.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.176 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.68 -64.96 0.99 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.4 1.59 0.39 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.46 73.82 11.12 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.3 Cg_endo -93.54 170.19 2.07 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.191 2.594 . . . . 0.0 111.85 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 m -81.29 119.31 23.48 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.5 p -84.88 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -80.0 -179.84 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.076 1.851 . . . . 0.0 111.519 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.66 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.57 2.18 . . . . 0.0 113.98 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.94 158.56 43.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.62 159.75 19.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.701 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.6 104.58 16.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.986 0.422 . . . . 0.0 110.862 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.84 127.85 23.44 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.059 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.52 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.549 0 C-N-CA 124.205 -1.165 . . . . 0.0 113.626 -0.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.5 33.98 20.94 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.229 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.38 81.15 18.15 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.69 -33.87 2.73 Favored 'Cis proline' 0 C--N 1.372 1.813 0 C-N-CA 125.275 -0.719 . . . . 0.0 112.803 -0.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -88.09 153.61 21.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.34 -167.07 14.44 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.851 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.17 154.1 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.5 m -87.18 99.21 11.77 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.759 0.314 . . . . 0.0 110.593 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -106.94 155.42 19.8 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.361 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.11 132.83 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.77 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.156 -0.925 . . . . 0.0 111.307 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.464 0 CA-C-O 120.2 -0.222 . . . . 0.0 113.183 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -129.46 166.46 19.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 122.381 0.272 . . . . 0.0 110.345 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -80.15 132.93 36.01 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.723 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.97 123.26 39.5 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.203 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.35 156.1 17.81 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.486 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.82 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.138 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -97.97 -65.02 0.99 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.71 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.66 1.51 0.37 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.23 73.95 10.5 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.7 Cg_endo -93.57 170.24 2.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.278 2.652 . . . . 0.0 111.946 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -81.44 119.42 23.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.628 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.02 -36.43 0.57 Allowed Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.628 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.92 -179.8 5.6 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.181 1.921 . . . . 0.0 111.431 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.0 62.37 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.618 2.212 . . . . 0.0 113.943 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.74 158.47 44.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.385 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.54 159.8 19.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.42 16.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.67 127.9 23.52 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.44 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.553 0 C-N-CA 124.202 -1.166 . . . . 0.0 113.625 -0.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.38 34.07 21.06 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.545 -0.359 . . . . 0.0 113.254 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.2 80.94 18.98 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.82 -33.83 2.73 Favored 'Cis proline' 0 C--N 1.372 1.806 0 C-N-CA 125.2 -0.75 . . . . 0.0 112.812 -0.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.67 153.45 21.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.248 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.42 -167.08 14.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.862 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.17 154.17 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.26 99.15 11.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.775 0.321 . . . . 0.0 110.552 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -106.96 155.29 19.95 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.88 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.297 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.406 0 CA-C-O 120.29 -0.172 . . . . 0.0 112.9 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -128.06 164.92 21.35 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.482 0.313 . . . . 0.0 110.395 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -81.01 129.84 34.73 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.571 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.04 123.59 41.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.91 157.17 17.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.55 16.85 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.163 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.9 -64.67 1.03 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.723 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.72 3.56 0.47 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.28 70.11 21.72 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.3 Cg_endo -93.24 171.02 2.11 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.242 2.628 . . . . 0.0 111.963 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 m -85.79 106.23 16.88 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.694 0.283 . . . . 0.0 110.316 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -79.25 -40.55 1.51 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.835 -0.602 . . . . 0.0 112.38 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.09 -178.53 2.13 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.309 2.006 . . . . 0.0 111.44 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.568 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.68 55.17 0.33 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.638 2.225 . . . . 0.0 114.544 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.74 156.33 48.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.248 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 160.02 18.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.799 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.3 t -98.67 105.07 17.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.04 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.946 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.53 -51.24 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.222 -1.157 . . . . 0.0 113.62 -0.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.02 19.1 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.446 -0.407 . . . . 0.0 113.242 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.59 81.59 17.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -33.72 2.84 Favored 'Cis proline' 0 C--N 1.372 1.786 0 C-N-CA 125.295 -0.71 . . . . 0.0 112.836 -0.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.91 154.12 20.5 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.18 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.53 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.27 -166.88 14.23 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.814 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.5 mm -133.36 154.41 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.22 98.58 11.4 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.847 0.356 . . . . 0.0 110.468 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.56 155.99 18.67 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.43 133.19 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.766 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.325 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 CA-C-O 120.062 -0.299 . . . . 0.0 113.312 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -97.41 167.01 11.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.398 0.279 . . . . 0.0 110.622 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -82.61 137.39 34.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.477 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 p -127.27 123.64 36.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.467 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.96 17.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.42 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 16.11 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.209 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.74 -64.43 1.04 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -151.0 3.43 0.45 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.3 70.2 22.12 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.3 Cg_endo -92.67 170.56 2.42 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.228 2.618 . . . . 0.0 111.85 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 m -83.86 106.89 15.9 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.748 0.309 . . . . 0.0 110.474 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 64.4 m -80.02 -40.08 1.29 Allowed Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.458 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.3 Cg_exo -71.65 -179.48 3.78 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.31 2.007 . . . . 0.0 111.179 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.571 ' O ' HD13 ' A' ' 21' ' ' LEU . 35.3 Cg_endo -64.76 56.59 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.445 2.096 . . . . 0.0 114.644 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.07 156.2 48.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.2 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.3 t -112.28 159.74 18.33 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.39 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.979 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -129.98 127.96 22.8 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.014 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 44.2 Cg_endo -69.62 -51.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.578 0 C-N-CA 124.171 -1.179 . . . . 0.0 113.665 -0.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 34.68 16.27 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.444 -0.407 . . . . 0.0 113.177 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' OD1' ' HB2' ' A' ' 25' ' ' PRO . 2.8 p-10 -140.36 80.73 18.88 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.43 -34.01 2.73 Favored 'Cis proline' 0 C--N 1.372 1.778 0 CA-C-N 119.147 0.731 . . . . 0.0 112.88 -0.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.02 153.78 21.01 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.272 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.22 -167.32 14.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.77 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.0 mm -133.19 153.92 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 22' ' ' THR . 88.1 m -86.83 98.37 11.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 120.893 0.378 . . . . 0.0 110.559 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.27 155.03 19.46 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.261 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.61 132.86 34.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.399 0 CA-C-O 120.19 -0.228 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.77 166.64 20.36 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.473 0.309 . . . . 0.0 110.355 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.35 130.89 35.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.727 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.67 123.43 40.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.283 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.525 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.29 15.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.181 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -98.93 -65.02 0.99 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.715 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.28 1.62 0.4 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.57 73.75 11.39 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.49 170.41 2.07 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.169 2.579 . . . . 0.0 111.851 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.64 119.6 24.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.95 -36.46 0.58 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.84 -179.84 5.65 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.585 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.57 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.549 2.166 . . . . 0.0 114.006 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.38 44.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.267 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.58 159.81 19.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.71 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.46 104.52 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.85 127.95 23.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.042 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.41 -51.14 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.516 0 C-N-CA 124.232 -1.153 . . . . 0.0 113.69 -0.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.62 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.436 -0.412 . . . . 0.0 113.226 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.16 81.1 18.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.78 2.77 Favored 'Cis proline' 0 C--N 1.373 1.83 0 C-N-CA 125.237 -0.735 . . . . 0.0 112.824 -0.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.91 153.61 21.17 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.43 -166.95 14.35 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.868 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 153.95 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.4 m -87.09 99.0 11.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.834 0.349 . . . . 0.0 110.634 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 152.91 23.17 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.314 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.32 134.14 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.271 -179.884 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.041 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.19 164.82 22.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.524 0.329 . . . . 0.0 110.145 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -79.95 132.88 36.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.909 0.385 . . . . 0.0 111.672 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.69 124.56 42.45 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.71 156.41 17.66 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.55 16.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.13 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.93 -65.03 0.99 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.757 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.43 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.14 1.59 0.41 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.49 73.85 11.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.6 Cg_endo -93.6 170.76 2.0 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.278 2.652 . . . . 0.0 111.924 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.92 119.76 24.35 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.626 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.07 -36.35 0.57 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.626 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.81 5.61 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.436 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.03 62.55 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.52 2.146 . . . . 0.0 114.028 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.43 44.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.6 159.78 19.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.775 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.62 16.67 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.8 128.15 23.47 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.32 -51.08 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.593 0 C-N-CA 124.257 -1.143 . . . . 0.0 113.648 -0.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.6 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.478 -0.392 . . . . 0.0 113.307 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.38 81.18 18.12 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -33.84 2.75 Favored 'Cis proline' 0 C--N 1.373 1.828 0 C-N-CA 125.251 -0.729 . . . . 0.0 112.77 -0.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.16 153.74 21.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.3 -166.9 14.26 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.886 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.0 mm -133.35 154.33 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.3 99.07 11.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.73 155.56 19.56 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.337 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.27 132.94 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.354 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -109.52 96.25 6.15 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.392 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.7 m -81.62 148.86 63.08 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.834 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.33 163.96 35.96 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 123.282 2.655 . . . . 0.0 113.37 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.76 -162.04 24.04 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.99 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' OE1' HD11 ' A' ' 21' ' ' LEU . 29.1 tt0 -78.89 122.17 25.77 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.433 0.293 . . . . 0.0 110.926 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.93 32.65 7.81 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.883 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.04 164.95 21.27 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.495 0.318 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.97 129.91 34.76 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.65 41.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.385 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.88 157.13 17.08 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.446 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.5 16.38 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.173 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.29 -64.73 1.02 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.697 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.71 3.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.28 70.15 21.84 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.2 Cg_endo -93.28 170.99 2.1 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 123.225 2.617 . . . . 0.0 111.912 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.2 m -85.54 106.16 16.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.342 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.2 -40.57 1.52 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.341 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.18 -178.5 2.15 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.263 1.975 . . . . 0.0 111.45 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.67 55.16 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.649 2.233 . . . . 0.0 114.548 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.26 48.32 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.202 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.28 159.96 18.12 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.853 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.65 105.02 17.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.1 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.961 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.43 -51.28 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.268 -1.138 . . . . 0.0 113.71 -0.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 34.02 19.17 Favored Glycine 0 C--N 1.344 0.995 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.271 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.56 81.5 17.19 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.61 -33.63 2.85 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 125.293 -0.711 . . . . 0.0 112.792 -0.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.92 154.17 20.45 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.165 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.28 -166.79 14.15 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.806 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.44 154.38 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.14 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.858 0.361 . . . . 0.0 110.528 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -105.54 155.96 18.69 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.41 133.14 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.734 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.186 -0.912 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.52 96.31 6.19 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.296 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.2 m -81.68 148.83 62.78 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.89 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.36 163.99 35.84 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.26 2.64 . . . . 0.0 113.341 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.76 -162.08 24.04 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.981 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' OE1' HD11 ' A' ' 21' ' ' LEU . 29.2 tt0 -78.94 122.1 25.71 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.735 0.302 . . . . 0.0 110.912 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.0 32.75 7.71 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.842 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.14 165.03 21.19 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.506 0.322 . . . . 0.0 110.391 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.94 129.86 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.61 41.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.465 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.86 157.07 17.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.432 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.53 16.27 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.146 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.14 -64.61 1.03 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.76 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.76 3.38 0.47 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.22 70.15 21.24 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.28 170.9 2.11 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.16 2.573 . . . . 0.0 111.859 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.4 m -85.4 106.13 16.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.365 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.22 -40.48 1.51 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.381 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.23 -178.46 2.15 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.247 1.965 . . . . 0.0 111.466 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -65.6 55.08 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.723 2.282 . . . . 0.0 114.559 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.3 48.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.202 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 159.9 18.25 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.823 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.6 104.98 17.07 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.949 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -129.45 128.14 23.12 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.46 -51.27 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.57 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.664 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 34.03 19.04 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.28 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.53 81.52 17.28 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.74 2.81 Favored 'Cis proline' 0 C--N 1.373 1.847 0 C-N-CA 125.282 -0.716 . . . . 0.0 112.749 -0.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -88.75 154.09 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.216 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.29 -166.81 14.16 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.793 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.4 mm -133.36 154.36 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.13 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.825 0.345 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.58 155.93 18.73 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.218 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.45 133.12 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.332 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.254 . . . . . . . 0 C--O 1.235 0.313 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.17 96.23 6.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.346 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.0 m -81.26 148.76 64.18 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.909 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.8 164.05 34.93 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 123.328 2.685 . . . . 0.0 113.408 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.41 -164.44 23.63 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.17 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.4 tt0 -77.05 122.78 25.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.742 0.306 . . . . 0.0 111.161 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.39 0.76 58.09 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.324 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -97.72 167.01 11.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.306 0.243 . . . . 0.0 110.574 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -82.78 137.16 34.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.393 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.92 124.19 38.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.69 156.93 17.3 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.357 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.45 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.164 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.82 -64.61 1.02 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.739 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.09 3.4 0.44 Allowed 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.3 70.3 22.25 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.79 170.14 2.4 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.202 2.601 . . . . 0.0 111.807 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 m -83.85 106.32 15.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.737 0.303 . . . . 0.0 110.479 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -79.71 -40.6 1.41 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.313 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.59 -178.23 2.18 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.206 1.937 . . . . 0.0 111.422 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.564 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.73 55.27 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.598 2.198 . . . . 0.0 114.515 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.89 156.18 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.247 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.3 160.02 18.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.813 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.51 105.2 17.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.007 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.9 22.73 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.061 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.69 -51.53 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.598 0 C-N-CA 124.28 -1.133 . . . . 0.0 113.695 -0.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.52 34.1 17.51 Favored Glycine 0 C--N 1.344 1.027 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.267 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.46 81.41 17.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.56 -33.88 2.76 Favored 'Cis proline' 0 C--N 1.37 1.709 0 C-N-CA 125.227 -0.739 . . . . 0.0 112.743 -0.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.53 154.06 20.65 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.22 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.22 -167.22 14.55 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.769 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.3 mm -133.1 154.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 22' ' ' THR . 81.2 m -86.96 98.26 11.15 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.595 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.22 155.2 19.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.237 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.79 132.93 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.742 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.182 -0.914 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.236 0.36 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -111.31 96.64 6.24 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.313 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.6 m -80.73 148.34 65.06 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.909 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.07 163.34 38.08 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 123.361 2.708 . . . . 0.0 113.415 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.41 -166.4 23.72 Favored Glycine 0 C--N 1.337 0.637 0 O-C-N 123.654 0.596 . . . . 0.0 112.088 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.0 tt0 -75.29 121.23 21.88 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.466 0.306 . . . . 0.0 111.165 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.18 -0.64 57.32 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.365 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -96.68 167.07 11.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.399 0.28 . . . . 0.0 110.597 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.59 137.49 34.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.477 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 p -126.93 124.56 39.79 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.448 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -102.61 156.49 17.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.413 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.62 15.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.04 -64.44 1.04 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.72 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.1 2.93 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.46 70.28 23.92 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.2 Cg_endo -92.65 169.89 2.5 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.128 2.552 . . . . 0.0 111.784 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.2 m -82.11 105.94 13.62 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.5 m -79.39 -40.59 1.48 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.293 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.12 -178.12 2.32 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.257 1.971 . . . . 0.0 111.41 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.561 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -66.0 55.43 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.634 2.223 . . . . 0.0 114.436 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.01 156.09 48.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.23 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.02 159.84 18.06 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.795 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.44 105.25 17.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.92 22.74 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.022 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.66 -51.67 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 124.252 -1.145 . . . . 0.0 113.667 -0.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.56 34.41 16.45 Favored Glycine 0 C--N 1.344 1.014 0 C-N-CA 121.435 -0.412 . . . . 0.0 113.196 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.27 81.25 18.33 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.96 2.73 Favored 'Cis proline' 0 C--N 1.373 1.852 0 C-N-CA 125.174 -0.761 . . . . 0.0 112.794 -0.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.2 154.0 20.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.11 -167.05 14.32 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.819 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.525 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.8 mm -132.98 153.91 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 22' ' ' THR . 90.5 m -86.83 98.33 11.13 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.59 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.31 155.14 19.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.27 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.75 132.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.772 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.358 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -110.29 96.55 6.28 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.998 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.2 m -81.68 148.6 62.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.925 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.55 163.87 36.46 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 123.25 2.633 . . . . 0.0 113.357 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.61 -162.42 24.22 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.956 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.434 ' OE1' HD11 ' A' ' 21' ' ' LEU . 29.3 tt0 -78.67 121.93 25.32 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.768 0.318 . . . . 0.0 110.963 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.02 32.51 7.86 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.939 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.16 165.11 21.05 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.52 0.328 . . . . 0.0 110.397 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.98 129.98 34.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.01 123.8 41.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.329 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.75 156.89 17.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 15.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.135 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.09 -64.69 1.01 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.743 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.22 0.46 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.2 70.27 21.21 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.9 Cg_endo -93.27 170.89 2.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.164 2.576 . . . . 0.0 111.816 178.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 m -84.89 105.98 16.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.707 0.289 . . . . 0.0 110.341 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.1 -40.52 1.54 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.378 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.21 -178.48 2.16 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.254 1.969 . . . . 0.0 111.495 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.74 55.13 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.672 2.248 . . . . 0.0 114.51 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.84 156.2 48.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.245 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.18 159.84 18.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.61 104.95 17.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.48 128.1 23.1 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.45 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.561 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.669 -0.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 33.89 19.44 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 121.39 -0.433 . . . . 0.0 113.285 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.34 81.5 17.82 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.65 -33.64 2.84 Favored 'Cis proline' 0 C--N 1.372 1.792 0 C-N-CA 125.311 -0.704 . . . . 0.0 112.775 -0.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -88.83 154.11 20.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.203 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.3 -166.67 14.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.841 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.7 mm -133.39 154.34 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.12 98.58 11.37 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 120.836 0.35 . . . . 0.0 110.568 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.63 155.84 18.84 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 133.25 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.68 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.412 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.331 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.65 96.21 5.85 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.348 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.8 p -87.51 147.15 41.13 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.667 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.5 Cg_endo -69.65 168.19 22.14 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.445 2.763 . . . . 0.0 113.882 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.56 -157.57 13.31 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.713 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' OE1' HD11 ' A' ' 21' ' ' LEU . 32.9 tt0 -78.87 122.2 25.79 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.766 0.283 . . . . 0.0 111.008 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.61 32.94 8.25 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.081 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -130.47 166.81 19.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.419 0.288 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.33 130.99 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.789 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.76 123.36 40.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.207 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.41 17.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.49 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.31 15.78 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.146 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.08 -65.09 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.08 1.64 0.41 Allowed 'General case' 0 C--N 1.349 0.568 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -118.64 73.71 11.6 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -93.51 170.34 2.07 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.241 2.628 . . . . 0.0 111.945 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.7 m -81.71 119.57 24.01 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.625 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -84.94 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.91 -179.82 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.02 62.44 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.622 2.215 . . . . 0.0 114.05 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.73 158.35 44.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.336 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.51 159.71 19.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.699 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.48 104.66 16.72 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.89 127.92 23.42 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.904 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.43 -51.13 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.564 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.632 -0.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.58 34.03 20.55 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.279 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.25 81.16 18.52 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.66 -33.76 2.79 Favored 'Cis proline' 0 C--N 1.372 1.803 0 C-N-CA 125.29 -0.712 . . . . 0.0 112.854 -0.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.92 153.48 21.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.193 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.35 -167.04 14.41 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.85 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.13 154.06 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.6 m -87.29 99.07 11.7 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.64 155.52 19.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.3 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 132.94 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.351 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.46 96.21 5.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.428 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.6 p -87.56 147.17 41.08 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.581 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.4 Cg_endo -69.7 168.21 22.12 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 123.377 2.718 . . . . 0.0 113.874 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.58 -157.59 13.31 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.68 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' OE1' HD11 ' A' ' 21' ' ' LEU . 32.9 tt0 -78.85 122.32 25.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.755 0.278 . . . . 0.0 110.998 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.58 32.76 8.4 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.216 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -130.39 166.77 19.76 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 122.398 0.279 . . . . 0.0 110.404 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.33 130.98 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.752 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -123.76 123.21 40.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.268 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.45 156.47 17.58 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.38 15.8 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.191 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.03 -65.07 0.98 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.804 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.15 1.77 0.41 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -118.8 73.54 11.96 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.4 Cg_endo -93.43 170.29 2.1 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 123.226 2.618 . . . . 0.0 111.889 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -81.7 119.58 24.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.625 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.2 p -85.09 -36.29 0.57 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.86 5.66 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.214 1.943 . . . . 0.0 111.463 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.546 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.99 62.47 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.584 2.19 . . . . 0.0 113.972 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.83 158.33 44.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.256 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.46 159.73 19.2 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.717 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.44 104.59 16.64 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.87 127.89 23.43 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.42 -51.03 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.208 -1.164 . . . . 0.0 113.67 -0.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.05 21.05 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 121.449 -0.405 . . . . 0.0 113.298 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.28 81.11 18.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.75 2.78 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 125.259 -0.725 . . . . 0.0 112.858 -0.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.91 153.46 21.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.208 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.35 -166.94 14.31 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.828 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.1 mm -133.16 154.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.2 98.99 11.62 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.854 0.359 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.64 155.45 19.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.408 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.15 132.92 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.308 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.235 0.312 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.46 96.5 6.23 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.257 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.7 m -80.9 148.59 65.1 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.88 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.96 163.78 36.26 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 123.294 2.663 . . . . 0.0 113.394 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.41 -165.26 23.66 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.083 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.456 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.2 tt0 -76.36 122.12 24.01 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.462 0.305 . . . . 0.0 111.176 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.62 0.66 57.79 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.366 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -97.82 167.04 11.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.435 0.294 . . . . 0.0 110.548 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.6 137.29 34.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.448 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 p -126.97 124.29 39.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.58 156.78 17.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.349 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.59 15.33 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.191 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.53 -64.53 1.03 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.745 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.03 3.22 0.44 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.38 70.29 23.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.76 170.16 2.41 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.137 2.558 . . . . 0.0 111.818 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -83.22 106.1 14.73 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.745 0.307 . . . . 0.0 110.517 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -79.48 -40.65 1.46 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.251 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.85 -178.18 2.26 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.243 1.962 . . . . 0.0 111.376 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.565 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.0 Cg_exo -65.82 55.24 0.35 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.68 2.254 . . . . 0.0 114.47 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.86 156.0 48.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.28 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.03 160.0 17.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.49 105.14 17.25 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -130.06 127.94 22.74 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.57 -51.58 0.16 OUTLIER 'Cis proline' 0 C--N 1.369 1.618 0 C-N-CA 124.245 -1.148 . . . . 0.0 113.695 -0.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.45 34.33 17.03 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 121.44 -0.41 . . . . 0.0 113.231 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.48 81.34 17.62 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.544 0.172 . . . . 0.0 111.444 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.54 -33.89 2.76 Favored 'Cis proline' 0 C--N 1.373 1.835 0 C-N-CA 125.258 -0.726 . . . . 0.0 112.807 -0.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.46 154.02 20.7 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.187 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.14 -167.25 14.54 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.756 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.1 mm -133.03 154.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 22' ' ' THR . 85.0 m -86.93 98.23 11.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.933 0.397 . . . . 0.0 110.581 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -105.23 155.14 19.34 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.277 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.65 132.84 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.776 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.333 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.254 . . . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -115.68 97.5 6.17 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.351 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.2 p -85.28 147.03 46.25 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.746 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.6 Cg_endo -69.82 168.08 22.68 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.361 2.707 . . . . 0.0 113.86 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.47 -157.52 13.38 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.672 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.0 tt0 -78.94 122.11 25.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.754 0.311 . . . . 0.0 110.998 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.72 32.79 8.31 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.101 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.4 166.81 19.67 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.481 0.312 . . . . 0.0 110.393 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.32 131.07 35.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.699 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.87 123.47 40.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.206 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.49 156.46 17.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.519 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.34 15.61 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.143 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 -65.12 0.98 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.735 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.14 1.74 0.41 Allowed 'General case' 0 C--N 1.349 0.581 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -118.55 73.74 11.34 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.4 Cg_endo -93.58 170.34 2.04 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 123.227 2.618 . . . . 0.0 111.88 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 m -81.6 119.53 23.9 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.86 -36.42 0.58 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.83 5.63 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.135 1.89 . . . . 0.0 111.534 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.07 62.62 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.591 2.194 . . . . 0.0 114.058 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.89 158.36 44.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.241 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.53 159.63 19.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.805 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.38 104.55 16.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.0 mt -128.93 127.95 23.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.946 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.48 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.22 -1.158 . . . . 0.0 113.647 -0.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.54 34.06 20.59 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.486 -0.388 . . . . 0.0 113.193 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.12 81.0 19.14 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.79 -33.77 2.76 Favored 'Cis proline' 0 C--N 1.372 1.794 0 C-N-CA 125.225 -0.739 . . . . 0.0 112.833 -0.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.88 153.55 21.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.38 -166.91 14.3 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.877 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.14 154.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.1 m -87.29 99.04 11.68 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.828 0.346 . . . . 0.0 110.61 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 155.46 19.65 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.93 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.788 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.307 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.254 . . . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -118.07 98.67 6.43 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.4 p -83.78 146.84 50.35 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.747 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.6 Cg_endo -69.7 168.03 22.64 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 123.404 2.736 . . . . 0.0 113.87 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.53 -157.74 13.43 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.69 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.517 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.2 tt0 -78.74 122.03 25.5 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.714 0.293 . . . . 0.0 111.029 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.02 31.35 9.26 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.128 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -129.67 166.49 19.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.432 0.293 . . . . 0.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -79.99 132.96 36.12 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.807 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.25 123.64 39.96 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.258 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.48 156.37 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.508 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.28 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.88 -65.16 0.98 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.09 1.57 0.41 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -118.48 73.8 11.16 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.2 Cg_endo -93.51 170.29 2.07 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.272 2.648 . . . . 0.0 111.883 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -81.31 119.56 23.82 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.631 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.3 p -84.88 -36.56 0.58 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.631 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.96 5.74 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.142 1.894 . . . . 0.0 111.552 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.95 62.76 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.587 2.191 . . . . 0.0 113.996 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.93 158.58 43.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.65 159.66 19.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.785 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.47 104.59 16.64 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.81 128.02 23.46 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.996 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.45 -50.99 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.573 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.694 -0.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.45 34.05 20.91 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.21 81.15 18.66 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.71 -33.86 2.74 Favored 'Cis proline' 0 C--N 1.371 1.741 0 C-N-CA 125.243 -0.732 . . . . 0.0 112.768 -0.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.96 153.51 21.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.23 -166.94 14.27 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.864 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.21 154.2 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.31 99.15 11.76 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.859 0.361 . . . . 0.0 110.585 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.01 155.47 19.77 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.373 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.17 132.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.777 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.292 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -120.92 100.03 6.85 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.207 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.6 p -81.92 146.77 56.54 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.843 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.9 Cg_endo -69.74 168.21 22.17 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 123.359 2.706 . . . . 0.0 113.942 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.55 -157.68 13.38 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.676 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.513 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.1 tt0 -78.75 122.07 25.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.748 0.274 . . . . 0.0 111.013 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.72 32.7 8.39 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.184 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 166.82 19.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.433 0.293 . . . . 0.0 110.434 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.34 131.18 35.59 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.726 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.86 123.54 40.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.243 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.41 17.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.483 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.42 15.53 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.239 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.64 -64.91 1.0 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.773 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.37 1.66 0.39 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -118.5 73.81 11.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.4 Cg_endo -93.48 170.5 2.07 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.21 2.607 . . . . 0.0 111.877 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 m -81.51 119.47 23.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.631 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.4 p -84.79 -36.48 0.59 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.631 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 Cg_endo -79.99 -179.9 5.67 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.172 1.915 . . . . 0.0 111.499 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.05 62.79 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.565 2.177 . . . . 0.0 114.051 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.92 158.45 44.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.302 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.56 159.62 19.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.782 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.47 104.58 16.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.77 128.0 23.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.36 -51.09 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.523 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.716 -0.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.57 34.02 20.61 Favored Glycine 0 C--N 1.345 1.041 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.27 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.21 81.0 18.87 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.82 -33.8 2.74 Favored 'Cis proline' 0 C--N 1.373 1.823 0 C-N-CA 125.272 -0.72 . . . . 0.0 112.823 -0.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -87.88 153.62 21.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.203 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.39 -166.96 14.34 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.829 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 154.02 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.6 m -87.2 99.16 11.75 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.859 0.361 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.86 155.6 19.57 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.24 133.0 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.408 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.325 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.235 0.29 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -122.71 100.98 7.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.259 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.9 p -80.64 146.76 61.4 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.921 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.8 Cg_endo -69.81 168.1 22.6 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.365 2.71 . . . . 0.0 113.891 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.46 -157.61 13.44 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.678 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.2 tt0 -78.89 122.01 25.58 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.803 0.301 . . . . 0.0 111.054 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.09 31.41 9.17 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.134 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -129.73 166.59 19.55 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.456 0.302 . . . . 0.0 110.381 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -80.04 132.99 36.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.758 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.42 123.67 39.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.242 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.33 17.66 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.525 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.32 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.214 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.69 -65.15 0.98 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.763 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t80 -151.22 1.69 0.41 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -118.5 73.82 11.25 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -93.47 170.48 2.07 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.254 2.636 . . . . 0.0 111.952 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.9 m -81.39 119.49 23.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.63 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.0 p -84.66 -36.68 0.6 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.63 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.96 -179.95 5.72 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.117 1.878 . . . . 0.0 111.456 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.7 Cg_exo -64.91 62.72 0.29 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.62 2.213 . . . . 0.0 114.018 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.9 158.64 43.74 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.331 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.71 159.66 19.47 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.708 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.49 104.47 16.51 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.75 128.02 23.49 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.988 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.38 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.583 0 C-N-CA 124.195 -1.169 . . . . 0.0 113.717 -0.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 33.96 20.8 Favored Glycine 0 C--N 1.345 1.032 0 C-N-CA 121.469 -0.396 . . . . 0.0 113.251 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -140.22 81.07 18.74 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.66 -33.9 2.73 Favored 'Cis proline' 0 C--N 1.372 1.811 0 C-N-CA 125.267 -0.722 . . . . 0.0 112.833 -0.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -87.93 153.63 21.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.24 -167.06 14.39 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.9 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.22 154.24 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.8 m -87.34 99.27 11.86 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.607 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.05 155.45 19.82 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.353 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.11 132.89 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.708 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.236 0.348 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.87 96.91 6.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.337 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.3 m -80.63 148.67 66.28 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.97 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.16 163.92 36.84 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.357 2.705 . . . . 0.0 113.288 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.45 -162.93 23.51 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.024 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.4 tt0 -78.04 121.71 24.6 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.667 0.27 . . . . 0.0 111.007 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.52 30.97 8.62 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.885 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.38 164.89 20.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.446 0.298 . . . . 0.0 110.302 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.7 131.92 35.51 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.588 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.27 123.82 41.07 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.365 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.67 156.77 17.29 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.475 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.68 16.61 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.226 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.2 -64.54 1.03 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.712 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.83 3.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.18 70.64 21.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.3 171.32 2.06 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.201 2.6 . . . . 0.0 111.892 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.37 105.98 15.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.768 0.318 . . . . 0.0 110.301 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 63.6 m -78.91 -39.89 1.54 Allowed Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.562 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.5 Cg_exo -71.5 -179.65 3.86 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.193 1.929 . . . . 0.0 111.176 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' O ' HD13 ' A' ' 21' ' ' LEU . 35.8 Cg_endo -64.64 56.41 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.354 2.036 . . . . 0.0 114.83 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.03 156.47 48.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.106 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.28 159.75 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.767 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.1 t -98.65 104.8 16.87 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.3 128.01 23.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.944 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.5 -51.35 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.556 0 C-N-CA 124.221 -1.158 . . . . 0.0 113.743 -0.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.27 33.9 18.83 Favored Glycine 0 C--N 1.345 1.047 0 C-N-CA 121.358 -0.448 . . . . 0.0 113.197 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.5 81.64 17.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.48 -33.7 2.84 Favored 'Cis proline' 0 C--N 1.372 1.779 0 C-N-CA 125.271 -0.721 . . . . 0.0 112.837 -0.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.91 154.24 20.4 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.21 -166.7 14.04 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.43 154.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 22' ' ' THR . 76.4 m -87.24 98.77 11.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.881 0.372 . . . . 0.0 110.57 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 153.46 22.02 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.211 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.5 tt -94.65 134.45 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.709 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.278 -179.95 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.338 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -109.38 96.27 6.18 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.7 m -81.64 148.89 63.11 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.918 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.71 163.76 37.02 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 123.317 2.678 . . . . 0.0 113.399 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.18 -160.01 24.34 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 123.682 0.614 . . . . 0.0 111.892 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.413 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.9 tt0 -80.4 123.24 27.86 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.677 0.275 . . . . 0.0 110.963 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.52 33.86 7.31 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.817 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -129.25 162.44 27.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.527 0.331 . . . . 0.0 110.245 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -79.85 130.44 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.446 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 124.33 42.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.464 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.97 157.12 17.09 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.44 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.71 18.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.22 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.53 -64.51 1.06 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.782 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.39 0.46 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.14 70.34 20.63 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.53 171.25 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 123.209 2.606 . . . . 0.0 111.991 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.41 106.17 17.25 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.317 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.4 m -79.29 -40.38 1.48 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.392 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.94 -178.58 2.09 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.248 1.965 . . . . 0.0 111.488 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.57 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.3 Cg_exo -65.63 55.26 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.648 2.232 . . . . 0.0 114.567 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.83 156.34 48.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.218 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.38 160.04 18.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.4 t -98.74 105.09 17.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -129.56 128.23 23.07 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.016 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.32 -51.15 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.53 0 C-N-CA 124.295 -1.127 . . . . 0.0 113.722 -0.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 33.86 19.61 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.77 81.75 16.34 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -33.63 2.88 Favored 'Cis proline' 0 C--N 1.373 1.826 0 C-N-CA 125.326 -0.698 . . . . 0.0 112.864 -0.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -89.19 154.29 20.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.241 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.531 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.27 -166.66 14.02 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.848 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.531 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.71 154.74 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 22' ' ' THR . 70.9 m -87.12 98.54 11.35 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.812 0.339 . . . . 0.0 110.57 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -105.65 156.14 18.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.273 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.56 133.29 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.721 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.365 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.258 . . . . . . . 0 C--O 1.235 0.301 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.18 97.86 6.29 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.072 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.3 p -85.17 146.95 46.36 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.813 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.5 Cg_endo -69.65 168.06 22.5 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 123.384 2.723 . . . . 0.0 113.926 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.38 -157.56 13.49 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.76 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.518 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.2 tt0 -79.04 122.32 26.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.792 0.296 . . . . 0.0 111.009 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.85 31.09 9.57 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.157 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -129.26 166.6 19.11 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.422 0.289 . . . . 0.0 110.331 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.13 132.93 36.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.835 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.08 123.48 39.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.238 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.44 15.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.176 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.68 -64.96 0.99 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.4 1.59 0.39 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -118.46 73.82 11.12 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.3 Cg_endo -93.54 170.19 2.07 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.191 2.594 . . . . 0.0 111.85 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 m -81.29 119.31 23.48 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.5 p -84.88 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -80.0 -179.84 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.076 1.851 . . . . 0.0 111.519 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.66 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.57 2.18 . . . . 0.0 113.98 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.94 158.56 43.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.62 159.75 19.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.701 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.6 104.58 16.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.986 0.422 . . . . 0.0 110.862 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.84 127.85 23.44 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.059 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.52 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.549 0 C-N-CA 124.205 -1.165 . . . . 0.0 113.626 -0.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.5 33.98 20.94 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.229 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.38 81.15 18.15 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.69 -33.87 2.73 Favored 'Cis proline' 0 C--N 1.372 1.813 0 C-N-CA 125.275 -0.719 . . . . 0.0 112.803 -0.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -88.09 153.61 21.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.34 -167.07 14.44 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.851 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.17 154.1 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.5 m -87.18 99.21 11.77 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.759 0.314 . . . . 0.0 110.593 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -106.94 155.42 19.8 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.361 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.11 132.83 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.77 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.156 -0.925 . . . . 0.0 111.307 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.57 96.16 5.83 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.398 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.8 p -87.81 147.12 40.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.595 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.6 Cg_endo -69.71 168.32 21.82 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 123.358 2.705 . . . . 0.0 113.889 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.56 -157.67 13.36 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.727 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.517 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.1 tt0 -78.94 122.36 26.05 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.686 0.279 . . . . 0.0 111.064 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.9 31.14 9.5 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.183 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -129.46 166.46 19.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 122.381 0.272 . . . . 0.0 110.345 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -80.15 132.93 36.01 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.723 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.97 123.26 39.5 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.203 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.35 156.1 17.81 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.486 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.82 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.138 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -97.97 -65.02 0.99 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.71 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.66 1.51 0.37 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -118.23 73.95 10.5 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.7 Cg_endo -93.57 170.24 2.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.278 2.652 . . . . 0.0 111.946 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -81.44 119.42 23.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.628 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.02 -36.43 0.57 Allowed Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.628 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.92 -179.8 5.6 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.181 1.921 . . . . 0.0 111.431 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.0 62.37 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.618 2.212 . . . . 0.0 113.943 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.74 158.47 44.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.385 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.54 159.8 19.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.42 16.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.67 127.9 23.52 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.44 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.553 0 C-N-CA 124.202 -1.166 . . . . 0.0 113.625 -0.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.38 34.07 21.06 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.545 -0.359 . . . . 0.0 113.254 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.2 80.94 18.98 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.82 -33.83 2.73 Favored 'Cis proline' 0 C--N 1.372 1.806 0 C-N-CA 125.2 -0.75 . . . . 0.0 112.812 -0.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.67 153.45 21.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.248 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.42 -167.08 14.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.862 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.17 154.17 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.26 99.15 11.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.775 0.321 . . . . 0.0 110.552 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -106.96 155.29 19.95 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.88 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.297 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -108.69 95.62 5.78 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.2 m -81.58 149.0 63.62 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.906 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.3 164.11 35.32 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.299 2.666 . . . . 0.0 113.323 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.85 -161.77 23.92 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.989 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.425 ' OE1' HD11 ' A' ' 21' ' ' LEU . 29.1 tt0 -79.07 122.3 26.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.754 0.312 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.95 32.69 7.78 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.9 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -128.06 164.92 21.35 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.482 0.313 . . . . 0.0 110.395 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -81.01 129.84 34.73 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.571 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.04 123.59 41.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.91 157.17 17.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.55 16.85 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.163 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.9 -64.67 1.03 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.723 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.72 3.56 0.47 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.28 70.11 21.72 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.3 Cg_endo -93.24 171.02 2.11 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.242 2.628 . . . . 0.0 111.963 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 m -85.79 106.23 16.88 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.694 0.283 . . . . 0.0 110.316 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -79.25 -40.55 1.51 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.835 -0.602 . . . . 0.0 112.38 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.09 -178.53 2.13 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.309 2.006 . . . . 0.0 111.44 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.568 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.68 55.17 0.33 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.638 2.225 . . . . 0.0 114.544 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.74 156.33 48.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.248 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 160.02 18.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.799 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.3 t -98.67 105.07 17.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.04 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.946 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.53 -51.24 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.222 -1.157 . . . . 0.0 113.62 -0.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.02 19.1 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.446 -0.407 . . . . 0.0 113.242 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.59 81.59 17.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -33.72 2.84 Favored 'Cis proline' 0 C--N 1.372 1.786 0 C-N-CA 125.295 -0.71 . . . . 0.0 112.836 -0.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.91 154.12 20.5 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.18 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.53 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.27 -166.88 14.23 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.814 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.5 mm -133.36 154.41 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.22 98.58 11.4 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.847 0.356 . . . . 0.0 110.468 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.56 155.99 18.67 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.43 133.19 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.766 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.325 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.46 96.41 6.26 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.362 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.5 m -80.96 149.03 66.06 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.912 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.13 164.17 34.97 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 123.316 2.677 . . . . 0.0 113.333 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.47 -165.04 22.71 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.108 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.435 ' OE1' HD11 ' A' ' 21' ' ' LEU . 27.7 tt0 -76.23 122.02 23.76 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.526 0.331 . . . . 0.0 111.185 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.36 57.29 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.312 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -97.41 167.01 11.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.398 0.279 . . . . 0.0 110.622 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -82.61 137.39 34.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.477 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 p -127.27 123.64 36.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.467 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.96 17.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.42 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 16.11 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.209 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.74 -64.43 1.04 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -151.0 3.43 0.45 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.3 70.2 22.12 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.3 Cg_endo -92.67 170.56 2.42 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.228 2.618 . . . . 0.0 111.85 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 m -83.86 106.89 15.9 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.748 0.309 . . . . 0.0 110.474 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 64.4 m -80.02 -40.08 1.29 Allowed Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.458 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.3 Cg_exo -71.65 -179.48 3.78 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.31 2.007 . . . . 0.0 111.179 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.571 ' O ' HD13 ' A' ' 21' ' ' LEU . 35.3 Cg_endo -64.76 56.59 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.445 2.096 . . . . 0.0 114.644 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.07 156.2 48.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.2 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.3 t -112.28 159.74 18.33 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.39 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.979 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -129.98 127.96 22.8 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.014 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 44.2 Cg_endo -69.62 -51.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.578 0 C-N-CA 124.171 -1.179 . . . . 0.0 113.665 -0.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 34.68 16.27 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.444 -0.407 . . . . 0.0 113.177 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' OD1' ' HB2' ' A' ' 25' ' ' PRO . 2.8 p-10 -140.36 80.73 18.88 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.43 -34.01 2.73 Favored 'Cis proline' 0 C--N 1.372 1.778 0 CA-C-N 119.147 0.731 . . . . 0.0 112.88 -0.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.02 153.78 21.01 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.272 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.22 -167.32 14.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.77 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.0 mm -133.19 153.92 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 22' ' ' THR . 88.1 m -86.83 98.37 11.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 120.893 0.378 . . . . 0.0 110.559 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.27 155.03 19.46 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.261 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.61 132.86 34.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.253 . . . . . . . 0 C--O 1.234 0.289 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.74 98.72 6.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.067 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.1 p -84.14 147.03 49.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.723 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.8 Cg_endo -69.71 168.37 21.67 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 123.428 2.752 . . . . 0.0 113.851 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.75 -157.53 13.1 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.691 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' OE1' HD11 ' A' ' 21' ' ' LEU . 32.9 tt0 -78.88 122.32 25.96 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.745 0.307 . . . . 0.0 111.031 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.44 33.17 8.18 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.104 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.77 166.64 20.36 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.473 0.309 . . . . 0.0 110.355 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.35 130.89 35.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.727 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.67 123.43 40.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.283 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.525 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.29 15.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.181 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -98.93 -65.02 0.99 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.715 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.28 1.62 0.4 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -118.57 73.75 11.39 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -93.49 170.41 2.07 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.169 2.579 . . . . 0.0 111.851 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.64 119.6 24.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.95 -36.46 0.58 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.84 -179.84 5.65 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.585 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.57 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.549 2.166 . . . . 0.0 114.006 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.38 44.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.267 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.58 159.81 19.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.71 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.46 104.52 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.85 127.95 23.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.042 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.41 -51.14 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.516 0 C-N-CA 124.232 -1.153 . . . . 0.0 113.69 -0.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.62 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.436 -0.412 . . . . 0.0 113.226 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.16 81.1 18.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.78 2.77 Favored 'Cis proline' 0 C--N 1.373 1.83 0 C-N-CA 125.237 -0.735 . . . . 0.0 112.824 -0.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.91 153.61 21.17 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.43 -166.95 14.35 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.868 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 153.95 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.4 m -87.09 99.0 11.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.834 0.349 . . . . 0.0 110.634 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 152.91 23.17 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.314 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.32 134.14 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.271 -179.884 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -116.74 98.14 6.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.2 p -84.53 147.0 48.37 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.764 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HB3' ' OE1' ' A' ' 8' ' ' GLU . 57.5 Cg_endo -69.71 168.66 20.86 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.355 2.704 . . . . 0.0 113.959 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.99 -157.57 12.87 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.702 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.506 ' OE1' HD11 ' A' ' 21' ' ' LEU . 32.8 tt0 -78.94 122.36 26.05 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.747 0.308 . . . . 0.0 110.98 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.82 31.47 9.3 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.041 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.484 ' OE1' ' HB3' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -129.19 164.82 22.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.524 0.329 . . . . 0.0 110.145 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -79.95 132.88 36.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.909 0.385 . . . . 0.0 111.672 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.69 124.56 42.45 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.71 156.41 17.66 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.55 16.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.13 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.93 -65.03 0.99 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.757 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.43 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.14 1.59 0.41 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -118.49 73.85 11.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.6 Cg_endo -93.6 170.76 2.0 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.278 2.652 . . . . 0.0 111.924 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.92 119.76 24.35 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.626 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.07 -36.35 0.57 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.626 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.81 5.61 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.436 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.03 62.55 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.52 2.146 . . . . 0.0 114.028 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.43 44.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.6 159.78 19.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.775 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.62 16.67 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.8 128.15 23.47 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.32 -51.08 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.593 0 C-N-CA 124.257 -1.143 . . . . 0.0 113.648 -0.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.6 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.478 -0.392 . . . . 0.0 113.307 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.38 81.18 18.12 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -33.84 2.75 Favored 'Cis proline' 0 C--N 1.373 1.828 0 C-N-CA 125.251 -0.729 . . . . 0.0 112.77 -0.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.16 153.74 21.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.3 -166.9 14.26 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.886 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.0 mm -133.35 154.33 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.3 99.07 11.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.73 155.56 19.56 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.337 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.27 132.94 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.354 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 CA-C-O 120.301 -0.166 . . . . 0.0 112.883 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.04 164.95 21.27 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.495 0.318 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.97 129.91 34.76 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.65 41.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.385 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.88 157.13 17.08 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.446 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.5 16.38 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.173 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.29 -64.73 1.02 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.697 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.71 3.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.28 70.15 21.84 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.2 Cg_endo -93.28 170.99 2.1 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 123.225 2.617 . . . . 0.0 111.912 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.2 m -85.54 106.16 16.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.342 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.2 -40.57 1.52 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.341 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.18 -178.5 2.15 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.263 1.975 . . . . 0.0 111.45 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.67 55.16 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.649 2.233 . . . . 0.0 114.548 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.26 48.32 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.202 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.28 159.96 18.12 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.853 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.65 105.02 17.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.1 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.961 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.43 -51.28 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.268 -1.138 . . . . 0.0 113.71 -0.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 34.02 19.17 Favored Glycine 0 C--N 1.344 0.995 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.271 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.56 81.5 17.19 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.61 -33.63 2.85 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 125.293 -0.711 . . . . 0.0 112.792 -0.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.92 154.17 20.45 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.165 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.28 -166.79 14.15 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.806 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.44 154.38 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.14 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.858 0.361 . . . . 0.0 110.528 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -105.54 155.96 18.69 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.41 133.14 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.734 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.186 -0.912 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 CA-C-O 120.292 -0.171 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.14 165.03 21.19 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.506 0.322 . . . . 0.0 110.391 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.94 129.86 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.61 41.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.465 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.86 157.07 17.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.432 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.53 16.27 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.146 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.14 -64.61 1.03 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.76 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.76 3.38 0.47 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.22 70.15 21.24 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.28 170.9 2.11 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.16 2.573 . . . . 0.0 111.859 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.4 m -85.4 106.13 16.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.365 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.22 -40.48 1.51 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.381 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.23 -178.46 2.15 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.247 1.965 . . . . 0.0 111.466 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -65.6 55.08 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.723 2.282 . . . . 0.0 114.559 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.3 48.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.202 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 159.9 18.25 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.823 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.6 104.98 17.07 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.949 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -129.45 128.14 23.12 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.46 -51.27 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.57 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.664 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 34.03 19.04 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.28 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.53 81.52 17.28 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.74 2.81 Favored 'Cis proline' 0 C--N 1.373 1.847 0 C-N-CA 125.282 -0.716 . . . . 0.0 112.749 -0.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -88.75 154.09 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.216 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.29 -166.81 14.16 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.793 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.4 mm -133.36 154.36 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.13 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.825 0.345 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.58 155.93 18.73 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.218 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.45 133.12 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.332 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 CA-C-O 119.972 -0.349 . . . . 0.0 113.324 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -97.72 167.01 11.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.306 0.243 . . . . 0.0 110.574 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -82.78 137.16 34.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.393 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.92 124.19 38.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.69 156.93 17.3 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.357 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.45 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.164 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.82 -64.61 1.02 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.739 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.09 3.4 0.44 Allowed 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.3 70.3 22.25 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.79 170.14 2.4 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.202 2.601 . . . . 0.0 111.807 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 m -83.85 106.32 15.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.737 0.303 . . . . 0.0 110.479 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -79.71 -40.6 1.41 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.313 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.59 -178.23 2.18 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.206 1.937 . . . . 0.0 111.422 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.564 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.73 55.27 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.598 2.198 . . . . 0.0 114.515 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.89 156.18 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.247 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.3 160.02 18.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.813 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.51 105.2 17.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.007 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.9 22.73 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.061 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.69 -51.53 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.598 0 C-N-CA 124.28 -1.133 . . . . 0.0 113.695 -0.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.52 34.1 17.51 Favored Glycine 0 C--N 1.344 1.027 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.267 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.46 81.41 17.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.56 -33.88 2.76 Favored 'Cis proline' 0 C--N 1.37 1.709 0 C-N-CA 125.227 -0.739 . . . . 0.0 112.743 -0.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.53 154.06 20.65 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.22 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.22 -167.22 14.55 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.769 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.3 mm -133.1 154.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 22' ' ' THR . 81.2 m -86.96 98.26 11.15 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.595 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.22 155.2 19.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.237 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.79 132.93 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.742 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.182 -0.914 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.531 0 CA-C-O 120.083 -0.287 . . . . 0.0 113.365 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -96.68 167.07 11.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.399 0.28 . . . . 0.0 110.597 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.59 137.49 34.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.477 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 p -126.93 124.56 39.79 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.448 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -102.61 156.49 17.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.413 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.62 15.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.04 -64.44 1.04 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.72 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.1 2.93 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.46 70.28 23.92 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.2 Cg_endo -92.65 169.89 2.5 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.128 2.552 . . . . 0.0 111.784 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.2 m -82.11 105.94 13.62 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.5 m -79.39 -40.59 1.48 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.293 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.12 -178.12 2.32 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.257 1.971 . . . . 0.0 111.41 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.561 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -66.0 55.43 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.634 2.223 . . . . 0.0 114.436 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.01 156.09 48.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.23 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.02 159.84 18.06 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.795 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.44 105.25 17.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.92 22.74 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.022 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.66 -51.67 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 124.252 -1.145 . . . . 0.0 113.667 -0.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.56 34.41 16.45 Favored Glycine 0 C--N 1.344 1.014 0 C-N-CA 121.435 -0.412 . . . . 0.0 113.196 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.27 81.25 18.33 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.96 2.73 Favored 'Cis proline' 0 C--N 1.373 1.852 0 C-N-CA 125.174 -0.761 . . . . 0.0 112.794 -0.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.2 154.0 20.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.11 -167.05 14.32 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.819 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.525 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.8 mm -132.98 153.91 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 22' ' ' THR . 90.5 m -86.83 98.33 11.13 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.59 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.31 155.14 19.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.27 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.75 132.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.772 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.358 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 CA-C-O 120.293 -0.171 . . . . 0.0 112.939 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.16 165.11 21.05 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.52 0.328 . . . . 0.0 110.397 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.98 129.98 34.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.01 123.8 41.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.329 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.75 156.89 17.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 15.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.135 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.09 -64.69 1.01 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.743 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.22 0.46 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.2 70.27 21.21 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.9 Cg_endo -93.27 170.89 2.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.164 2.576 . . . . 0.0 111.816 178.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 m -84.89 105.98 16.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.707 0.289 . . . . 0.0 110.341 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.1 -40.52 1.54 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.378 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.21 -178.48 2.16 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.254 1.969 . . . . 0.0 111.495 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.74 55.13 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.672 2.248 . . . . 0.0 114.51 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.84 156.2 48.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.245 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.18 159.84 18.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.61 104.95 17.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.48 128.1 23.1 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.45 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.561 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.669 -0.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 33.89 19.44 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 121.39 -0.433 . . . . 0.0 113.285 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.34 81.5 17.82 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.65 -33.64 2.84 Favored 'Cis proline' 0 C--N 1.372 1.792 0 C-N-CA 125.311 -0.704 . . . . 0.0 112.775 -0.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -88.83 154.11 20.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.203 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.3 -166.67 14.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.841 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.7 mm -133.39 154.34 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.12 98.58 11.37 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 120.836 0.35 . . . . 0.0 110.568 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.63 155.84 18.84 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 133.25 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.68 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.412 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.331 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 CA-C-O 120.227 -0.207 . . . . 0.0 113.081 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -130.47 166.81 19.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.419 0.288 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.33 130.99 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.789 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.76 123.36 40.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.207 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.41 17.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.49 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.31 15.78 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.146 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.08 -65.09 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.08 1.64 0.41 Allowed 'General case' 0 C--N 1.349 0.568 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -118.64 73.71 11.6 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.51 170.34 2.07 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.241 2.628 . . . . 0.0 111.945 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.7 m -81.71 119.57 24.01 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.625 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -84.94 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.91 -179.82 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.02 62.44 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.622 2.215 . . . . 0.0 114.05 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.73 158.35 44.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.336 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.51 159.71 19.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.699 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.48 104.66 16.72 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.89 127.92 23.42 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.904 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.43 -51.13 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.564 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.632 -0.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.58 34.03 20.55 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.279 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.25 81.16 18.52 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.66 -33.76 2.79 Favored 'Cis proline' 0 C--N 1.372 1.803 0 C-N-CA 125.29 -0.712 . . . . 0.0 112.854 -0.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.92 153.48 21.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.193 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.35 -167.04 14.41 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.85 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.13 154.06 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.6 m -87.29 99.07 11.7 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.64 155.52 19.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.3 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 132.94 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.351 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 CA-C-O 120.217 -0.213 . . . . 0.0 113.216 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -130.39 166.77 19.76 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 122.398 0.279 . . . . 0.0 110.404 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.33 130.98 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.752 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -123.76 123.21 40.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.268 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.45 156.47 17.58 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.38 15.8 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.191 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.03 -65.07 0.98 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.804 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.15 1.77 0.41 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.8 73.54 11.96 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.4 Cg_endo -93.43 170.29 2.1 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 123.226 2.618 . . . . 0.0 111.889 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -81.7 119.58 24.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.625 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.2 p -85.09 -36.29 0.57 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.86 5.66 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.214 1.943 . . . . 0.0 111.463 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.546 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.99 62.47 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.584 2.19 . . . . 0.0 113.972 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.83 158.33 44.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.256 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.46 159.73 19.2 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.717 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.44 104.59 16.64 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.87 127.89 23.43 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.42 -51.03 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.208 -1.164 . . . . 0.0 113.67 -0.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.05 21.05 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 121.449 -0.405 . . . . 0.0 113.298 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.28 81.11 18.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.75 2.78 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 125.259 -0.725 . . . . 0.0 112.858 -0.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.91 153.46 21.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.208 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.35 -166.94 14.31 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.828 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.1 mm -133.16 154.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.2 98.99 11.62 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.854 0.359 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.64 155.45 19.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.408 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.15 132.92 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.308 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.489 0 CA-C-O 120.086 -0.285 . . . . 0.0 113.366 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -97.82 167.04 11.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.435 0.294 . . . . 0.0 110.548 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.6 137.29 34.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.448 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 p -126.97 124.29 39.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.58 156.78 17.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.349 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.59 15.33 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.191 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.53 -64.53 1.03 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.745 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.03 3.22 0.44 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.38 70.29 23.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.76 170.16 2.41 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.137 2.558 . . . . 0.0 111.818 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -83.22 106.1 14.73 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.745 0.307 . . . . 0.0 110.517 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -79.48 -40.65 1.46 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.251 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.85 -178.18 2.26 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.243 1.962 . . . . 0.0 111.376 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.565 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.0 Cg_exo -65.82 55.24 0.35 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.68 2.254 . . . . 0.0 114.47 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.86 156.0 48.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.28 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.03 160.0 17.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.49 105.14 17.25 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -130.06 127.94 22.74 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.57 -51.58 0.16 OUTLIER 'Cis proline' 0 C--N 1.369 1.618 0 C-N-CA 124.245 -1.148 . . . . 0.0 113.695 -0.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.45 34.33 17.03 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 121.44 -0.41 . . . . 0.0 113.231 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.48 81.34 17.62 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.544 0.172 . . . . 0.0 111.444 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.54 -33.89 2.76 Favored 'Cis proline' 0 C--N 1.373 1.835 0 C-N-CA 125.258 -0.726 . . . . 0.0 112.807 -0.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.46 154.02 20.7 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.187 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.14 -167.25 14.54 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.756 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.1 mm -133.03 154.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 22' ' ' THR . 85.0 m -86.93 98.23 11.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.933 0.397 . . . . 0.0 110.581 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -105.23 155.14 19.34 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.277 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.65 132.84 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.776 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.333 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.45 0 CA-C-O 120.241 -0.199 . . . . 0.0 113.101 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.4 166.81 19.67 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.481 0.312 . . . . 0.0 110.393 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.32 131.07 35.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.699 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.87 123.47 40.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.206 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.49 156.46 17.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.519 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.34 15.61 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.143 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 -65.12 0.98 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.735 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.14 1.74 0.41 Allowed 'General case' 0 C--N 1.349 0.581 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.55 73.74 11.34 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.4 Cg_endo -93.58 170.34 2.04 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 123.227 2.618 . . . . 0.0 111.88 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 m -81.6 119.53 23.9 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.86 -36.42 0.58 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.83 5.63 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.135 1.89 . . . . 0.0 111.534 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.07 62.62 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.591 2.194 . . . . 0.0 114.058 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.89 158.36 44.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.241 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.53 159.63 19.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.805 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.38 104.55 16.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.0 mt -128.93 127.95 23.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.946 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.48 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.22 -1.158 . . . . 0.0 113.647 -0.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.54 34.06 20.59 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.486 -0.388 . . . . 0.0 113.193 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.12 81.0 19.14 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.79 -33.77 2.76 Favored 'Cis proline' 0 C--N 1.372 1.794 0 C-N-CA 125.225 -0.739 . . . . 0.0 112.833 -0.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.88 153.55 21.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.38 -166.91 14.3 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.877 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.14 154.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.1 m -87.29 99.04 11.68 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.828 0.346 . . . . 0.0 110.61 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 155.46 19.65 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.93 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.788 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.307 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.547 0 CA-C-O 120.143 -0.254 . . . . 0.0 113.128 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -129.67 166.49 19.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.432 0.293 . . . . 0.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -79.99 132.96 36.12 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.807 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.25 123.64 39.96 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.258 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.48 156.37 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.508 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.28 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.88 -65.16 0.98 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.09 1.57 0.41 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.48 73.8 11.16 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.2 Cg_endo -93.51 170.29 2.07 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.272 2.648 . . . . 0.0 111.883 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -81.31 119.56 23.82 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.631 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.3 p -84.88 -36.56 0.58 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.631 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.96 5.74 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.142 1.894 . . . . 0.0 111.552 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.95 62.76 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.587 2.191 . . . . 0.0 113.996 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.93 158.58 43.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.65 159.66 19.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.785 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.47 104.59 16.64 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.81 128.02 23.46 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.996 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.45 -50.99 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.573 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.694 -0.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.45 34.05 20.91 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.21 81.15 18.66 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.71 -33.86 2.74 Favored 'Cis proline' 0 C--N 1.371 1.741 0 C-N-CA 125.243 -0.732 . . . . 0.0 112.768 -0.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.96 153.51 21.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.23 -166.94 14.27 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.864 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.21 154.2 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.31 99.15 11.76 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.859 0.361 . . . . 0.0 110.585 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.01 155.47 19.77 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.373 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.17 132.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.777 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.292 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.435 0 CA-C-O 120.266 -0.185 . . . . 0.0 113.184 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 166.82 19.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.433 0.293 . . . . 0.0 110.434 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.34 131.18 35.59 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.726 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.86 123.54 40.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.243 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.41 17.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.483 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.42 15.53 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.239 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.64 -64.91 1.0 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.773 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.37 1.66 0.39 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.5 73.81 11.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.4 Cg_endo -93.48 170.5 2.07 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.21 2.607 . . . . 0.0 111.877 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 m -81.51 119.47 23.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.631 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.4 p -84.79 -36.48 0.59 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.631 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 Cg_endo -79.99 -179.9 5.67 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.172 1.915 . . . . 0.0 111.499 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.05 62.79 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.565 2.177 . . . . 0.0 114.051 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.92 158.45 44.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.302 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.56 159.62 19.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.782 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.47 104.58 16.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.77 128.0 23.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.36 -51.09 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.523 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.716 -0.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.57 34.02 20.61 Favored Glycine 0 C--N 1.345 1.041 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.27 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.21 81.0 18.87 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.82 -33.8 2.74 Favored 'Cis proline' 0 C--N 1.373 1.823 0 C-N-CA 125.272 -0.72 . . . . 0.0 112.823 -0.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -87.88 153.62 21.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.203 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.39 -166.96 14.34 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.829 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 154.02 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.6 m -87.2 99.16 11.75 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.859 0.361 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.86 155.6 19.57 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.24 133.0 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.408 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.325 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 CA-C-O 120.211 -0.216 . . . . 0.0 113.134 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -129.73 166.59 19.55 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.456 0.302 . . . . 0.0 110.381 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -80.04 132.99 36.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.758 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.42 123.67 39.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.242 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.33 17.66 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.525 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.32 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.214 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.69 -65.15 0.98 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.763 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t80 -151.22 1.69 0.41 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.5 73.82 11.25 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.47 170.48 2.07 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.254 2.636 . . . . 0.0 111.952 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.9 m -81.39 119.49 23.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.63 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.0 p -84.66 -36.68 0.6 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.63 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.96 -179.95 5.72 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.117 1.878 . . . . 0.0 111.456 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.7 Cg_exo -64.91 62.72 0.29 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.62 2.213 . . . . 0.0 114.018 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.9 158.64 43.74 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.331 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.71 159.66 19.47 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.708 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.49 104.47 16.51 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.75 128.02 23.49 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.988 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.38 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.583 0 C-N-CA 124.195 -1.169 . . . . 0.0 113.717 -0.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 33.96 20.8 Favored Glycine 0 C--N 1.345 1.032 0 C-N-CA 121.469 -0.396 . . . . 0.0 113.251 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -140.22 81.07 18.74 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.66 -33.9 2.73 Favored 'Cis proline' 0 C--N 1.372 1.811 0 C-N-CA 125.267 -0.722 . . . . 0.0 112.833 -0.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -87.93 153.63 21.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.24 -167.06 14.39 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.9 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.22 154.24 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.8 m -87.34 99.27 11.86 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.607 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.05 155.45 19.82 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.353 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.11 132.89 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.708 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.449 0 CA-C-O 120.3 -0.166 . . . . 0.0 112.885 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.38 164.89 20.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.446 0.298 . . . . 0.0 110.302 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.7 131.92 35.51 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.588 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.27 123.82 41.07 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.365 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.67 156.77 17.29 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.475 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.68 16.61 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.226 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.2 -64.54 1.03 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.712 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.83 3.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.18 70.64 21.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.3 171.32 2.06 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.201 2.6 . . . . 0.0 111.892 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.37 105.98 15.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.768 0.318 . . . . 0.0 110.301 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 63.6 m -78.91 -39.89 1.54 Allowed Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.562 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.5 Cg_exo -71.5 -179.65 3.86 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.193 1.929 . . . . 0.0 111.176 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' O ' HD13 ' A' ' 21' ' ' LEU . 35.8 Cg_endo -64.64 56.41 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.354 2.036 . . . . 0.0 114.83 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.03 156.47 48.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.106 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.28 159.75 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.767 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.1 t -98.65 104.8 16.87 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.3 128.01 23.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.944 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.5 -51.35 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.556 0 C-N-CA 124.221 -1.158 . . . . 0.0 113.743 -0.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.27 33.9 18.83 Favored Glycine 0 C--N 1.345 1.047 0 C-N-CA 121.358 -0.448 . . . . 0.0 113.197 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.5 81.64 17.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.48 -33.7 2.84 Favored 'Cis proline' 0 C--N 1.372 1.779 0 C-N-CA 125.271 -0.721 . . . . 0.0 112.837 -0.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.91 154.24 20.4 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.21 -166.7 14.04 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.43 154.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 22' ' ' THR . 76.4 m -87.24 98.77 11.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.881 0.372 . . . . 0.0 110.57 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 153.46 22.02 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.211 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.5 tt -94.65 134.45 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.709 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.278 -179.95 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.436 0 CA-C-O 120.329 -0.151 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -129.25 162.44 27.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.527 0.331 . . . . 0.0 110.245 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -79.85 130.44 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.446 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 124.33 42.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.464 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.97 157.12 17.09 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.44 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.71 18.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.22 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.53 -64.51 1.06 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.782 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.39 0.46 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.14 70.34 20.63 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.53 171.25 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 123.209 2.606 . . . . 0.0 111.991 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.41 106.17 17.25 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.317 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.4 m -79.29 -40.38 1.48 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.392 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.94 -178.58 2.09 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.248 1.965 . . . . 0.0 111.488 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.57 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.3 Cg_exo -65.63 55.26 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.648 2.232 . . . . 0.0 114.567 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.83 156.34 48.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.218 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.38 160.04 18.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.4 t -98.74 105.09 17.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -129.56 128.23 23.07 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.016 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.32 -51.15 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.53 0 C-N-CA 124.295 -1.127 . . . . 0.0 113.722 -0.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 33.86 19.61 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.77 81.75 16.34 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -33.63 2.88 Favored 'Cis proline' 0 C--N 1.373 1.826 0 C-N-CA 125.326 -0.698 . . . . 0.0 112.864 -0.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -89.19 154.29 20.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.241 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.531 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.27 -166.66 14.02 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.848 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.531 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.71 154.74 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 22' ' ' THR . 70.9 m -87.12 98.54 11.35 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.812 0.339 . . . . 0.0 110.57 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -105.65 156.14 18.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.273 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.56 133.29 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.721 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.365 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.47 0 CA-C-O 120.18 -0.234 . . . . 0.0 113.157 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -129.26 166.6 19.11 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.422 0.289 . . . . 0.0 110.331 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.13 132.93 36.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.835 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.08 123.48 39.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.238 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.44 15.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.176 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.68 -64.96 0.99 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.4 1.59 0.39 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.46 73.82 11.12 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.3 Cg_endo -93.54 170.19 2.07 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.191 2.594 . . . . 0.0 111.85 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 m -81.29 119.31 23.48 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.5 p -84.88 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -80.0 -179.84 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.076 1.851 . . . . 0.0 111.519 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.66 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.57 2.18 . . . . 0.0 113.98 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.94 158.56 43.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.62 159.75 19.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.701 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.6 104.58 16.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.986 0.422 . . . . 0.0 110.862 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.84 127.85 23.44 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.059 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.52 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.549 0 C-N-CA 124.205 -1.165 . . . . 0.0 113.626 -0.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.5 33.98 20.94 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.229 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.38 81.15 18.15 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.69 -33.87 2.73 Favored 'Cis proline' 0 C--N 1.372 1.813 0 C-N-CA 125.275 -0.719 . . . . 0.0 112.803 -0.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -88.09 153.61 21.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.34 -167.07 14.44 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.851 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.17 154.1 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.5 m -87.18 99.21 11.77 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.759 0.314 . . . . 0.0 110.593 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -106.94 155.42 19.8 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.361 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.11 132.83 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.77 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.156 -0.925 . . . . 0.0 111.307 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.464 0 CA-C-O 120.2 -0.222 . . . . 0.0 113.183 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -129.46 166.46 19.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 122.381 0.272 . . . . 0.0 110.345 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -80.15 132.93 36.01 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.723 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.97 123.26 39.5 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.203 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.35 156.1 17.81 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.486 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.82 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.138 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -97.97 -65.02 0.99 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.71 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.66 1.51 0.37 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.23 73.95 10.5 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.7 Cg_endo -93.57 170.24 2.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.278 2.652 . . . . 0.0 111.946 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -81.44 119.42 23.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.628 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.02 -36.43 0.57 Allowed Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.628 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.92 -179.8 5.6 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.181 1.921 . . . . 0.0 111.431 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.0 62.37 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.618 2.212 . . . . 0.0 113.943 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.74 158.47 44.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.385 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.54 159.8 19.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.42 16.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.67 127.9 23.52 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.44 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.553 0 C-N-CA 124.202 -1.166 . . . . 0.0 113.625 -0.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.38 34.07 21.06 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.545 -0.359 . . . . 0.0 113.254 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.2 80.94 18.98 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.82 -33.83 2.73 Favored 'Cis proline' 0 C--N 1.372 1.806 0 C-N-CA 125.2 -0.75 . . . . 0.0 112.812 -0.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.67 153.45 21.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.248 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.42 -167.08 14.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.862 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.17 154.17 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.26 99.15 11.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.775 0.321 . . . . 0.0 110.552 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -106.96 155.29 19.95 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.88 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.297 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.406 0 CA-C-O 120.29 -0.172 . . . . 0.0 112.9 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -128.06 164.92 21.35 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.482 0.313 . . . . 0.0 110.395 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -81.01 129.84 34.73 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.571 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.04 123.59 41.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.91 157.17 17.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.55 16.85 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.163 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.9 -64.67 1.03 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.723 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.72 3.56 0.47 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.28 70.11 21.72 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.3 Cg_endo -93.24 171.02 2.11 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.242 2.628 . . . . 0.0 111.963 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 m -85.79 106.23 16.88 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.694 0.283 . . . . 0.0 110.316 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -79.25 -40.55 1.51 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.835 -0.602 . . . . 0.0 112.38 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.09 -178.53 2.13 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.309 2.006 . . . . 0.0 111.44 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.568 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.68 55.17 0.33 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.638 2.225 . . . . 0.0 114.544 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.74 156.33 48.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.248 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 160.02 18.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.799 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.3 t -98.67 105.07 17.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.04 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.946 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.53 -51.24 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.222 -1.157 . . . . 0.0 113.62 -0.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.02 19.1 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.446 -0.407 . . . . 0.0 113.242 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.59 81.59 17.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -33.72 2.84 Favored 'Cis proline' 0 C--N 1.372 1.786 0 C-N-CA 125.295 -0.71 . . . . 0.0 112.836 -0.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.91 154.12 20.5 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.18 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.53 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.27 -166.88 14.23 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.814 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.5 mm -133.36 154.41 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.22 98.58 11.4 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.847 0.356 . . . . 0.0 110.468 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.56 155.99 18.67 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.43 133.19 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.766 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.325 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 CA-C-O 120.062 -0.299 . . . . 0.0 113.312 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -97.41 167.01 11.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.398 0.279 . . . . 0.0 110.622 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -82.61 137.39 34.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.477 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 p -127.27 123.64 36.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.467 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.96 17.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.42 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 16.11 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.209 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.74 -64.43 1.04 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -151.0 3.43 0.45 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.3 70.2 22.12 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.3 Cg_endo -92.67 170.56 2.42 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.228 2.618 . . . . 0.0 111.85 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 m -83.86 106.89 15.9 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.748 0.309 . . . . 0.0 110.474 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 64.4 m -80.02 -40.08 1.29 Allowed Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.458 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.3 Cg_exo -71.65 -179.48 3.78 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.31 2.007 . . . . 0.0 111.179 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.571 ' O ' HD13 ' A' ' 21' ' ' LEU . 35.3 Cg_endo -64.76 56.59 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.445 2.096 . . . . 0.0 114.644 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.07 156.2 48.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.2 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.3 t -112.28 159.74 18.33 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.39 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.979 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -129.98 127.96 22.8 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.014 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 44.2 Cg_endo -69.62 -51.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.578 0 C-N-CA 124.171 -1.179 . . . . 0.0 113.665 -0.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 34.68 16.27 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.444 -0.407 . . . . 0.0 113.177 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.522 ' OD1' ' HB2' ' A' ' 25' ' ' PRO . 2.8 p-10 -140.36 80.73 18.88 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.43 -34.01 2.73 Favored 'Cis proline' 0 C--N 1.372 1.778 0 CA-C-N 119.147 0.731 . . . . 0.0 112.88 -0.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.02 153.78 21.01 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.272 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.22 -167.32 14.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.77 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.0 mm -133.19 153.92 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 22' ' ' THR . 88.1 m -86.83 98.37 11.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 120.893 0.378 . . . . 0.0 110.559 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.27 155.03 19.46 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.261 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.61 132.86 34.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.399 0 CA-C-O 120.19 -0.228 . . . . 0.0 113.104 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.77 166.64 20.36 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.473 0.309 . . . . 0.0 110.355 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.35 130.89 35.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.727 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.67 123.43 40.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.283 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.525 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.29 15.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.181 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -98.93 -65.02 0.99 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.715 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.28 1.62 0.4 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.57 73.75 11.39 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.49 170.41 2.07 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.169 2.579 . . . . 0.0 111.851 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.64 119.6 24.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.95 -36.46 0.58 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.84 -179.84 5.65 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.585 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.57 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.549 2.166 . . . . 0.0 114.006 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.38 44.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.267 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.58 159.81 19.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.71 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.46 104.52 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.85 127.95 23.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.042 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.41 -51.14 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.516 0 C-N-CA 124.232 -1.153 . . . . 0.0 113.69 -0.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.62 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.436 -0.412 . . . . 0.0 113.226 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.16 81.1 18.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.78 2.77 Favored 'Cis proline' 0 C--N 1.373 1.83 0 C-N-CA 125.237 -0.735 . . . . 0.0 112.824 -0.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.91 153.61 21.17 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.43 -166.95 14.35 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.868 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 153.95 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.4 m -87.09 99.0 11.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.834 0.349 . . . . 0.0 110.634 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 152.91 23.17 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.314 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.32 134.14 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.271 -179.884 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.496 0 CA-C-O 120.269 -0.184 . . . . 0.0 113.041 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.19 164.82 22.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.524 0.329 . . . . 0.0 110.145 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -79.95 132.88 36.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.909 0.385 . . . . 0.0 111.672 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.69 124.56 42.45 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.71 156.41 17.66 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.55 16.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.13 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.93 -65.03 0.99 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.757 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.43 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.14 1.59 0.41 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.49 73.85 11.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.6 Cg_endo -93.6 170.76 2.0 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.278 2.652 . . . . 0.0 111.924 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.92 119.76 24.35 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.626 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.07 -36.35 0.57 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.626 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.81 5.61 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.436 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.03 62.55 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.52 2.146 . . . . 0.0 114.028 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.43 44.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.6 159.78 19.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.775 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.62 16.67 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.8 128.15 23.47 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.32 -51.08 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.593 0 C-N-CA 124.257 -1.143 . . . . 0.0 113.648 -0.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.6 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.478 -0.392 . . . . 0.0 113.307 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.38 81.18 18.12 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -33.84 2.75 Favored 'Cis proline' 0 C--N 1.373 1.828 0 C-N-CA 125.251 -0.729 . . . . 0.0 112.77 -0.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.16 153.74 21.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.3 -166.9 14.26 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.886 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.0 mm -133.35 154.33 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.3 99.07 11.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.73 155.56 19.56 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.337 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.27 132.94 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.354 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.236 0.346 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -109.52 96.25 6.15 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.392 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.7 m -81.62 148.86 63.08 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.834 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -69.33 163.96 35.96 Favored 'Trans proline' 0 C--N 1.366 1.491 0 C-N-CA 123.282 2.655 . . . . 0.0 113.37 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.76 -162.04 24.04 Favored Glycine 0 C--N 1.338 0.641 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.99 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' OE1' HD11 ' A' ' 21' ' ' LEU . 29.1 tt0 -78.89 122.17 25.77 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 122.433 0.293 . . . . 0.0 110.926 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.93 32.65 7.81 Favored Glycine 0 C--N 1.338 0.671 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.883 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.04 164.95 21.27 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.495 0.318 . . . . 0.0 110.403 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.97 129.91 34.76 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.484 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.65 41.34 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.385 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.88 157.13 17.08 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.446 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.5 16.38 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.173 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.29 -64.73 1.02 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.697 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.71 3.51 0.47 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.28 70.15 21.84 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.2 Cg_endo -93.28 170.99 2.1 Favored 'Trans proline' 0 C--N 1.369 1.643 0 C-N-CA 123.225 2.617 . . . . 0.0 111.912 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.2 m -85.54 106.16 16.66 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.342 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.2 -40.57 1.52 Allowed Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.341 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.18 -178.5 2.15 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.263 1.975 . . . . 0.0 111.45 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.67 55.16 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.285 0 C-N-CA 122.649 2.233 . . . . 0.0 114.548 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.26 48.32 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.202 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.28 159.96 18.12 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.853 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.65 105.02 17.11 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.976 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.1 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.961 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.43 -51.28 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.268 -1.138 . . . . 0.0 113.71 -0.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 34.02 19.17 Favored Glycine 0 C--N 1.344 0.995 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.271 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.56 81.5 17.19 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.61 -33.63 2.85 Favored 'Cis proline' 0 C--N 1.372 1.773 0 C-N-CA 125.293 -0.711 . . . . 0.0 112.792 -0.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.92 154.17 20.45 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.165 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.28 -166.79 14.15 Favored Glycine 0 C--N 1.333 0.403 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.806 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.44 154.38 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.14 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.858 0.361 . . . . 0.0 110.528 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -105.54 155.96 18.69 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.24 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.41 133.14 34.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.734 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.186 -0.912 . . . . 0.0 111.32 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.326 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.52 96.31 6.19 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.296 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.2 m -81.68 148.83 62.78 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.89 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -69.36 163.99 35.84 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 123.26 2.64 . . . . 0.0 113.341 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.76 -162.08 24.04 Favored Glycine 0 C--N 1.338 0.664 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.981 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' OE1' HD11 ' A' ' 21' ' ' LEU . 29.2 tt0 -78.94 122.1 25.71 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.735 0.302 . . . . 0.0 110.912 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.0 32.75 7.71 Favored Glycine 0 C--N 1.338 0.694 0 CA-C-N 115.559 -0.746 . . . . 0.0 112.842 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -128.14 165.03 21.19 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 122.506 0.322 . . . . 0.0 110.391 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.94 129.86 34.74 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.515 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.05 123.61 41.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.465 179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -101.86 157.07 17.11 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.432 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.53 16.27 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-N 115.566 -0.743 . . . . 0.0 112.146 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -100.14 -64.61 1.03 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.76 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.76 3.38 0.47 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.22 70.15 21.24 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.28 170.9 2.11 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 123.16 2.573 . . . . 0.0 111.859 178.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.4 m -85.4 106.13 16.55 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.734 0.302 . . . . 0.0 110.365 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.2 m -79.22 -40.48 1.51 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.769 -0.634 . . . . 0.0 112.381 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.23 -178.46 2.15 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.247 1.965 . . . . 0.0 111.466 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -65.6 55.08 0.32 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.723 2.282 . . . . 0.0 114.559 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.78 156.3 48.24 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.202 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 159.9 18.25 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.823 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.6 104.98 17.07 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.949 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.9 mt -129.45 128.14 23.12 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.979 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.46 -51.27 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.57 0 C-N-CA 124.177 -1.176 . . . . 0.0 113.664 -0.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 34.03 19.04 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.454 -0.403 . . . . 0.0 113.28 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.53 81.52 17.28 Favored Pre-proline 0 CA--C 1.546 0.8 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.74 2.81 Favored 'Cis proline' 0 C--N 1.373 1.847 0 C-N-CA 125.282 -0.716 . . . . 0.0 112.749 -0.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -88.75 154.09 20.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.216 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.29 -166.81 14.16 Favored Glycine 0 C--N 1.334 0.446 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.793 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.4 mm -133.36 154.36 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.13 98.58 11.38 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.825 0.345 . . . . 0.0 110.532 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.58 155.93 18.73 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.218 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.45 133.12 34.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.735 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.332 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.254 . . . . . . . 0 C--O 1.235 0.313 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.17 96.23 6.16 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.346 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 85.0 m -81.26 148.76 64.18 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.909 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.8 164.05 34.93 Favored 'Trans proline' 0 C--N 1.367 1.51 0 C-N-CA 123.328 2.685 . . . . 0.0 113.408 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.41 -164.44 23.63 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.17 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.4 tt0 -77.05 122.78 25.42 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.742 0.306 . . . . 0.0 111.161 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.39 0.76 58.09 Favored Glycine 0 C--N 1.339 0.714 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.324 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -97.72 167.01 11.21 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.306 0.243 . . . . 0.0 110.574 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -82.78 137.16 34.45 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.393 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.6 p -126.92 124.19 38.95 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.478 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.69 156.93 17.3 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.357 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.45 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.164 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.82 -64.61 1.02 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.739 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.09 3.4 0.44 Allowed 'General case' 0 C--N 1.349 0.551 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.3 70.3 22.25 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.79 170.14 2.4 Favored 'Trans proline' 0 C--N 1.369 1.627 0 C-N-CA 123.202 2.601 . . . . 0.0 111.807 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 12.6 m -83.85 106.32 15.44 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.737 0.303 . . . . 0.0 110.479 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -79.71 -40.6 1.41 Allowed Pre-proline 0 CA--C 1.546 0.791 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.313 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.59 -178.23 2.18 Favored 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.206 1.937 . . . . 0.0 111.422 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.564 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.73 55.27 0.34 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.598 2.198 . . . . 0.0 114.515 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.564 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.89 156.18 48.56 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.247 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.3 160.02 18.07 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.813 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.51 105.2 17.31 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.007 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.9 22.73 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.061 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.69 -51.53 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.598 0 C-N-CA 124.28 -1.133 . . . . 0.0 113.695 -0.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.52 34.1 17.51 Favored Glycine 0 C--N 1.344 1.027 0 C-N-CA 121.407 -0.425 . . . . 0.0 113.267 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.46 81.41 17.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.56 -33.88 2.76 Favored 'Cis proline' 0 C--N 1.37 1.709 0 C-N-CA 125.227 -0.739 . . . . 0.0 112.743 -0.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.53 154.06 20.65 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.22 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.22 -167.22 14.55 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.723 -0.671 . . . . 0.0 112.769 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.3 mm -133.1 154.2 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 22' ' ' THR . 81.2 m -86.96 98.26 11.15 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.595 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.22 155.2 19.28 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.237 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.79 132.93 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.742 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.182 -0.914 . . . . 0.0 111.304 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.236 0.36 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -111.31 96.64 6.24 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.313 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 71.6 m -80.73 148.34 65.06 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.909 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -69.07 163.34 38.08 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 123.361 2.708 . . . . 0.0 113.415 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.41 -166.4 23.72 Favored Glycine 0 C--N 1.337 0.637 0 O-C-N 123.654 0.596 . . . . 0.0 112.088 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.0 tt0 -75.29 121.23 21.88 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.466 0.306 . . . . 0.0 111.165 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.18 -0.64 57.32 Favored Glycine 0 C--N 1.337 0.617 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.365 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -96.68 167.07 11.35 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.399 0.28 . . . . 0.0 110.597 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.59 137.49 34.53 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.477 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.5 p -126.93 124.56 39.79 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.448 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -102.61 156.49 17.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.413 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.62 15.16 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.234 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.04 -64.44 1.04 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.72 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.1 2.93 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.46 70.28 23.92 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.2 Cg_endo -92.65 169.89 2.5 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 123.128 2.552 . . . . 0.0 111.784 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.2 m -82.11 105.94 13.62 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.835 0.35 . . . . 0.0 110.598 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.5 m -79.39 -40.59 1.48 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.773 -0.632 . . . . 0.0 112.293 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -70.12 -178.12 2.32 Favored 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.257 1.971 . . . . 0.0 111.41 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.561 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.1 Cg_exo -66.0 55.43 0.37 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.634 2.223 . . . . 0.0 114.436 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.561 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.01 156.09 48.82 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.23 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.02 159.84 18.06 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.795 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.44 105.25 17.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.006 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.07 127.92 22.74 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.022 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.66 -51.67 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.571 0 C-N-CA 124.252 -1.145 . . . . 0.0 113.667 -0.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.56 34.41 16.45 Favored Glycine 0 C--N 1.344 1.014 0 C-N-CA 121.435 -0.412 . . . . 0.0 113.196 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.27 81.25 18.33 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.463 0.172 . . . . 0.0 111.463 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.56 -33.96 2.73 Favored 'Cis proline' 0 C--N 1.373 1.852 0 C-N-CA 125.174 -0.761 . . . . 0.0 112.794 -0.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.2 154.0 20.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.141 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.525 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.11 -167.05 14.32 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.819 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.525 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.8 mm -132.98 153.91 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 22' ' ' THR . 90.5 m -86.83 98.33 11.13 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.59 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.31 155.14 19.37 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.27 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.75 132.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.772 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.358 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.235 0.336 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -110.29 96.55 6.28 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.998 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.2 m -81.68 148.6 62.17 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.176 -0.92 . . . . 0.0 111.925 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -69.55 163.87 36.46 Favored 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 123.25 2.633 . . . . 0.0 113.357 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.61 -162.42 24.22 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.956 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.434 ' OE1' HD11 ' A' ' 21' ' ' LEU . 29.3 tt0 -78.67 121.93 25.32 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.768 0.318 . . . . 0.0 110.963 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.02 32.51 7.86 Favored Glycine 0 C--N 1.338 0.689 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.939 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -128.16 165.11 21.05 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.52 0.328 . . . . 0.0 110.397 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -80.98 129.98 34.79 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.523 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.01 123.8 41.69 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.329 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.75 156.89 17.23 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.427 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 15.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.135 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.09 -64.69 1.01 Allowed 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.743 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.22 0.46 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.2 70.27 21.21 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.9 Cg_endo -93.27 170.89 2.12 Favored 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.164 2.576 . . . . 0.0 111.816 178.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.8 m -84.89 105.98 16.07 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.707 0.289 . . . . 0.0 110.341 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.4 m -79.1 -40.52 1.54 Allowed Pre-proline 0 CA--C 1.546 0.789 0 CA-C-O 118.853 -0.594 . . . . 0.0 112.378 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -69.21 -178.48 2.16 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.254 1.969 . . . . 0.0 111.495 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.74 55.13 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 122.672 2.248 . . . . 0.0 114.51 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.569 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.84 156.2 48.48 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.245 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.18 159.84 18.17 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.876 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.2 t -98.61 104.95 17.04 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.894 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.48 128.1 23.1 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.969 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.45 -51.25 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.561 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.669 -0.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.08 33.89 19.44 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 121.39 -0.433 . . . . 0.0 113.285 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.34 81.5 17.82 Favored Pre-proline 0 CA--C 1.545 0.785 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.65 -33.64 2.84 Favored 'Cis proline' 0 C--N 1.372 1.792 0 C-N-CA 125.311 -0.704 . . . . 0.0 112.775 -0.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -88.83 154.11 20.52 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.203 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.3 -166.67 14.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.841 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.7 mm -133.39 154.34 38.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.543 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.2 m -87.12 98.58 11.37 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-O 120.836 0.35 . . . . 0.0 110.568 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -105.63 155.84 18.84 Favored 'General case' 0 C--N 1.342 0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.212 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 133.25 34.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.68 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.412 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.356 -0.831 . . . . 0.0 111.331 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.235 0.297 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.65 96.21 5.85 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.348 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.8 p -87.51 147.15 41.13 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.667 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.5 Cg_endo -69.65 168.19 22.14 Favored 'Trans proline' 0 C--N 1.367 1.528 0 C-N-CA 123.445 2.763 . . . . 0.0 113.882 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.56 -157.57 13.31 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.713 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' OE1' HD11 ' A' ' 21' ' ' LEU . 32.9 tt0 -78.87 122.2 25.79 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.766 0.283 . . . . 0.0 111.008 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.61 32.94 8.25 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 115.58 -0.736 . . . . 0.0 113.081 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -130.47 166.81 19.74 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.419 0.288 . . . . 0.0 110.393 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.33 130.99 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.789 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.76 123.36 40.32 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.207 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.41 17.63 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.49 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.31 15.78 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.146 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.08 -65.09 0.98 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.08 1.64 0.41 Allowed 'General case' 0 C--N 1.349 0.568 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -118.64 73.71 11.6 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -93.51 170.34 2.07 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.241 2.628 . . . . 0.0 111.945 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.7 m -81.71 119.57 24.01 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 110.495 -0.187 . . . . 0.0 110.495 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.625 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -84.94 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.91 -179.82 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.131 1.887 . . . . 0.0 111.496 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.02 62.44 0.3 Allowed 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 122.622 2.215 . . . . 0.0 114.05 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.73 158.35 44.36 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.336 178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.51 159.71 19.26 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.699 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.48 104.66 16.72 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.878 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.89 127.92 23.42 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.904 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.43 -51.13 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.564 0 C-N-CA 124.259 -1.142 . . . . 0.0 113.632 -0.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.58 34.03 20.55 Favored Glycine 0 C--N 1.344 1.011 0 C-N-CA 121.514 -0.374 . . . . 0.0 113.279 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.25 81.16 18.52 Favored Pre-proline 0 CA--C 1.546 0.813 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.66 -33.76 2.79 Favored 'Cis proline' 0 C--N 1.372 1.803 0 C-N-CA 125.29 -0.712 . . . . 0.0 112.854 -0.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.92 153.48 21.27 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.193 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.35 -167.04 14.41 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.85 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.13 154.06 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.6 m -87.29 99.07 11.7 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.811 0.339 . . . . 0.0 110.471 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.64 155.52 19.56 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.3 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.29 132.94 35.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.636 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.351 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.257 . . . . . . . 0 C--O 1.235 0.299 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.46 96.21 5.87 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.428 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.6 p -87.56 147.17 41.08 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.581 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.4 Cg_endo -69.7 168.21 22.12 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 123.377 2.718 . . . . 0.0 113.874 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.58 -157.59 13.31 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.68 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' OE1' HD11 ' A' ' 21' ' ' LEU . 32.9 tt0 -78.85 122.32 25.93 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.755 0.278 . . . . 0.0 110.998 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.58 32.76 8.4 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.216 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -130.39 166.77 19.76 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 122.398 0.279 . . . . 0.0 110.404 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.33 130.98 35.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.752 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.9 p -123.76 123.21 40.0 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.268 179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.45 156.47 17.58 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.476 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.38 15.8 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.191 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.03 -65.07 0.98 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.804 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.15 1.77 0.41 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.8 73.54 11.96 Favored Pre-proline 0 CA--C 1.549 0.939 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.4 Cg_endo -93.43 170.29 2.1 Favored 'Trans proline' 0 C--N 1.37 1.66 0 C-N-CA 123.226 2.618 . . . . 0.0 111.889 177.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -81.7 119.58 24.03 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.625 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.2 p -85.09 -36.29 0.57 Allowed Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.86 5.66 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.214 1.943 . . . . 0.0 111.463 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.546 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.99 62.47 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.584 2.19 . . . . 0.0 113.972 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.83 158.33 44.5 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.256 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.46 159.73 19.2 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.717 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.44 104.59 16.64 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.886 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.87 127.89 23.43 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.962 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.42 -51.03 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.208 -1.164 . . . . 0.0 113.67 -0.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.4 34.05 21.05 Favored Glycine 0 C--N 1.345 1.028 0 C-N-CA 121.449 -0.405 . . . . 0.0 113.298 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.28 81.11 18.51 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 111.47 0.174 . . . . 0.0 111.47 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.75 2.78 Favored 'Cis proline' 0 C--N 1.373 1.838 0 C-N-CA 125.259 -0.725 . . . . 0.0 112.858 -0.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.91 153.46 21.29 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.208 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.35 -166.94 14.31 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.828 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.1 mm -133.16 154.0 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.2 98.99 11.62 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.854 0.359 . . . . 0.0 110.52 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.64 155.45 19.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.408 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.15 132.92 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.749 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.455 -0.784 . . . . 0.0 111.308 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.235 0.312 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -110.46 96.5 6.23 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.257 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 83.7 m -80.9 148.59 65.1 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.88 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.96 163.78 36.26 Favored 'Trans proline' 0 C--N 1.365 1.444 0 C-N-CA 123.294 2.663 . . . . 0.0 113.394 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.41 -165.26 23.66 Favored Glycine 0 C--N 1.338 0.67 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.083 179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.456 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.2 tt0 -76.36 122.12 24.01 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.462 0.305 . . . . 0.0 111.176 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.62 0.66 57.79 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.366 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -97.82 167.04 11.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 122.435 0.294 . . . . 0.0 110.548 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -82.6 137.29 34.57 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.448 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 p -126.97 124.29 39.1 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.49 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.58 156.78 17.39 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.349 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.59 15.33 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.191 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -98.53 -64.53 1.03 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.745 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.03 3.22 0.44 Allowed 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.38 70.29 23.12 Favored Pre-proline 0 CA--C 1.549 0.907 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.4 Cg_endo -92.76 170.16 2.41 Favored 'Trans proline' 0 C--N 1.371 1.721 0 C-N-CA 123.137 2.558 . . . . 0.0 111.818 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.8 m -83.22 106.1 14.73 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 120.745 0.307 . . . . 0.0 110.517 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.7 m -79.48 -40.65 1.46 Allowed Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.818 -0.61 . . . . 0.0 112.251 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.85 -178.18 2.26 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.243 1.962 . . . . 0.0 111.376 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.565 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.0 Cg_exo -65.82 55.24 0.35 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.68 2.254 . . . . 0.0 114.47 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -133.86 156.0 48.86 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.28 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.547 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.2 t -112.03 160.0 17.92 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.844 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.49 105.14 17.25 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -130.06 127.94 22.74 Favored Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.947 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.57 -51.58 0.16 OUTLIER 'Cis proline' 0 C--N 1.369 1.618 0 C-N-CA 124.245 -1.148 . . . . 0.0 113.695 -0.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.45 34.33 17.03 Favored Glycine 0 C--N 1.343 0.969 0 C-N-CA 121.44 -0.41 . . . . 0.0 113.231 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.48 81.34 17.62 Favored Pre-proline 0 CA--C 1.545 0.782 0 CA-C-N 116.544 0.172 . . . . 0.0 111.444 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.54 -33.89 2.76 Favored 'Cis proline' 0 C--N 1.373 1.835 0 C-N-CA 125.258 -0.726 . . . . 0.0 112.807 -0.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -88.46 154.02 20.7 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.187 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.14 -167.25 14.54 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.756 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.1 mm -133.03 154.02 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 22' ' ' THR . 85.0 m -86.93 98.23 11.12 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 120.933 0.397 . . . . 0.0 110.581 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -105.23 155.14 19.34 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.277 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -91.65 132.84 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.776 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.099 -0.953 . . . . 0.0 111.333 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.254 . . . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -115.68 97.5 6.17 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.351 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.2 p -85.28 147.03 46.25 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.746 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.6 Cg_endo -69.82 168.08 22.68 Favored 'Trans proline' 0 C--N 1.366 1.498 0 C-N-CA 123.361 2.707 . . . . 0.0 113.86 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.47 -157.52 13.38 Favored Glycine 0 C--N 1.339 0.725 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.672 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.51 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.0 tt0 -78.94 122.11 25.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.754 0.311 . . . . 0.0 110.998 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.72 32.79 8.31 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.101 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.4 166.81 19.67 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 122.481 0.312 . . . . 0.0 110.393 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -80.32 131.07 35.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.699 -179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.87 123.47 40.5 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.206 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.49 156.46 17.59 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.519 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.34 15.61 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.143 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.9 -65.12 0.98 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.735 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.14 1.74 0.41 Allowed 'General case' 0 C--N 1.349 0.581 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.55 73.74 11.34 Favored Pre-proline 0 CA--C 1.549 0.929 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.4 Cg_endo -93.58 170.34 2.04 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 123.227 2.618 . . . . 0.0 111.88 177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 m -81.6 119.53 23.9 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.86 -36.42 0.58 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.92 -179.83 5.63 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.135 1.89 . . . . 0.0 111.534 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -65.07 62.62 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.591 2.194 . . . . 0.0 114.058 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.89 158.36 44.45 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.241 179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -113.53 159.63 19.37 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.805 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.38 104.55 16.6 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.915 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 21.0 mt -128.93 127.95 23.41 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.946 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.48 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.566 0 C-N-CA 124.22 -1.158 . . . . 0.0 113.647 -0.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.54 34.06 20.59 Favored Glycine 0 C--N 1.343 0.966 0 C-N-CA 121.486 -0.388 . . . . 0.0 113.193 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.12 81.0 19.14 Favored Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.79 -33.77 2.76 Favored 'Cis proline' 0 C--N 1.372 1.794 0 C-N-CA 125.225 -0.739 . . . . 0.0 112.833 -0.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -87.88 153.55 21.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.253 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.38 -166.91 14.3 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.877 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.14 154.08 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.1 m -87.29 99.04 11.68 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 120.828 0.346 . . . . 0.0 110.61 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 155.46 19.65 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.284 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.93 35.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.788 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.354 -0.832 . . . . 0.0 111.307 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.254 . . . . . . . 0 C--O 1.235 0.3 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -118.07 98.67 6.43 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.372 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.4 p -83.78 146.84 50.35 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.747 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.6 Cg_endo -69.7 168.03 22.64 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 123.404 2.736 . . . . 0.0 113.87 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.53 -157.74 13.43 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.69 178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.517 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.2 tt0 -78.74 122.03 25.5 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.714 0.293 . . . . 0.0 111.029 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.02 31.35 9.26 Favored Glycine 0 C--N 1.339 0.746 0 CA-C-N 115.587 -0.733 . . . . 0.0 113.128 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -129.67 166.49 19.69 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.432 0.293 . . . . 0.0 110.342 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -79.99 132.96 36.12 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.807 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.25 123.64 39.96 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.258 179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.48 156.37 17.65 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.508 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.28 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.88 -65.16 0.98 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.758 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.09 1.57 0.41 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.48 73.8 11.16 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.2 Cg_endo -93.51 170.29 2.07 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.272 2.648 . . . . 0.0 111.883 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -81.31 119.56 23.82 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.631 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.3 p -84.88 -36.56 0.58 Allowed Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.631 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.96 5.74 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.142 1.894 . . . . 0.0 111.552 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.5 Cg_exo -64.95 62.76 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.587 2.191 . . . . 0.0 113.996 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.548 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.93 158.58 43.92 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.65 159.66 19.43 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.785 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.9 t -98.47 104.59 16.64 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.981 0.42 . . . . 0.0 110.956 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.81 128.02 23.46 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.996 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -69.45 -50.99 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.573 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.694 -0.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.45 34.05 20.91 Favored Glycine 0 C--N 1.344 0.976 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.264 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.21 81.15 18.66 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 111.465 0.172 . . . . 0.0 111.465 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.71 -33.86 2.74 Favored 'Cis proline' 0 C--N 1.371 1.741 0 C-N-CA 125.243 -0.732 . . . . 0.0 112.768 -0.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.96 153.51 21.24 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.14 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.23 -166.94 14.27 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.864 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.21 154.2 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.31 99.15 11.76 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-O 120.859 0.361 . . . . 0.0 110.585 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.01 155.47 19.77 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.373 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.17 132.82 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.777 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.375 -0.821 . . . . 0.0 111.292 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.236 0.344 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -120.92 100.03 6.85 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.207 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.6 p -81.92 146.77 56.54 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.843 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.9 Cg_endo -69.74 168.21 22.17 Favored 'Trans proline' 0 C--N 1.367 1.527 0 C-N-CA 123.359 2.706 . . . . 0.0 113.942 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.55 -157.68 13.38 Favored Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.676 178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.513 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.1 tt0 -78.75 122.07 25.55 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.748 0.274 . . . . 0.0 111.013 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.72 32.7 8.39 Favored Glycine 0 C--N 1.339 0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 113.184 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -130.49 166.82 19.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 122.433 0.293 . . . . 0.0 110.434 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.34 131.18 35.59 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.726 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.86 123.54 40.67 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.243 179.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.41 17.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.483 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 m -85.42 15.53 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.239 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.64 -64.91 1.0 Allowed 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.773 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.37 1.66 0.39 Allowed 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.627 0.603 . . . . 0.0 112.627 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.5 73.81 11.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.4 Cg_endo -93.48 170.5 2.07 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 123.21 2.607 . . . . 0.0 111.877 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.7 m -81.51 119.47 23.79 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.631 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.4 p -84.79 -36.48 0.59 Allowed Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.631 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.8 Cg_endo -79.99 -179.9 5.67 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.172 1.915 . . . . 0.0 111.499 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.05 62.79 0.31 Allowed 'Trans proline' 0 C--N 1.382 2.318 0 C-N-CA 122.565 2.177 . . . . 0.0 114.051 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.92 158.45 44.26 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.302 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.56 159.62 19.4 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.782 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.47 104.58 16.63 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.846 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.77 128.0 23.48 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.012 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.36 -51.09 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.523 0 C-N-CA 124.219 -1.159 . . . . 0.0 113.716 -0.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.57 34.02 20.61 Favored Glycine 0 C--N 1.345 1.041 0 C-N-CA 121.383 -0.437 . . . . 0.0 113.27 179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.21 81.0 18.87 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 111.542 0.201 . . . . 0.0 111.542 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.82 -33.8 2.74 Favored 'Cis proline' 0 C--N 1.373 1.823 0 C-N-CA 125.272 -0.72 . . . . 0.0 112.823 -0.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -87.88 153.62 21.17 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.203 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.39 -166.96 14.34 Favored Glycine 0 C--N 1.335 0.494 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.829 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 154.02 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.6 m -87.2 99.16 11.75 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 120.859 0.361 . . . . 0.0 110.536 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.86 155.6 19.57 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.31 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.24 133.0 35.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.755 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.408 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.188 -0.911 . . . . 0.0 111.325 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.235 0.29 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -122.71 100.98 7.2 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.259 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.9 p -80.64 146.76 61.4 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.921 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.8 Cg_endo -69.81 168.1 22.6 Favored 'Trans proline' 0 C--N 1.368 1.579 0 C-N-CA 123.365 2.71 . . . . 0.0 113.891 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.46 -157.61 13.44 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.678 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.516 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.2 tt0 -78.89 122.01 25.58 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.803 0.301 . . . . 0.0 111.054 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.09 31.41 9.17 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.134 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -129.73 166.59 19.55 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 122.456 0.302 . . . . 0.0 110.381 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -80.04 132.99 36.1 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.758 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -125.42 123.67 39.77 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.242 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.41 156.33 17.66 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.525 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.5 m -85.32 15.67 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.762 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.214 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -98.69 -65.15 0.98 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.763 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.3 t80 -151.22 1.69 0.41 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.5 73.82 11.25 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -93.47 170.48 2.07 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 123.254 2.636 . . . . 0.0 111.952 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.9 m -81.39 119.49 23.76 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 110.437 -0.208 . . . . 0.0 110.437 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.63 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.0 p -84.66 -36.68 0.6 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.63 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.96 -179.95 5.72 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.117 1.878 . . . . 0.0 111.456 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.7 Cg_exo -64.91 62.72 0.29 Allowed 'Trans proline' 0 C--N 1.381 2.284 0 C-N-CA 122.62 2.213 . . . . 0.0 114.018 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.9 158.64 43.74 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.331 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.536 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.71 159.66 19.47 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.708 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.49 104.47 16.51 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.91 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.6 mt -128.75 128.02 23.49 Favored Pre-proline 0 CA--C 1.538 0.516 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.988 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.38 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.583 0 C-N-CA 124.195 -1.169 . . . . 0.0 113.717 -0.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.56 33.96 20.8 Favored Glycine 0 C--N 1.345 1.032 0 C-N-CA 121.469 -0.396 . . . . 0.0 113.251 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -140.22 81.07 18.74 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.66 -33.9 2.73 Favored 'Cis proline' 0 C--N 1.372 1.811 0 C-N-CA 125.267 -0.722 . . . . 0.0 112.833 -0.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -87.93 153.63 21.15 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.24 -167.06 14.39 Favored Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.9 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.22 154.24 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.8 m -87.34 99.27 11.86 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.86 0.362 . . . . 0.0 110.607 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -107.05 155.45 19.82 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.353 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.11 132.89 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.708 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.409 HD12 ' OXT' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.116 -0.945 . . . . 0.0 111.305 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.236 0.348 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -111.87 96.91 6.33 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.337 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.3 m -80.63 148.67 66.28 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.97 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.16 163.92 36.84 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 123.357 2.705 . . . . 0.0 113.288 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -105.45 -162.93 23.51 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.024 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.428 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.4 tt0 -78.04 121.71 24.6 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.667 0.27 . . . . 0.0 111.007 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.52 30.97 8.62 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-N 115.628 -0.714 . . . . 0.0 112.885 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.38 164.89 20.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.446 0.298 . . . . 0.0 110.302 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -80.7 131.92 35.51 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.588 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.27 123.82 41.07 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.241 -0.891 . . . . 0.0 110.365 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.67 156.77 17.29 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.475 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.1 m -85.68 16.61 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.226 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.2 -64.54 1.03 Allowed 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.712 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.83 3.02 0.46 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.18 70.64 21.54 Favored Pre-proline 0 CA--C 1.55 0.956 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.1 Cg_endo -93.3 171.32 2.06 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.201 2.6 . . . . 0.0 111.892 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m -84.37 105.98 15.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.768 0.318 . . . . 0.0 110.301 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 63.6 m -78.91 -39.89 1.54 Allowed Pre-proline 0 CA--C 1.545 0.781 0 CA-C-O 118.752 -0.642 . . . . 0.0 112.562 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.5 Cg_exo -71.5 -179.65 3.86 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.193 1.929 . . . . 0.0 111.176 179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' O ' HD13 ' A' ' 21' ' ' LEU . 35.8 Cg_endo -64.64 56.41 0.25 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.354 2.036 . . . . 0.0 114.83 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.576 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.03 156.47 48.16 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.106 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.28 159.75 18.33 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.767 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.1 t -98.65 104.8 16.87 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.3 128.01 23.2 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.944 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.5 -51.35 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.556 0 C-N-CA 124.221 -1.158 . . . . 0.0 113.743 -0.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.27 33.9 18.83 Favored Glycine 0 C--N 1.345 1.047 0 C-N-CA 121.358 -0.448 . . . . 0.0 113.197 179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -140.5 81.64 17.19 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.522 0.193 . . . . 0.0 111.522 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.48 -33.7 2.84 Favored 'Cis proline' 0 C--N 1.372 1.779 0 C-N-CA 125.271 -0.721 . . . . 0.0 112.837 -0.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.91 154.24 20.4 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.199 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.21 -166.7 14.04 Favored Glycine 0 C--N 1.334 0.426 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.885 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.6 mm -133.43 154.39 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 22' ' ' THR . 76.4 m -87.24 98.77 11.51 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.881 0.372 . . . . 0.0 110.57 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -106.05 153.46 22.02 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.211 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.5 tt -94.65 134.45 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.709 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.462 -0.78 . . . . 0.0 111.278 -179.95 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.338 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -109.38 96.27 6.18 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.32 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 81.7 m -81.64 148.89 63.11 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.918 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.71 163.76 37.02 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 123.317 2.678 . . . . 0.0 113.399 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.18 -160.01 24.34 Favored Glycine 0 C--N 1.338 0.656 0 O-C-N 123.682 0.614 . . . . 0.0 111.892 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.413 ' OE1' HD11 ' A' ' 21' ' ' LEU . 28.9 tt0 -80.4 123.24 27.86 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.677 0.275 . . . . 0.0 110.963 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.52 33.86 7.31 Favored Glycine 0 C--N 1.338 0.688 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.817 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -129.25 162.44 27.88 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 122.527 0.331 . . . . 0.0 110.245 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -79.85 130.44 35.31 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.446 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.4 p -123.06 124.33 42.86 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.464 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.97 157.12 17.09 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.44 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -85.71 18.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.22 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.53 -64.51 1.06 Allowed 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.782 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.439 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -150.8 3.39 0.46 Allowed 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.14 70.34 20.63 Favored Pre-proline 0 CA--C 1.551 0.989 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.5 Cg_endo -93.53 171.25 1.98 Allowed 'Trans proline' 0 C--N 1.369 1.624 0 C-N-CA 123.209 2.606 . . . . 0.0 111.991 178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.8 m -86.41 106.17 17.25 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.765 0.317 . . . . 0.0 110.317 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.4 m -79.29 -40.38 1.48 Allowed Pre-proline 0 CA--C 1.546 0.792 0 CA-C-O 118.729 -0.653 . . . . 0.0 112.392 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.94 -178.58 2.09 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.248 1.965 . . . . 0.0 111.488 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.57 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.3 Cg_exo -65.63 55.26 0.33 Allowed 'Trans proline' 0 C--N 1.381 2.246 0 C-N-CA 122.648 2.232 . . . . 0.0 114.567 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.83 156.34 48.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.218 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.38 160.04 18.11 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.852 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.4 t -98.74 105.09 17.19 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.9 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.2 mt -129.56 128.23 23.07 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.016 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.32 -51.15 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.53 0 C-N-CA 124.295 -1.127 . . . . 0.0 113.722 -0.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.05 33.86 19.61 Favored Glycine 0 C--N 1.345 1.073 0 C-N-CA 121.438 -0.41 . . . . 0.0 113.288 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.77 81.75 16.34 Favored Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.4 -33.63 2.88 Favored 'Cis proline' 0 C--N 1.373 1.826 0 C-N-CA 125.326 -0.698 . . . . 0.0 112.864 -0.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -89.19 154.29 20.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.241 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.531 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.27 -166.66 14.02 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.848 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.531 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.71 154.74 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 22' ' ' THR . 70.9 m -87.12 98.54 11.35 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 120.812 0.339 . . . . 0.0 110.57 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -105.65 156.14 18.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.273 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.56 133.29 34.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.721 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.413 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.385 -0.817 . . . . 0.0 111.365 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.258 . . . . . . . 0 C--O 1.235 0.301 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -116.18 97.86 6.29 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.072 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.3 p -85.17 146.95 46.36 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.813 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.5 Cg_endo -69.65 168.06 22.5 Favored 'Trans proline' 0 C--N 1.367 1.505 0 C-N-CA 123.384 2.723 . . . . 0.0 113.926 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.38 -157.56 13.49 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.76 178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.518 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.2 tt0 -79.04 122.32 26.05 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 116.792 0.296 . . . . 0.0 111.009 179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.85 31.09 9.57 Favored Glycine 0 C--N 1.339 0.728 0 CA-C-N 115.631 -0.713 . . . . 0.0 113.157 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -129.26 166.6 19.11 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.422 0.289 . . . . 0.0 110.331 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -80.13 132.93 36.02 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.835 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -125.08 123.48 39.83 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.238 179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.463 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.44 15.77 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.48 -0.782 . . . . 0.0 112.176 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.68 -64.96 0.99 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.748 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.428 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.4 1.59 0.39 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.46 73.82 11.12 Favored Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.3 Cg_endo -93.54 170.19 2.07 Favored 'Trans proline' 0 C--N 1.369 1.631 0 C-N-CA 123.191 2.594 . . . . 0.0 111.85 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.5 m -81.29 119.31 23.48 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.5 p -84.88 -36.37 0.58 Allowed Pre-proline 0 CA--C 1.549 0.905 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -80.0 -179.84 5.62 Favored 'Trans proline' 0 C--N 1.379 2.149 0 C-N-CA 122.076 1.851 . . . . 0.0 111.519 179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.66 0.31 Allowed 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.57 2.18 . . . . 0.0 113.98 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.94 158.56 43.98 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.27 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.62 159.75 19.31 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.701 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.6 104.58 16.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.986 0.422 . . . . 0.0 110.862 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.84 127.85 23.44 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.059 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.52 -51.07 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.549 0 C-N-CA 124.205 -1.165 . . . . 0.0 113.626 -0.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.5 33.98 20.94 Favored Glycine 0 C--N 1.344 0.987 0 C-N-CA 121.492 -0.385 . . . . 0.0 113.229 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.38 81.15 18.15 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.69 -33.87 2.73 Favored 'Cis proline' 0 C--N 1.372 1.813 0 C-N-CA 125.275 -0.719 . . . . 0.0 112.803 -0.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -88.09 153.61 21.12 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.215 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.34 -167.07 14.44 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.851 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.3 mm -133.17 154.1 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.5 m -87.18 99.21 11.77 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.759 0.314 . . . . 0.0 110.593 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -106.94 155.42 19.8 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.361 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.11 132.83 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.77 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.156 -0.925 . . . . 0.0 111.307 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.236 0.376 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -112.57 96.16 5.83 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.398 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 24.8 p -87.81 147.12 40.44 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.595 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.6 Cg_endo -69.71 168.32 21.82 Favored 'Trans proline' 0 C--N 1.367 1.504 0 C-N-CA 123.358 2.705 . . . . 0.0 113.889 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.56 -157.67 13.36 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.727 178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.517 ' OE1' HD11 ' A' ' 21' ' ' LEU . 33.1 tt0 -78.94 122.36 26.05 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.686 0.279 . . . . 0.0 111.064 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.9 31.14 9.5 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.183 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -129.46 166.46 19.56 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 122.381 0.272 . . . . 0.0 110.345 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -80.15 132.93 36.01 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.723 -179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.7 p -124.97 123.26 39.5 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.203 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.35 156.1 17.81 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.486 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 m -85.43 15.82 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.138 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -97.97 -65.02 0.99 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.71 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.66 1.51 0.37 Allowed 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.23 73.95 10.5 Favored Pre-proline 0 CA--C 1.549 0.909 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -179.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.7 Cg_endo -93.57 170.24 2.05 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.278 2.652 . . . . 0.0 111.946 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.4 m -81.44 119.42 23.69 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 110.478 -0.193 . . . . 0.0 110.478 179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.628 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.02 -36.43 0.57 Allowed Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.628 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 3.0 Cg_endo -79.92 -179.8 5.6 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.181 1.921 . . . . 0.0 111.431 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.549 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.0 62.37 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 122.618 2.212 . . . . 0.0 113.943 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.549 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.74 158.47 44.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.385 178.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.54 159.8 19.19 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.757 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.42 16.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.896 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.5 mt -128.67 127.9 23.52 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.03 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.44 -51.06 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.553 0 C-N-CA 124.202 -1.166 . . . . 0.0 113.625 -0.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.38 34.07 21.06 Favored Glycine 0 C--N 1.344 1.021 0 C-N-CA 121.545 -0.359 . . . . 0.0 113.254 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.2 80.94 18.98 Favored Pre-proline 0 CA--C 1.546 0.802 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.82 -33.83 2.73 Favored 'Cis proline' 0 C--N 1.372 1.806 0 C-N-CA 125.2 -0.75 . . . . 0.0 112.812 -0.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -87.67 153.45 21.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.248 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.528 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.42 -167.08 14.48 Favored Glycine 0 C--N 1.334 0.42 0 CA-C-N 115.855 -0.612 . . . . 0.0 112.862 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.528 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.17 154.17 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.2 m -87.26 99.15 11.75 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-O 120.775 0.321 . . . . 0.0 110.552 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -106.96 155.29 19.95 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.318 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.14 132.88 35.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.739 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.403 -0.808 . . . . 0.0 111.297 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.256 . . . . . . . 0 C--O 1.236 0.357 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -108.69 95.62 5.78 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 84.2 m -81.58 149.0 63.62 Favored Pre-proline 0 CA--C 1.538 0.493 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.906 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -69.3 164.11 35.32 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.299 2.666 . . . . 0.0 113.323 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -104.85 -161.77 23.92 Favored Glycine 0 C--N 1.339 0.718 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.989 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.425 ' OE1' HD11 ' A' ' 21' ' ' LEU . 29.1 tt0 -79.07 122.3 26.05 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.754 0.312 . . . . 0.0 110.919 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.95 32.69 7.78 Favored Glycine 0 C--N 1.339 0.729 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.9 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -128.06 164.92 21.35 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 122.482 0.313 . . . . 0.0 110.395 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -81.01 129.84 34.73 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.571 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.0 p -123.04 123.59 41.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.412 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -101.91 157.17 17.05 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.382 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.55 16.85 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.163 -179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -100.9 -64.67 1.03 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.723 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.441 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -150.72 3.56 0.47 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -121.28 70.11 21.72 Favored Pre-proline 0 CA--C 1.55 0.977 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 10.3 Cg_endo -93.24 171.02 2.11 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 123.242 2.628 . . . . 0.0 111.963 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.1 m -85.79 106.23 16.88 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.694 0.283 . . . . 0.0 110.316 179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.0 m -79.25 -40.55 1.51 Allowed Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 118.835 -0.602 . . . . 0.0 112.38 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.09 -178.53 2.13 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.309 2.006 . . . . 0.0 111.44 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.568 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.2 Cg_exo -65.68 55.17 0.33 Allowed 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 122.638 2.225 . . . . 0.0 114.544 -179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.568 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -133.74 156.33 48.16 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.248 178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.1 t -112.39 160.02 18.14 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.799 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.3 t -98.67 105.07 17.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.955 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.1 mt -129.58 128.04 23.04 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.946 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.53 -51.24 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.56 0 C-N-CA 124.222 -1.157 . . . . 0.0 113.62 -0.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.07 34.02 19.1 Favored Glycine 0 C--N 1.344 1.009 0 C-N-CA 121.446 -0.407 . . . . 0.0 113.242 179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.59 81.59 17.01 Favored Pre-proline 0 CA--C 1.545 0.783 0 N-CA-C 111.469 0.174 . . . . 0.0 111.469 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -33.72 2.84 Favored 'Cis proline' 0 C--N 1.372 1.786 0 C-N-CA 125.295 -0.71 . . . . 0.0 112.836 -0.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -88.91 154.12 20.5 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.18 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.53 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.27 -166.88 14.23 Favored Glycine 0 C--N 1.334 0.464 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.814 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.53 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.5 mm -133.36 154.41 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 22' ' ' THR . 73.0 m -87.22 98.58 11.4 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-O 120.847 0.356 . . . . 0.0 110.468 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.56 155.99 18.67 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.217 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -92.43 133.19 34.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.766 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.148 -0.929 . . . . 0.0 111.325 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.309 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -109.46 96.41 6.26 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.362 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 79.5 m -80.96 149.03 66.06 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.912 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.13 164.17 34.97 Favored 'Trans proline' 0 C--N 1.366 1.458 0 C-N-CA 123.316 2.677 . . . . 0.0 113.333 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -106.47 -165.04 22.71 Favored Glycine 0 C--N 1.338 0.655 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.108 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.435 ' OE1' HD11 ' A' ' 21' ' ' LEU . 27.7 tt0 -76.23 122.02 23.76 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 122.526 0.331 . . . . 0.0 111.185 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.04 0.36 57.29 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.662 -0.699 . . . . 0.0 113.312 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -97.41 167.01 11.26 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 122.398 0.279 . . . . 0.0 110.622 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -82.61 137.39 34.53 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.477 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.8 p -127.27 123.64 36.94 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.467 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.51 156.96 17.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.42 -179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.0 m -85.49 16.11 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.657 -0.701 . . . . 0.0 112.209 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -99.74 -64.43 1.04 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.6 t80 -151.0 3.43 0.45 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -121.3 70.2 22.12 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HD3' ' C ' ' A' ' 14' ' ' PHE . 9.3 Cg_endo -92.67 170.56 2.42 Favored 'Trans proline' 0 C--N 1.368 1.598 0 C-N-CA 123.228 2.618 . . . . 0.0 111.85 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 15.5 m -83.86 106.89 15.9 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.748 0.309 . . . . 0.0 110.474 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 64.4 m -80.02 -40.08 1.29 Allowed Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.458 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 18' ' ' CYS . 8.3 Cg_exo -71.65 -179.48 3.78 Favored 'Trans proline' 0 C--N 1.38 2.194 0 C-N-CA 122.31 2.007 . . . . 0.0 111.179 179.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.571 ' O ' HD13 ' A' ' 21' ' ' LEU . 35.3 Cg_endo -64.76 56.59 0.26 Allowed 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.445 2.096 . . . . 0.0 114.644 -179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.571 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.5 mm? -134.07 156.2 48.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.2 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.3 t -112.28 159.74 18.33 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.815 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 4.8 t -98.39 105.12 17.22 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.979 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.8 mt -129.98 127.96 22.8 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.014 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.522 ' HB2' ' OD1' ' A' ' 27' ' ' ASP . 44.2 Cg_endo -69.62 -51.65 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.578 0 C-N-CA 124.171 -1.179 . . . . 0.0 113.665 -0.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.36 34.68 16.27 Favored Glycine 0 C--N 1.345 1.049 0 C-N-CA 121.444 -0.407 . . . . 0.0 113.177 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.522 ' OD1' ' HB2' ' A' ' 25' ' ' PRO . 2.8 p-10 -140.36 80.73 18.88 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.43 -34.01 2.73 Favored 'Cis proline' 0 C--N 1.372 1.778 0 CA-C-N 119.147 0.731 . . . . 0.0 112.88 -0.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -88.02 153.78 21.01 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.272 -179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.22 -167.32 14.65 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.77 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 30' ' ' GLY . 13.0 mm -133.19 153.92 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 22' ' ' THR . 88.1 m -86.83 98.37 11.16 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 120.893 0.378 . . . . 0.0 110.559 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -105.27 155.03 19.46 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.261 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -91.61 132.86 34.94 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.41 HD12 ' O ' ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.409 -0.805 . . . . 0.0 111.253 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.253 . . . . . . . 0 C--O 1.234 0.289 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.74 98.72 6.51 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.067 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.1 p -84.14 147.03 49.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.723 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 16' ' ' PRO . 57.8 Cg_endo -69.71 168.37 21.67 Favored 'Trans proline' 0 C--N 1.366 1.476 0 C-N-CA 123.428 2.752 . . . . 0.0 113.851 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.75 -157.53 13.1 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.691 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.512 ' OE1' HD11 ' A' ' 21' ' ' LEU . 32.9 tt0 -78.88 122.32 25.96 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.745 0.307 . . . . 0.0 111.031 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.44 33.17 8.18 Favored Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.599 -0.728 . . . . 0.0 113.104 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -130.77 166.64 20.36 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 122.473 0.309 . . . . 0.0 110.355 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -80.35 130.89 35.48 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.727 -179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.8 p -123.67 123.43 40.52 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.283 179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.46 156.39 17.63 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.525 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.4 m -85.29 15.69 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.181 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -98.93 -65.02 0.99 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.715 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.4 t80 -151.28 1.62 0.4 Allowed 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.57 73.75 11.39 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.5 Cg_endo -93.49 170.41 2.07 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.169 2.579 . . . . 0.0 111.851 177.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.64 119.6 24.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.461 -0.2 . . . . 0.0 110.461 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.627 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 25.7 p -84.95 -36.46 0.58 Allowed Pre-proline 0 CA--C 1.547 0.864 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.627 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.84 -179.84 5.65 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.585 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.09 62.57 0.31 Allowed 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.549 2.166 . . . . 0.0 114.006 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.38 44.34 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.267 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.58 159.81 19.21 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.71 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.46 104.52 16.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.985 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.7 mt -128.85 127.95 23.44 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.042 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.41 -51.14 0.16 OUTLIER 'Cis proline' 0 C--N 1.367 1.516 0 C-N-CA 124.232 -1.153 . . . . 0.0 113.69 -0.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.62 Favored Glycine 0 C--N 1.344 1.02 0 C-N-CA 121.436 -0.412 . . . . 0.0 113.226 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -140.16 81.1 18.86 Favored Pre-proline 0 CA--C 1.546 0.789 0 N-CA-C 111.547 0.203 . . . . 0.0 111.547 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.73 -33.78 2.77 Favored 'Cis proline' 0 C--N 1.373 1.83 0 C-N-CA 125.237 -0.735 . . . . 0.0 112.824 -0.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -87.91 153.61 21.17 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.229 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.43 -166.95 14.35 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.868 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.526 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.2 mm -133.12 153.95 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' THR . 83.4 m -87.09 99.0 11.6 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 120.834 0.349 . . . . 0.0 110.634 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -106.7 152.91 23.17 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.314 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.3 tt -94.32 134.14 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.784 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.5 pt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.271 -179.884 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PCA . . . . . . . . . . . . 0.255 . . . . . . . 0 C--O 1.235 0.291 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -116.74 98.14 6.36 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.307 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 25.2 p -84.53 147.0 48.37 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.764 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HB3' ' OE1' ' A' ' 8' ' ' GLU . 57.5 Cg_endo -69.71 168.66 20.86 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 123.355 2.704 . . . . 0.0 113.959 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -112.99 -157.57 12.87 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.702 178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.506 ' OE1' HD11 ' A' ' 21' ' ' LEU . 32.8 tt0 -78.94 122.36 26.05 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.747 0.308 . . . . 0.0 110.98 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.82 31.47 9.3 Favored Glycine 0 C--N 1.341 0.806 0 CA-C-N 115.661 -0.7 . . . . 0.0 113.041 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.484 ' OE1' ' HB3' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -129.19 164.82 22.58 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 122.524 0.329 . . . . 0.0 110.145 179.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -79.95 132.88 36.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.909 0.385 . . . . 0.0 111.672 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.3 p -124.69 124.56 42.45 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.291 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -102.71 156.41 17.66 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.55 16.63 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 115.492 -0.777 . . . . 0.0 112.13 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -99.93 -65.03 0.99 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.757 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.43 ' C ' ' HD3' ' A' ' 16' ' ' PRO . 3.5 t80 -151.14 1.59 0.41 Allowed 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 -178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -118.49 73.85 11.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.433 ' O ' ' HD2' ' A' ' 4' ' ' PRO . 10.6 Cg_endo -93.6 170.76 2.0 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 123.278 2.652 . . . . 0.0 111.924 177.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 m -81.92 119.76 24.35 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.626 ' SG ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 p -85.07 -36.35 0.57 Allowed Pre-proline 0 CA--C 1.547 0.847 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.626 ' HD3' ' SG ' ' A' ' 18' ' ' CYS . 2.9 Cg_endo -79.94 -179.81 5.61 Favored 'Trans proline' 0 C--N 1.379 2.151 0 C-N-CA 122.134 1.889 . . . . 0.0 111.436 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' O ' HD13 ' A' ' 21' ' ' LEU . 24.6 Cg_exo -65.03 62.55 0.3 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.52 2.146 . . . . 0.0 114.028 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD13 ' O ' ' A' ' 20' ' ' PRO . 2.6 mm? -134.81 158.43 44.22 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.238 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 32' ' ' CYS . 6.0 t -113.6 159.78 19.26 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.775 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 t -98.56 104.62 16.67 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.847 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 20.8 mt -128.8 128.15 23.47 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.975 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.32 -51.08 0.16 OUTLIER 'Cis proline' 0 C--N 1.368 1.593 0 C-N-CA 124.257 -1.143 . . . . 0.0 113.648 -0.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 83.6 33.99 20.6 Favored Glycine 0 C--N 1.343 0.95 0 C-N-CA 121.478 -0.392 . . . . 0.0 113.307 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -140.38 81.18 18.12 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 111.536 0.199 . . . . 0.0 111.536 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.71 -33.84 2.75 Favored 'Cis proline' 0 C--N 1.373 1.828 0 C-N-CA 125.251 -0.729 . . . . 0.0 112.77 -0.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -88.16 153.74 21.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.529 ' O ' HD13 ' A' ' 31' ' ' ILE . . . -151.3 -166.9 14.26 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.886 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' O ' ' A' ' 30' ' ' GLY . 12.0 mm -133.35 154.33 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 22' ' ' THR . 82.5 m -87.3 99.07 11.71 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 120.854 0.359 . . . . 0.0 110.562 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -106.73 155.56 19.56 Favored 'General case' 0 C--N 1.342 0.26 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.337 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.4 tt -92.27 132.94 35.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.705 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.411 ' OXT' HD12 ' A' ' 35' ' ' ILE . 1.6 pp . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.186 -0.911 . . . . 0.0 111.354 -179.919 . . . . . . . . 1 1 . 1 stop_ save_